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Retina is a unique site in the human body where the microcirculation can be imaged 
directly and non-invasively, allowing us to study in vivo the structure and pathology of 
the human microcirculation. Retinal images can be quantitatively assessed with 
computerized imaging techniques, enabling us to measure several different quantitative 
traits derived from the retinal vasculature. Arterial and venular calibres are the most 
extensively studied traits of the retinal microvasculature and numerous epidemiological 
studies demonstrated promising associations with systemic and ocular diseases as well 
as with disease markers. However, there has been a lack of research into 
pathophysiological processes leading to retinal vascular signs, and how they link retinal 
microcirculation with coronary and cerebral microvasculature change. Information about 
genetic determinants underlying retinal vascular structure is therefore important for 
understanding the processes leading to microvascular pathophysiology. Two genome 
wide association studies have been published so far revealing four loci associated with 
retinal venular calibre and one locus with arteriolar calibre. Here the results from the 
genome-wide association analysis of 10 different retinal vessel traits in two population 
based cohorts are presented. Retinal images were measured in non-mydriatic fundus 
images from 808 subjects in the Orkney Complex Disease Study (ORCADES) and 390 
subjects from the Croatian island of Korcula, using the semi-automated retinal 
vasculature measurement programme SIVA and VAMPIRE. Using pairwise estimates of 
kinship based on genomic sharing, heritability was calculated for each trait. Estimates of 
tortuosity measure and fractal dimensions present first published reports of heritability 
estimates for those traits. In addition correlation analysis with systemic risk factor was 
also completed, confirming already published results as well as revealing some new 
associations. A genome wide association analysis of retinal arteriolar width revealed a 
genome wide significant hit (1.8x10-7) in a region of chromosome 2q32 (within TTN 
gene). Replication was sought in a further independent Scottish population (LBC) and 
additional 400 retinal images were graded. The result did not replicate, however the 
direction of the effect was consistent and a larger sample size is required. Analysis of the 
remaining traits did not yield genome wide significant result,s and will also require 
larger sample sizes. 
Genetic analysis of a binary retinal trait was also explored in a case control study of 
retinal detachment, which is an important cause of vision loss. A two-stage genetic 
association discovery phase followed by a replication phase in a combined total of 2,833 
RRD cases and 7,871 controls was carried out. None of the SNPs tested in the discovery 
phase reached the threshold for association. Further testing was carried out in 
independent case-control series from London (846 cases) and Croatia (120 cases). The 
combined meta-analysis identified one association reaching genome-wide significance 
for rs267738 (OR=1.29, p=2.11x10-8), a missense coding SNP and eQTL for CERS2 
encoding the protein ceramide synthase 2. Additional genetic risk score, pathway 





The following publication has resulted from the work involved in genetic analysis of 
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Chapter 1. Introduction 
 
The purpose of this thesis was to examine and possibly decipher the genetic basis of 
quantitative retinal vasculature parameters using unselected population samples and of a 
binary trait, retinal detachment in a case-control study. Various analysis processes were 
included in this study. Analysis of quantitative vascular traits involved phenotypic data 
collection using semi-automated software for analysis of retinal microvasculature. In 
total 1593  retinal vessel images were graded and seventeen retinal microvascular 
phenotypes were derived and analysed for correlation with cardiovascular biomarkers, 
estimation of heritability, genetic correlation and genome wide association studies 
(GWAS). Analysis of a binary trait (rhegmatogenous retinal detachment) was a 
continuation of an on-going population-based epidemiology study of rhegmatogenous 
retinal detachment in Scotland. This part of the thesis involved different aspects of 
genetic analysis, from the selection and genotyping of genetic markers, data imputation, 
to genetic association analysis in a case control design and downstream pathway 
analysis. This chapter presents the background and the overview on the retina and retinal 
microvasculature, and its abnormalities.  The pathology of rhegmatogenous retinal 
detachment is also presented, as well as the background on the genetic architecture of 













1.1. Overview of the retinal anatomy and physiology 
 
1.1.2. Anatomy and physiology of the eye 
 
1.1.2.1 The eye (Bulbus oculi) 
 
The eye of an adult is spherical organ and is approximately 25 mm in diameter. The 
interior of the eye is separated by the lens into two main cavities (anterior and posterior 
cavity). The anterior cavity is subdivided by the iris in two chambers (anterior and 
posterior chamber). Those two chambers connect through the pupil and are filled with a 
watery fluid (aqueous humour, the daily production of which maintains an internal eye 
pressure). Behind the lens is the posterior cavity filled with a transparent jellylike 
vitreous humour (which also contributes to the internal eye pressure to maintain the 
shape of the eyeball). Unlike aqueous humour, vitreous humour is not produced daily, 
but formed prenatally.  The wall of the eye consists of three basic layers (fibrous tunic, 
vascular tunic, internal tunic-retina). The fibrous tunic is the outer layer of the eye and is 
divided into sclera (the white of the eye) and cornea (convex shaped to refract incoming 
light). The sclera is a protective outer layer of the eye and it maintains the shape of the 
eye. The cornea is transparent and allows light to enter the eye.  The vascular tunic 
consists of the choroid, the ciliary body and the iris. The choroid contains the blood 
vessels that provide nourishment to the outer layers of the retina. The iris is the part of 
the eye that gives its colour. It consists of muscular tissue that responds to surrounding 
light. Light enters the pupil, falls onto the lens of the eye where it is altered before 
passing through to the retina. The lens is a transparent, biconvex structure and its 
function is to refract and focus incoming light onto the retina, where the light reaches 
photoreceptors and is transformed into neural impulses. The internal tunic of the eye or 






Figure 1.1. Anatomical diagram of human eye (from Encyclopaedia Britannica) 
 
 
1.1.2.2. Retina  
 
The retina consists of two layers, the outer pigmented layer and inner nervous layer or 
visual portion. The nervous layer is composed of three layers of neurons; rod and cone 
cells, bipolar neurons and ganglion neurons. Light first passes the layer of ganglion 
cells, then the bipolar cells and then stimulates the photoreceptor cells (rods and cones). 
Rods are longer and thinner and they respond to dim light to provide black and white 
vision. Cones are less sensitive to light and they provide colour vision and greater visual 
acuity. Cones are concentrated in a depression near the centre of the retina called the 
fovea centralis (the area of keenest vision). The macula lutea surrounds the fovea 
centralis and also contains an abundance of cones. There are no photoreceptors where 
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the optic nerve is attached to the eye. This area is called the blind spot and is usually 
referred to as the optic disc. The retina is considered part of the central nervous 
system (CNS). Embryologically, it is formed from the optic cup, an outpouching of the 
neural tube.  It is connected with the brain through a bundle of fibres (the optic nerve) 
and is the only part of the CNS that can be visualised non-invasively (Zigmond et al. 
1999, Taarnhoj 2008, van de Graaff et al. 1997).  
  
 
             
     a)                                                                    b)                                                                
Figure1. 2 a) Cross-sectional view of the human eye (form science.nasa.gov); b) Retinal fundus image 
from ORCADES  
 
 
1.1.2.3. Anatomy and physiology of the retinal vascular system 
 
There are two different arterial systems that supply, abundantly, the retina with blood. 
The choroidal circulation supplies the outer third of the retina and the branches from the 
central retinal vessels that supply the inner two thirds of the retina. The central retinal 
artery and vein branch from the ophthalmic artery and vein and they pierce the optic 
nerve and come to the retina through the gap in the lamina cribrosa. Both the retinal 
artery and vein branch into four major vessels. Each of the four major retinal artery 
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branches supplies one quadrant of the retina. The only part of the retina that is not 
supplied by the retinal artery is the fovea, which is a capillary free zone in order to allow 
light to pass through. The fovea is supplied by choriocapillaries. The perfusion pressure 
of the ocular circulation is related to both systemic blood pressure and intraocular 
pressure. For the retinal circulation to regulate blood flow over a range of different 
systemic blood pressures, its vascular resistance has to adapt to it. This alteration of the 
vascular resistance is regulated by vascular smooth muscles and pericytes (connective 
tissue cells that occur in small blood vessels) (Taarnhoj et al. 2008, Zhang, 1994, 
Henkind et al. 1979, Patton et al. 2005). 
 
Retinal blood pressure is regulated by the combination of myogenic (smooth muscle 
reaction) and metabolic mechanisms. Metabolic mechanisms act in way to increase 
blood pressure in areas of increased metabolic activity, especially under the conditions 
of light exposure (Yu et al. 2007). The vascular endothelium cells and the neural and 
glial cells are mainly involved in the regulation of retinal blood pressure. Nitric oxide 
(NO) play a vital role in dilation of retinal vessels when flickering light is projected onto 
the retina. Myogenic mechanisms are defined as the contraction of vascular smooth 
muscle cells and pericytes in response to transmural pressure (difference in pressure 
between two sides of a wall) (Ursino, 1991). However, a big increase in systemic blood 
pressure and intraocular pressure can overcome these auto regulatory mechanisms 
causing the retinal blood flow to increase (Robinson et al. 1986).  
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Figure 1.3. Vascular system supplying the retina. CRA –central retinal artery; CRV – central retinal vein; 
SAS –subarachnoid space;  PCA- posterior ciliary artery;  PR –prelaminar region; LC-lamina cribrosa. 
Modified from Hayreh, (1974). 
 
 
1.1.2.4. Anatomy of the optic disc and cup 
 
The optic disc is the location where ganglion cell axons exit the eye to form the optic 
nerve. The diameter of the optic nerve is 1.62mm, made up of about 1 million nerve 
fibres that form the optic disc. In this area of the eye there are no light sensitive rods or 
cones and therefore no response to light stimuli. It is place 3 to 4 mm to nasal side of the 
fovea. The optic cup is the white, cup-like area in the centre of the optic disc. The cup is 
really an empty space in the middle of the optic nerve surrounded by optic nerve 
fibres. The physiologic cup size varies from less that 0.1 to 0.9 of the total disc diameter 
and the average cup to disc ratio is about 0.3.  The larger the cup, the larger the scleral 
opening at the back of the globe.  The space between the cup and the edge of the disc is 
the neuro-retinal rim. The area around the disc is called the peri-papillary disc area. 







Figure 1.4.  Retinal fundus image displays of optic disc and cup (Orkney image). 
 
 
1.2. Retinal microvascular changes in response to stress and 
disease 
 
Most changes to the retinal microvasculature are caused by hemodynamic changes, 
oxygen saturation and metabolic changes associated with elevated blood pressure, 
diabetes mellitus and old age. Persistent elevated blood pressure results in increased 
peripheral vascular resistance, which is a result of protective vasoconstriction of 
arterioles. Increased arteriolar intraluminal pressure leads to narrowing of the vessel 
through stretch-activated calcium channels (Muraki et al. 2003). This narrowing of the 
arterioles is seen best in vessels where sclerotic changes did not start and the vessel most 
affected are the precapillary arterioles (Garner et al. 1975). Persistent hypertension (and 
diabetes mellitus) can lead to arteriosclerotic changes to the small vessels, that include 
intimal thickening, hyperplasia of the tunica media and hyaline degeneration of the 
arteriolar wall (the general architecture of blood vessels is similar across the human 
vasculature and is given in Figure 1.5.). Arteriosclerotic changes also occur in a normal 
aging population. Long term hypertension can lead to degeneration of vascular smooth 
muscle and endothelial cell necrosis, along with narrowing of the arteriolar lumen and 





Figure 1.5. Schematic image of different layers of blood vessels (taken from Wikipedia). Both arteries 
and venes have three different layers. Tunic intima (layer of endothelial cells surrounded by the 
connective tissue), tunica media (may be rich in vascular smooth muscle (arteries), which control the 
caliber of the vessel) and tunica adventitia (outer layer made of connective tissue).  
  
 
The retina adapts to variations in oxygen saturation, especially to oxygen requirements 
of photoreceptors.  Hypoxia has a profound effect on retinal microvasculature as its 
chronic form leads to an increase in Hypoxia-inducible factor (HIF)-1alpha, which in 
turn induces the up-regulation of molecules such as endothelin-1 (ET-1) and vascular 
endothelial growth factor (VEGF). These molecules can induce neovascularisation, 
weakening of the blood–retina barrier, and vasoconstriction of veins.  
 
Type 1 and Type 2 diabetes mellitus patients present retinal microvascular changes, as a 
result of several metabolic stresses (elevated blood glucose levels, dyslipidaemia) and 
hypertension. Increased blood flow and lack of auto-regulation (myogenic and 
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metabolic) are the main features of diabetic retinopathy. In addition to these 
haemodynamic abnormalities, increased capillary and venular pressure and diameters, 
thickening of the basement membrane and loss of perycites are observed. A combination 
of these abnormalities leads to chronic hypoxia.  
 
Retinal arterial and venous narrowing have also been reported to be associated with 
open-angle glaucoma in the Blue Mountain Eye Study (Mitchell et al. 2005), although 





1.2.1. Retinal vessel microvasculature and cardiovascular disease 
 
Since retinal vasculature is thought to characterise the vascular system elsewhere in the 
body and it is the only part of the human vasculature that can be visualised non-
invasively in vivo in humans, retinal imaging has developed into a very commonly used 
and accessible way of studying vascular traits. Retinal vasculature is thought to share the 
same physiological and anatomical characteristics as cerebral and coronary vascular 
systems (Goto et al.1972). The main hypothesis in retinal microvascular research is that 
retinal vessels parallel pathological processes occurring in coronary microvessels and 
can represent processes occurring there, since they are approximately the same scale as 
coronary microvasculature (~100-250μm in diameter). There is some evidence that 
retinal microcirculation changes do parallel pathophysiological changes in the coronary 
micro and macro circulation. Narrowing of the retinal arterioles have been reported to be 
associated with coronary artery disease diagnosed by angiography (coronary artery 
occlusion) (Michelson et al. 1979, Tedeschi-Reiner et al. 2005) although, these studies 
did not use a quantitative measure of vessel width, and included a very small number of 
subjects (respectively N=70and, N=109.). In addition a study using MESA (multi ethnic 
study of atherosclerosis) cohort found association between retinal arteriolar narrowing 
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and retinopathy with MRI findings suggestive of left ventricular remodelling (Cheung et 
al. 2007). Recent studies using large population-based cohorts and quantitative vessel 
calibre measurements have found significant associations between retinal microvascular 
changes and incident coronary disease or cardiovascular death (Wong et al. 2002, Witt et 
al. 2006, Wong et al 2006, Wang et al. 2006, Cheung et al. 2007). The ARIC study 
(atherosclerosis risk in community study) found a two-fold increased risk of incident 
heart failure in all persons with signs of retinopathy, however no significant relationship 
between retinal arteriolar narrowing was found (Wong et al. 2005). Similarly no 
association was found between increased coronary artery calcium score and vessel 
calibre (Wong et al. 2008). There is also evidence of alterations in retinal 
microvasculature in patients that suffered lacunar stroke (Schneinder et al. 1993). 
Despite that some evidence exists supporting the hypothesis that retinal microvascular 
changes give insight into coronary microcirculation, the extent to which it represents 
microvasculature changes elsewhere in the body still remains unclear. Direct post 
mortem histopathological evidence is still needed in order to confirm this homology.  
 
The important question in microvascular research is whether these changes are the 
consequences of the systemic vascular disease or if they play a part in its development, 
or both. It has been proposed that changes in renal microvasculature (decrease in 
arteriolar calibre) occur in the early stages of essential hypertension (Norrelund et al. 
1994). A few prospective studies have presented evidence that narrowing of the 
arteriolar calibre precedes the development of hypertension (Wong et al. 2004, Wong et 
al. 2004, Ikram et al. 2006), supporting the hypothesis that it may be an integral part in 
the development of cardiovascular disease.  
 
Vascular architecture develops in a way that optimises the efficacy of blood flow, as 
theoretical and experimental evidence suggest, and deviation from this optimality occurs 
in pathological processes (Zamir, 1976). Retinal microvascular parameter that can 
10 
 
contribute to this blood flow optimality (tortuosity, branching angles, fractal dimensions 
- a measure of the general complexity of microvasculature) should also help in 
understanding the changes that occur in microvasculature during cardiovascular disease. 
However these measurements have not been studied as extensively as vessel calibres, 
due to the unavailability of more automated measurements. Progress in the field of 
computerised imaging software enabled more accurate and reproducible measurements 
of these quantitative retinal vessel traits.  New softwares are now available, and will 
allow inclusion of these geometrical parameters of retinal vasculature in the explaining 
the pathological changes of the microvasculature. 
 
Quantitative retinal vessel characteristics have been measured in several epidemiological 
studies so far and demonstrated promising associations with systemic and ocular 
diseases as well as with disease markers (more detailed description given in Chapter 5). 
All the associations found so far account for a small proportion of variation in retinal 
vessel morphology. There is therefore scope for studying more traits describing retinal 
architecture. In particular, the extent of genetic research in the area of retinal 
microcirculation has been limited. Epidemiological studies have focused primarily on 
the associations of retinal vessel characteristics and systemic risk factors, and only a few 
of them explored the heritability of some of the possible retinal vessel traits. 
Determining the genetic basis of these traits could give us more insight into the 










1.3. Genetic analysis of retinal microvasculature 
 
The identification of genetic factors influencing common diseases such as 
cardiovascular and metabolic diseases is a major goal in medicine today. Identification 
of susceptibility variants often gives new insights into disease pathways and can help in 
identifying factors contributing to the earlier and more rapid development of the disease. 
It can also help in the development of genetic risk profiling either alongside or in place 
of traditional risk prediction using conventional risk factors. Revolutions in genetic 
technology, deriving originally from the human genome project have driven the 
discovery of over 2000 gene-disease or disease-trait associations (Hindorff et al. 2009). 
An understudied, but important area of inquiry is the retina, since its vasculature is 
thought to share the same physiological and anatomical characteristics as the cerebral 
and coronary vascular systems (Goto et al. 1975). 
 
Only a few studies so far have investigated the contribution of genetic factors to the 
morphology of retinal blood vessels. Lee et al. (2004) reported the first study about 
familial aggregation of quantitative retinal vessel traits. They reported a high correlation 
of retinal vessel calibres (CRAE –central retinal arterial equivalent, CRVE - central 
retinal arterial equivalent, AVR –arteriolar to venular diameter ratio) between relatives 
(more highly correlated than between unrelated individuals). Taarnhoj et al. (2006) 
reported heritabilities of 70% for CRAE, 61% for CRVE and 82% for tortuosity in a 
very small numbers - 55 monozygotic and 50 dizygotic same sex healthy individuals. 
Two studies have reported results of the linkage analysis of quantitative traits of retinal 
vessel (Xing et al. 2006, Sun et al.2009).  Xing et al. reported both specific and common 
signals for CRAE and CRVE (common signals in 3 regions and 7 specific regions for 
both CRAE and CRVE). The Australian Twins Eye study reported two multipoint peaks 
on chromosome 3p12.3 and 8p23.1 for CRAE, and two suggestive logarithm odds score 
for CRVE (on 2p14 and 9q21.13).  Finally, two large scale genome wide meta-analyses 
have reported genetic association between retinal arteriolar and venular calibres. Sim et 
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al. (2013) reported one marker significantly associated with CRAE on chromosome 5. 
There was no overlap between linkage studies and GWAS results, however both studies 
reported regions common to both retinal arteriolar and venular calibres (Ikram et. al 
2010, Sim et al. 2013). Four markers were reported to be associated with venular calibre 




1.4. Retinal detachment  
 
Retinal detachment is a condition in which the neurosensory retina separates from the 
underlying retinal pigment epithelium causing accumulation of the fluid in this space. 
The pigmented layer is attached to the choroid (highly vascular layer) and therefore 
retinal detachment leaves the neurosensory retina deprived of oxygen. The longer the 
separation lasts, the greater the risk of permanent vision loss in the affected eye. Retinal 
detachment can be separated into four types depending on the underlying causes (Ghazi 
and Green, 2002), but all types have in common the accumulation of subretinal fluid. 
Rhegmatogenous retinal detachment occurs due to a hole, tear, or break in the retina that 
allows fluid to pass from the vitreous space into the subretinal space between the 
sensory retina and the retinal pigment epithelium. Exudative retinal detachment occurs 
due to inflammation, injury or vascular abnormalities that results in fluid accumulating 
underneath the retina without the presence of a hole, tear, or break. Tractional retinal 
detachment occurs when fibrovascular tissue, caused by an injury, inflammation or 
neovascularization, pulls the sensory retina from the retinal pigment epithelium. The 
fourth type is combined traction-rhegmatogenous. Predisposing factors for retinal 
detachment are vitreoretinal adhesions in association with posterior vitreous detachment, 
local ocular diseases such as retinoschisis and myopia, cataract surgery, trauma, and 
most of the hyaloideoretinopathies. Most of these risk factors are predisposing to RRD 
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because of the high incidence of associated vitreous detachment and retinal breaks 
(Ghazi and Green, 2002).  
 
 Figure 1.5. Schematic image of retinal detachment (from Encyclopaedia Britannica, 2010). 
 
The vitreous is attached to the retina through a vitreous base, and the layer between 
vitreous and neural retinal is called the inner limiting membrane (ILM). ILM is a typical 
basement membrane and has a role in the adhesion of the vitreo-retinal border to the 
Muller cell (glial cell that provide support to the retinal neurons; they also channell light 
to the photoreceptor cell in the retina). The vitreous is comprised of collagen fibrils and 
glycoaminoglycans, and is supported by hyaluronic acid molecules. With aging the 
vitreous may collapse and liquify, due to the reduction in hyaluronic acid which causes 
loss of support to the collagen, resulting in detachment. As vitreous detachment occurs 
peripherally, areas of vitreoretinal adhesion can result in a tear in the sensory retina 
which can allow liquid vitreous to enter the potential subretinal space, resulting in a 
rhegmatogenous retinal detachment. However not all PVD lead to retinal tears. It occurs 
more often in myopic eyes, which have more pronounced vitreous liquefaction. Retinal 
break is important in formation of RRD, however most eyes with breaks do not develop 
14 
 
RRD as vitreoretinal traction is also needed to keep the break open. As described above, 
the separation of the neural retina from the underlying retinal pigment following a retinal 
tear, leaves the neurosensory retina deprived of oxygen and nutrients. The adhesion 
between the NSR and retinal pigment epithelium is relatively weak, since no junctional 
attachments exist between these two layers (Steinberg et al. 1974).  The adhesion is 
maintained by the physical interconnection of the RPE cells’ apical microvilli with the 
outer segments of NSR, mechanical support of the interphotoreceptor matrix, and 
through the net fluid transport from retina to choroid. Once these forces are 
overwhelmed, the interphotoreceptor space expands allowing for the fluid to accumulate 
and retinal detachment to occur. The exact mechanisms involved in this complex and 




1.4.1. Rhegmatogenous retinal detachment 
 
Rhegmatogenous retinal detachment (RRD) is a major cause of severe vision loss. 
Despite surgical advances it accounts for up to 4% of the blind and partial sight 
registrations in Ireland (Munier et al. 1998). On average the annual incidence of RRD is 
10-20 cases in 100,000 individulas (Mitry et al. 2010), with big differences between 
races (Wong et al. 1999, Mowat et al. 2003, Peters et al. 1995). The rate of RRD is 
reported to be higher in elderly patients (Haimann et al. 1982, Wong et al. 1999,  Sasaki 
et al. 1995) and in men compared to women (Algvere et al. 1999, Ivanisevic et al. 2000, 
Polkinghorne et al. 2004, Mowat et al. 2003). Other risk factors for rhegmatogenous 
retinal detachment include high myopia, lattice degeneration, trauma and previous 
cataract surgery. Up to 10% of RRD cases will also develop retinal detachment or 




1.4.1.1. Genetic predisposition to RRD 
 
Evidence of the genetic predisposition to RRD comes from a number of inherited 
disorders (with known causal genetic variants) which are associated with RRD and with 
familial aggregation studies reporting familial incidence of non-syndromic RRD (Mitry 
et al. 2011). Familial aggregation studies reported increased risk in the relatives of RRD 
patients. Siblings of patients with RRD presented two to three time higher frequency of 
the disease than the general population (Go et al. 2005, Mitry et al. 2011). However 
these studies used a relatively small number of sibships (N=501, Mitry et al 2011, 
N=181 Go et al. 2005). RRD has previously been reported to occur as a dominantly 
inherited trait (Richards et al. 2005, Go et al. 2003), but some of the cases had minimal 
systemic characteristic of Stickler syndrome and linkage analysis mapped the disease 
region to the COL2A1 gene (linked to Stickler’s syndrome) leaving the distinction 
between the two conditions uncertain (given the high variability of the phenotype of the 
syndrome). Very little is known about the genes underlying non-syndromic RRD in 
general population and no previous study has investigated common genetic variants 
associated with non-syndromic RRD.  
 
 
1.5. Genetic architecture of complex disease   
 
Explaining the heritable component of many complex diseases is one major avenue in 
biomedical research today to better understand their etiologies. Complex traits and 
disease are believed to result from the interplay of multiple susceptibility genetic 
variants and environmental factors. Genetic basis for common and complex diseases has 
been supported by evidence of familial clustering and family history in the diagnosis of 
such diseases. Finding genes influencing common late-onset human disease is important 
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for a number of reasons. The ultimate goal is to translate these findings into public 
health benefits and improvements in clinical decision making and disease management.  
 
 
1.5.1. Genetic analyses of complex traits 
 
Associations between complex disease and genotypes can be studied by genotyping 
candidate genes with a prior hypothesis of being in disease pathways, or agnostically by 
testing associations with genetic variants capturing a large part of the genome variations 
as facilitated by the amount of linkage disequilibrium in the human genome (linkage or 
association studies). Candidate gene studies presented very little success in identifying 
genes underlying complex diseases, mainly because of the incomplete knowledge of 
disease pathways and assumption involved in the design of these types of studies. 
 
Linkage and genome wide association studies have the advantage of no a priori 
hypothesis regarding biology of the disease. Linkage studies necessitate large pedigrees 
of individuals who are measured for the trait or disease, and are aimed at identifying 
regions of the genome that segregate with disease. The regions identified through 
linkage analysis tend to be very large (millions of base pairs). This type of analysis has 
not been very successful for complex traits since its power is in detecting variants that , 
singly or as a group of closely linked markers, account for large proportion of the 
phenotypic variance (large effect) and high penetrance, a non-common scenario for 
complex trait (Risch and Merikangas 1996). There were simply very few such loci to be 
found, linkage studies did not have the power to identify loci of smaller effect. 
 
Association analysis that test association between trait variation and genotypes of large 
numbers of genetic markers in a large sample of individuals, under the assumption that 
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individuals with similar phenotypes share an excess of the same risk variants are better 
suited for the dissection of complex traits. It represents a population-based alternative 
mapping approach to linkage analysis and is well powered for mapping of common 
variants (minor allele frequency, MAF > 0.05) of small effect size if large sample size 
can be assembled (Risch and Merikangas 1996). The principle is based on the sharing of 
a small genomic region identical by descent between distantly related individuals. These 
blocks descend from the same ancestral chromosome and over successive generations 
recombination reduces the portions of DNA passed on the successive generation which 
are identical to the original ancestral segment of DNA. These shared DNA regions are 
broken down to small blocks of a few tens to hundreds of kilobases and genetic loci 
within DNA blocks are described as being in linkage disequilibrium (LD) within a 
population. LD occurs due to recombination and is a description of the non-random 
association of alleles from two or more loci on the same chromosome. The extent of LD 
between two loci is calculated by checking how often the same alleles at these loci occur 
together compared to what would be expected by chance, given their allele frequencies. 
Haplotypes are blocks of alleles at neighboring loci that are inherited together, and 
therefore a smaller set of alleles can represent the entire haplotype block. This is the 
principle of tagging markers, which represent haplotype blocks, and other alleles within 
the block, throughout human genome. By carefully choosing tagging markers number of 
these markers needed to represent the whole genome is radically reduced, at least for the 
common variants coverage. Single nucleotide polymorphisms (SNPs) are the markers 
used in the whole genome association studies.  A SNP is a DNA sequence variation and 
occurs when a single nucleotide may take the form of either of two or more bases (A, T, 
C, G). SNPs are usually bi-allelic and there are thought to be about 30-50 million 
common SNPs in the human genome. Mutation rate of single base substitution is 
approximately 1.3x10-8 per site per generation (Manolio et al. 2008), and the chance of 
reversal of mutation is very low, which makes them heritable. However, their 
frequencies can be the result of ancestral founder effects and can be very different 




Regions identified through linkage studies are typically 5–10 Mb in size (containing tens 
to hundreds of genes), while association studies are able to define quantitative trait or 




1.5.1. Genome wide association analysis (GWAS) 
 
The basic principle behind genome wide association studies is that a marker located 
within the same haplotype as the causal variant should also be associated with a trait of 
interest. And by testing numerous tagging SNPs throughout the genome, haplotypes 
containing the causal variants will be identified. Identification of the tagging SNPs 
became possible after the release of the international HapMap Project (HapMap 
consortium 2005) which revealed a haplotype map of the human genome. Technology 
which enabled GWAS is a high-throughput method of hybridization of DNA in order to 
identify polymorphisms at specific nucleotides over the entire genome. This gene-chip 
technology allows for simultaneous genotyping of hundreds of thousands to millions of 
SNPs. Gene chips have oligonucleotide probes attached to a solid base and are used to 
hybridize a target sequences containing the SNP of interest. DNA is firstly fragmented 
and fluorescently labelled in order to generate a signal that depends on the hybridization 
conditions. The strength of the fluorescent signal is determined by the 
sequence/polymorphism at that site. Fluorescent signal intensities are then analysed and 
converted into a genotype.  
 
As mentioned before GWAS test the correlation between allele counts throughout the 
genome and phenotypes. One of the most important steps in the analysis is accurate 
phenotype definition, disease or trait, since phenotypic heterogeneity can reduce power 
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(Ioannidis et al. 2009). The statistical power of GWAS depends on sample size, effect 
size of the causal allele, its allele frequency, and how well it is captured by the panel of 
markers tested i.e. the correlation between marker and causal variants (Stranger et al. 
2011). Therefore large sample sizes are needed to detect moderate to small effect sizes, 
and joint meta-analysis of multiple populations have been proven the best way to detect 
variants of moderate effect sizes in GWAS. One of the major issues in GWAS is the 
multiple testing, given the vast number of tests performed and resulting Type I error. A 
conservative Bonferroni correction is used; for genotyped SNPs the most used threshold 
has been the value set by the Wellcome Trust Case Control Consortium of 5 × 10-
7 (WTCCC, 2007). For analysis of imputed data the general consensus is to correct for 
the number of independent SNPs in non-African population (estimated at a million 
independent variants); p=5x10-8 (Hoggart et al. 2008, Pe’er et al. 2008).  However, by 
controlling for Type 1 errors we may inflate Type 2 errors, particularly in the analyses 
with low power (small sample sizes, low frequency alleles, genetic factors with small 
effect sizes). This is usually overcome by inclusion of large sample, however due to 
various restrictions in practice this is not always possible. These issues are major 
considerations both for designing GWAS and interpreting GWAS results. 
There are two main GWAS study designs, case-control and quantitative trait analyses. 
Quantitative trait studies are easier to set-up (as aiming at explaining the natural 
variation in the trait it requires sampling cross-population) and allow to study a deep 
array of phenotypes in the same study. As some quantitative traits are strong predictors 
of disease and are considered to be intermediate phenotypes (endophenotypes) of more 
complex disease (e.g. HDL levels for cardiovascular disease), they can often be used to 
identify genes underlying the correlated disease. A big advantage of a quantitative trait 
over complex disease end-points is that they are less complex in nature. Since 
endophenotypes have fewer sources of variation than complex diseases, a process of 
identifying the variation underlying them will be simpler and have more statistical 
power. In addition many quantitative phenotypes are easier to define and measure, 
which is not the case with complex disease which often encompasses heterogeneous 
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conditions. By identifying risk variants underlying intermediate traits, new insights into 
the pathogenesis of complex diseases may be exposed.  However some diseases do not 
have well characterized endophenotypes and testing is performed on a qualitative trait 
(affected, not affected). In this scenario it is of great importance to correctly identify 
affected individuals, as well as selecting matched unaffected controls.  
 
Once genome wide significant results are detected they should be validated though 
replication in an independent set of subjects. The replication sample should be of 
sufficient sample size in order to detect the effect of the allele. However, since initial 
GWAS usually suffer from the effect of “winners curse”, the sample sizes should 
generally be larger in order to account for the over-estimation of the effect sizes.  It is 
also of great importance to use the same phenotype inclusion criteria as for the original 
GWAS population. In order for a marker to be replicated besides the significant p-value, 
it should also report the same direction and ideally size of the effect across all 
populations tested. 
 
SNPs identified in GWAS are unlikely to be the causal variants influencing a particular 
phenotype. Due to the LD pattern and selection of tagging SNPs, it is in most cases in 
high LD with the variant influencing a trait (Figure 1.6). In this case further work 
involving sequencing and possible functional work is needed in order to elucidate the 
real causal variant.  The final goal of GWAS is to identify this causal variant and to 
characterize the functional effects.  This involves fine mapping of an associated locus, 
followed by deep resequencing of the associated region which reveals possible 
functional variant. This is then followed by different bioinformatic and genomic 
methods in order to select variants for experimental studies to reveal the functional 






Figure 1.6. SNPs identified in GWAS are usually not the causal variants underlying a particular 
phenotype. Due to the LD pattern and selection of tagging SNPs, it is in most cases in high LD with the 





1.5.2. GWAS design achievements 
 
Genome wide association studies in recent years, in which hundreds of thousands to 
millions of genetic markers (SNPs- single nucleotide polymorphisms) are genotyped in 
typically tens of thousands of individuals have helped to find over a thousand of 
common genetic variants associated with such diseases and endophenotypes. These 
studies helped to gain new insights into the pathogenesis of complex human diseases and 
the underlying genetic architecture, and have identified around 2000 genotype-
phenotype associations with 300 different complex diseases and traits in around 1600 
publications since 2005 (Manolio et al. 2013).  The main driving force behind GWAS 
was the common disease/common variant (CD/CV) hypothesis (Lander, 1996), which 
suggested that small number of genetic variants, which occur commonly in the 
population (>5% of the population; Reich and Lander, 2001) can account for the genetic 
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variance of many common diseases. Another reason why GWAS become the focal point 
of genetic research in the last few years was the development and drop in price of off-
the-shelf commercial SNP arrays represent most of the common variation in the genome. 
Although GWAS helped to access some of the genetic architecture of common disease, 
most of the variants discovered explained only a small portion of the heritability of these 
diseases, even when as many as 40-60 variants affecting a trait have been identified 
(Voight et al. 2010, Morris et al. 2012, Scott et al. 2012), and raised a question of the so-
called “missing herritability“ problem. Identifying the sources of missing herritability 
still remains unresolved and the contribution of rare (<1% minor allele frequency; 
MAF), and  low frequency (1-5% MAF) variants not known. Many reasons explaining 
missing heritability has been proposed (Manolio et al. 2009), and since then three major 
causes contributing to genetic component have been recognised; a large number of small 
effects common variants across the allele frequency spectrum (the infinitesimal model), 
a large number of large effects rare variants (the rare allele model) and combination of 
genotypic, environmental and epigenetic interactions (broad sense heritability model) 
(Gibson, 2012).  
 
Empirically there is evidence that both common and rare variants play a role in the 
genetic architecture of complex diseases. As it was previously mentioned, around 1500 
significant associations with around 300 traits have been listed in the US National 
Human Genome Resources Institute GWAS catalogue. Also re-sequencing efforts of 
regions identified through GWAS have presented coding mutations conferring increases 








1.5.3. Isolated populations and GWAS 
 
The use of isolated population in genetic research has a long history in genetic mapping 
studies. They represent small, geographically (or culturally) isolated populations, 
removed from the migration processes, which in turn results in endogamy.  Such 
populations have higher levels of background inbreeding as a result of cryptic 
relatedness. This results in differences in allele frequencies from the more cosmopolitan 
populations due to both random genetic drift and the increased levels of homozygosity 
(McQuillan et al. 2009). Increased levels of homozygosity amplify the probability that a 
rare allele will be homozygous, increasing somewhat the chances of finding them. 
 
Easier detection of variants underlying complex traits also come from the founding 
effects and population bottlenecks that are typical for isolated populations. These effects 
accentuate the effect of genetic drift or natural selection and in turn lead to reduced 
genetic heterogeneity (multiple alleles influencing a trait). Some allele will be removed 
and some polymorphic alleles will be fixed (Pardo et al. 2005), resulting in smaller 
number of risk variants when compared to more heterogeneous populations.  
 
As a result of population bottlenecks and low effective population size over time, which 
is characteristic for isolated populations, a higher degree of linkage disequilibrium is 
observed. Consequently, coverage achieved with a tagging SNP will be greater in 
isolated populations and more reliable than in heterogeneous populations (where there is 
a greater allelic diversity of associated alleles).  
 
Finally, isolated populations have the advantage of reduced environmental variance, 
which should result in the increase proportion of genetic variance in the total phenotypic 
variation of a trait in question.    
 
Two isolated populations were used in this thesis for the analysis of quantitative retinal 
vessel traits; ORCADES and CROATIA-Korcula studies. Orkney is an archipelago in 
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northern Scotland and The Orkney Complex Disease Study (ORCADES) is an on-going 
family-based study which aims to identify common and rare genetic variants influencing 
the risk factors for common complex disease important in Scotland. In total 889 
genotyped individuals were available for the genetic analysis. The island of Korcula is 
located in the southern Croatian coastal region of Dalmatia. A total of 944 subjects were 
included in this study and most underwent complete eye examination (898 subjects 
available for genetic analysis). Family history data and pedigrees were available for 
ORCADES subjects, but not for Korcula. Both of these cohorts have been densely 
phenotyped and used for many GWAS and GWAMA (genome wide association meta-
analysis) studies. Largely, the common variants found by published GWAS were 


























The aims of this thesis were: 
1) to generate retinal microvasculature quantitative measures derived from fundus 
photographies available from the ORCADES and CROATIA-Korcula studies, test the 
strength of their correlation with systemic cardiovascular measures available, and 
analyse the genetic component of their variations using appropriate methods 
2) to perform genetic analysis on a binary retinal trait, rhegmatogenous retinal 
detachment,  using a case control study 
 
This second aim was added after my first year report as analysis of fundus photographs 
turned out to be a laborious and slow process and statistical analyses would not be 
possible before reaching sufficient number of reliable measures. This thus provided an 
opportunity to learn genetic association analysis, in a case control design. This was a 
continuation of an existing epidemiological and genetic study, and represented the first 
genome wide association study of this syndrome. The aim was to quantify the extent of 














1.6.2. Objectives  
 
Objectives of this thesis were as follows: 
 
For the retinal detachment in a case control study:  
a. Select markers for the second stage (i.e. follow up stage) of the genome-wide 
association study 
b. Test for genetic association for these markers in independent case-control 
sets and in all of the discovery sets combined 
c. Select best markers for replication (or follow-up if no significant results in 
discovery step revealed) and test for genetic association 
d. Quantify how much of the polygenic component underlying RRD disease 
liability can be accounted for by the combined common variants tested 
globally, i.e. whether reaching individual level of significance or not 
   
 
For the genetic analysis of quantitative retinal vasculature parameters; retinal vascular 
traits describing vessel calibres, vessel curvature and general complexity of the 
microvascular network (fractal dimensions). 
a. Assess methodologies available-Measure retinal microvasculature traits and  
    assess quality of measures   
b. Basic statistics on traits collected- and correlations with available  
   cardiovascular traits 
c. Calculate heritabilities and genetic correlations for all retinal quantitative traits 
   derived 
d. Perform a genome-wide association studies on individual studies, meta- 









This chapter describes the genetic analysis of rhegmatogenous retinal detachment using 
a case-control design.  Rhegmatogenous retinal detachment (RRD) is a major cause of 
severe vision loss with the average annual incidence of 10-20 cases in 100 000 
individuals (Mitry et al. 2010) and with the prevalence of 0.8% (Mitry et al. 2011). RRD 
occurs following a retinal tear that separates neural retina from the underlying retinal 
pigment epithelium (RPE) due to the passing of the fluid from the vitreous cavity into a 
subretinal space. This leaves the neurosensory retina (NSR) deprived of nutrients and 
oxygen, potentially severely reducing visual function especially when the macula is 
affected.  
Due to financial constrain, the analysis consisted of a two-staged discovery phase, a first 
stage using a genome-wide genotyping array, a second stage probing  ~6000 variants, 
and  a replication/follow-up phase which was limited to testing the seven best candidate 
SNPs from the discovery phase.  A combined total of 2833 RRD cases and 7871 
controls were analysed (Figure 2.1). The genome wide association study with close to 
300 000 single nucleotide polymorphisms (SNPs) was performed prior to my starting 
PhD, using 867 affected Scottish individuals and 1953 Scottish controls, and is briefly 
described here. The main focus of this chapter is the follow up of the most significant 
SNPs from the original GWAS (second step of the discovery phase), the joint meta-
analysis and the replication phase which I have carried on. Firstly the most significant 
GWAS results were tested in independent sets of cases and controls of Dutch (252 cases; 
320 controls) and British origin (748 cases; 2592 controls), after which replication and 
follow–up was sought through the use of further samples from populations of English 
(846 cases; 2737 controls) and Croatian descent (120 cases; 269 controls). Finally the 
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overall meta-analysis including all stages (discovery and replication) was performed. 
The analysis was expanded with the investigation of the genetic risk score of the most 
significant results in order to improve the empirical evidence of the genetic basis of  
RRD. Furthermore the proportion of risk of RRD associated with the collective additive 
effects of the genotyped SNPs was also estimated from the discovery genome-wide scan. 
Potential biological interactions between the most significant results were sought out 
using pathway analysis.  
 
Figure 2.1. The study included a two-stage discovery phase followed by a replication phase where the 
seven most promising findings were brought forward for testing. GWAS was conducted in a Scottish 
study in the first stage of the discovery phase. The best ranked SNPs were selected for follow-up and 
complemented with candidate gene markers. 4347 SNPs were thus genotyped and analysed in the UK and 
Dutch studies in the second stage of the discovery phase, and results from both discovery stages were 
combined in a meta-analysis. An overall combined meta-analysis of discovery (2 stages) and replication 
phases was completed for the seven SNPs carried all along. 
 
 
Work in this chapter was mainly done by me, unless stated otherwise. 
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All participating studies received approval from their local ethics committees and 
followed the tenets of the Declaration of Helsinki. 
  
 
2.2.1.1. Retinal detachment cases 
 
All incident Scottish  cases, aged 9-91 (mean=58.91),  were recruited as a part of a 
population-based epidemiology study of rhegmatogenous retinal detachment recently 
carried out in Scotland (Mitry et al. 2009). 912 were included in the first step and 121 as 
a part of the second step of the discovery phase. All incident cases of rhegmatogenous 
retinal detachment reported in any of the six vireo-retinal surgical sites (Ayr, Glasgow, 
Edinburgh, Dundee, Aberdeen and Inverness) were invited to participate in the study. 
The diagnosis of RRD was based on a case definition of “a full thickness break in the 
neurosensory retina with a surrounding area of sub-retinal fluid extending greater than 2 
disc diameters" (Zou et al. 2002, Li et al. 2003, Polkinghorne et al. 2004, Schepens, 
1951). All other types of retinal detachment (exudative, tractional and combined) and re-
detachment cases regardless of duration of attachment post-operatively were excluded. 
Also excluded were participants with a cataract surgery within 2 years of to the 
detachment diagnosis or with known syndromic features.  6.9 percent of Scottish RRD 
subjects evaluated reported an affected 1st degree relative (Mitry et al. 2011). 
 
Cases from London, UK (N=470 in discovery phase; aged 9-92, mean=57.87, N=846 in 
replication phase (aged 14-90, mean=58.58), Cambridge, UK (N=217; aged 15-91, 
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mean=61.38), Nijmegen, Netherlands ( N=256; aged12-95, mean=59.92) and Zagreb, 
Croatia (N=120 aged 20-83, mean=59.96) were collected using the same phenotypic 
inclusion criteria as for the Scottish samples.  Positive family history was recorded in 
11.3% of cases from the London recruitment, 7.1% of Croatian cases, and 5.6% of a 
subset of 180 Dutch cases had an affected first degree relative (Go et al. 2005). Family 





Control groups were readily available population-matched samples unselected with 
regards to RRD; i.e. unselected controls, a small fraction of which would have RRD 
(prevalence of RRD is 0.8%, Mitry et al. 2011). The Scottish Colorectal Cancer Study 
(SOCCS) was used as a control group for the Scottish samples in the first stage of the 
discovery phase. This is a prospective population-based study in Scotland (1999–2006), 
with colorectal cancer cases drawn from all over Scotland, matched to healthy controls 
by age, sex and area of residence (Tenesa et al. 2008). 1967 genotyped individuals were 
used in the analysis, aged 18-62 (mean=50.25).   
 
Two sets of control groups from the Wellcome Trust Case Control Consortium 
(WTCCC) were also used in subsequent stages: 2595 samples from the 1958 UK birth 
cohort were used in stage 2 of the discovery phase and 2737 individuals from National 
Blood Service (aged 17-69, mean=43.5) in the replication phase.  The Wellcome Trust 
Case Control Consortium (WTCCC) is a group of 50 research groups located across the 
UK (established in 2005) with the goal of studying association of common genetic 
variants to disease (Welcome Trust Case Control Consortium 2007). Access to the 
WTCCC data was obtained by application to the Wellcome Trust Case Control 
Consortium Data Access Committee. Control samples were selected based on the 
31 
 
genotyping platform used; samples genotyped on the Illumina arrays were chosen in 
order to gain the optimal overlap with the markers genotyped in RRD cases. 
 
Controls for the Dutch samples were 326 control individuals for an independent  
schizophrenia study that were locally recruited, aged 36-74 (mean=50.22).  Controls 
used in the final analysis represent only a subset of the original control sample (N=653), 
as the age distribution of the original controls sample were not matched to the cases’. In 
order to match the cases and controls regarding age, individuals older than 35 years were 
selected (326 out of the 653 controls).  
 
Finally, Croatian participants to an ongoing colorectal cancer case and control  study 




2.2.2. Genotyping and quality control 
 
2.2.2.1. Genome-wide scan 
 
912 Scottish RRD cases were genotyped using the Illumina CNV370v3-Quad array, and 
compared to population matched Scottish controls from the SOCCS study previously 
genotyped on the Illumina-300 and 240S HumanHap arrays. Raw data analysis was done 
using the Illumina genotype analysis software GenomeStudio with a GenCall scoring 
cut-off of 0.15 and solely on the new data itself (not using external references). A final 
clustering was done using only the 892 samples with an overall genotype call above 
90%. Further quality control was performed separately for cases and controls using the 
check.marker function of the “GenABEL” R package (Aulchenko et al. 2007). This step 
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removed SNPs with a low call rate (<97%), those in high Hardy-Weinberg 
disequilibrium (p<1x10-6), as well as samples identified as duplicates or highly related, 
mixed (high heterozygosity), individuals with a low call rate (<97%), sex discrepancies, 
and outliers based on whole-genome identity-by-state sharing. In total, 870 cases, 1,968 
controls and 299,789 common SNPs (minor allele frequency >0.02) remained for 
analysis. When cases and controls were analysed jointly, three additional samples failed 
quality control. Further to these standard QC steps, SNP showing strong signals in 
association analysis were examined more closely. Several were removed due to poor 
clustering in either cases or controls or both after visualization of individual clusters 
(e.g. presence of 4 rather than 3 clusters) and two SNPs, rs4862110 and rs4957798, were 
removed due to discordance between SNP arrays. In the final analysis presented here, 
299 737 SNPs, genotyped in both cases and controls and QCed, were used. This part of 
the quality control was done previously by Veronique Vitart. 
A deeper relatedness check based on genomic kinship coefficients derived from the 
whole-genome identity-by-state sharing identified 15 pairs of individuals related to first-
cousins or greater level (π-hat> 0.12) in PLINKv1.0 (Purcell et. al 2007),  Φ >0.0625 in 
“GenABEL”.  Removing one individual of each related pair left 867 cases and 1,953 
controls for the final analysis. Plots using principal components derived from the 
identity-by-state sharing measures showed good overlap of ancestry between the 
Scottish RRD cases and controls (Figure 2.2). 
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 Figure2.2. Ancestry clustering for cases and controls used in the Discovery phase one. Clustering was 
achieved by multi-dimentional scaling of the matrix of pairwise genetic distances derived from the identity 
by state sharing statistics obtained using the ibs function in the GenABEL R package.  N=858 Scottish 
RRD cases represented by red dots. N=1958 SOCCS controls represented by black dots (figure was done 




2.2.2.2. Discovery stage step 2 genotyping 
 
2.2.2.2.1. Selection of the genotyping platform 
 
My work on the project started here, with the selection of genotyping options for the 
discovery step two, carried out with Dutch and UK newly collected cases and using 
population-matched controls already genotyped using genome-wide arrays. As the 
funding was limited, only whole genome genotyping platform considered was the 
Illumina HumanCytoSNP-12 chip, however there were a few issues related to this chip; 
a risk of imperfect coverage compared to controls because it centers primarily on 
markers targeting all regions of known cytogenetic importance. I tested the proportion of 
34 
 
overlapping SNPs between HumanCytoSNP-12 chip and SNPs genotyped in Orkney 
(combination of Illuminas HumanHap 300v2 and 370CNV-Quad) and Korcula 
(370CNV-Quad chip). Overlap was low (83054 in Orkney and 86898 in Kocula). The 
overlap was greater when the SNPs present in the imputed genotypes of both 
ORCADES and Split individuals (a Croatian cohort available and genotyped on a 
genome array similar to the one used for the Scottish RRD cases) when compared to 
HumanCytoSNP-12 chip. The overlap was good (77% of SNPs on HumanCytoSNP-12 
chip are represented in the imputed genotypes) indicating that if cases genotyped by 
Cyto-12 were used 77% of the SNPs would be present in imputed controls and used in 
the analysis.  However this would require imputation of RRD cases which proved 
difficult (see paragraph 2.3.1.1.1.1. Analysis of the imputed data).  In addition, when the 
overlap was done between the SNPs present on the chip and the most significant results 
from the GWAS carried out on genotyped data only 27% of the most significant SNPs 
were represented on the HumanCytoSNP-12 chip. Therefore this option was considered 
too risky, and custom SNP array of the most significant SNPs was considered to be a 
better solution for discovery step two analysis.  
 
 
2.2.2.2.2. iSelect platform 
 
5981 SNPs were selected for the second stage of the discovery phase to be assayed on an 
iSelect Illumina platform, 4706 selected from the genome-wide scan results 
complemented by 1275 from 18 candidates gene regions. 
The top 4076 genome-wide scan SNPs were selected from merging the 1500 top results 
from 5 different primary GWAS analyses: all RRD Scottish cases versus all SOCCS 
Scottish controls, RRD cases with known high myopes (Spherical equivalent 
refraction ≤ -5) removed, SOCCS controls with cancer cases removed and gender 
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separate. Haplotype tagging SNPs in the candidate gene regions were selected with the 
Tagger program within the Haploview v4.0 software (Barret et al. 2005)  using  Centre 
d’Etude du Polymorphisme Humain from Utah (CEU) population of the HapMap project 
(International HapMap consortium 2005). A threshold for r2 was set at 0.8. Region of 
100kb upstream and downstream from each gene were used in the selection process.  
The candidate genes for this study were selected based on their function in some of the 
known inherited diseases associated with RRD and chosen by D.M and A.W..  
Clustering was done using Illumina Genome Studio software and QC steps (call rate, 
HWE, sex discrepancies) were carried as described for the genome-scan analysis. 
Gencall score cutoff was at the default genome studio’s of 0.15. Clustering of the allele-
probe intensities was done using our own dataset, which contained samples with call 
rates above 80%. Cluster plots for each SNP were inspected manually in order to assess 
its genotyping quality. Poorly clustered SNPs were excluded from further analysis. 
Difference in  genotype missingness rates between cases and control  was also tested 
separately for each new study using the function –test-missing in PLINKv1.07 (Purcell 
et al. 2007). No SNPs displayed significant missingness difference (p<0.00001) between 


























Dutch cases 5168 256 179 199 1 2 2 0 
Dutch 










controls 4456 2595 41 35 109 1 0 
 
0 
Table 2.1. Quality control summary statistics for Dutch and UK populations genotyped in the discovery 
stage step two analysis.  4456 SNPs  were extracted from WTCCC control data from the user-unfriendly 
format they were available in. Number of SNPs and individuals prior to the QC procedure is given, along 




813 (13.6%) assays failed  manufacture, comprising 183 of the candidate genes set and 
630 top ranked GWAS SNPs (in agreement with failure rate to be expected from the 
Illumina Infinium technology). These markers failed to be synthesised on the final 
iSelect platform (the manufacturer guarantees the conversion rate of 80%). Each 
manufacturing step can potentially lead to loss of a SNP (synthesising the oligo probes, 
attaching probes to beads, loading beads on to the array etc.). As we were not informed 
about this prior to the ordering of our array, several potentially important SNPs from the 
first stage of the analysis were omitted in the replication stage. Therefore the list of 
potentially important omitted SNPs was created to be genotyped additionally by the 
Taqman assay. The decision of which SNPs to genotype by TaqMan was based on the 
results of the original GWAS. The top 200 most significant SNPs from six different 
analysis were cross checked with the missing SNPs. This left 92 missing iSelect SNPs 
that were potentially important. These SNPs were investigated for the representativity by 
proxy (LD r2> 0.2) of those which failed on the iSelect chip or QC. SNPs located in the 
candidate gene regions were not included in this extra genotyping step, due to the 
financial restrictions of the project. The final number of SNPs carried on for the second 
step of the discovery phase was 4347.  
 
 
2.2.2.2.3. Single SNP typing 
 
Taqman technology was used for the additional genotyping of eight SNPs missed by 
iSelect technology, with initial p-values < 10-4 and not represented by proxy (LD r2> 
0.2) or in plausible functional gene, FRMD4A and GRM7, and for the genotyping of 
seven SNPs to be followed up in the replication phase. The call rates of all of the SNPs 
were above 90%; with the highest being 96.6% (rs1485179) and the lowest 91.8% 
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2.2.2.3. Replication phase genotyping 
 
Seven SNPs in total were genotyped in the replication phase using the Taqman 
technology. The six top associated SNPs which displayed consistent direction of effect 
across all cohorts and one additional SNP (rs913444) based on the pathway analysis 
results. Quality control checks were carried out as described above. The highest call rate 
in the London replication samples was 99.8% (rs8132771) and the lowest 93.5% 
(rs955943). Only one marker (rs12960119; call rate=93.6%) passed the 90% threshold in 
the Croatian samples.  
 
 
2.2.3. Candidate gene SNPs selection 
 
The majority of the candidate genes for this study were selected based on their function 
in some of the known inherited diseases associated with RRD. Vitreoretinal 
degenerations are a group of hereditary retinal dystrophies that often lead to retinal 
detachment. The most common one is Stickler’s syndrome. Different forms of this 
disease are associated with mutations in COL2A1 gene (type II collagen), COL11A1 
gene (type XI collagen) and COL9A1 gene (type IX collagen). Other retinal dystrophies 
include Wagner syndrome (CSPG gene), Knobloch syndrome (COL18A1 gene), familial 
exudative vitreoretinopathy (FZD4 gene) and snowflake vitreoretinal degeneration 
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(KCNJ13 gene). Another genetic condition associated with greater risk of RRD is 
Marfan syndrome thus the fibrilin 1 gene (FBN1) was also included in our study. Given 
the proposed mechanism in which changes in the vitreoretinal adhesion strength play an 
important role in RRD pathogenesis, molecules involved in the vitreoretinal adhesion 
represent plausible candidates (Mitry et al. 2010, Ghazi and Green 2002, Foos and 
Wheeler 1982). Laminin, fibronectin and collagens type 4 (COL4A4) and 6 (COL6A1) 
are present in the inner limiting membrane of the retina and are thought to play a role in 
the vitreoretinal adhesion (Ponsioen et al. 2008). In addition COL6A1 has been 
proposed to surround vitreous cortex and mediate adhesion between vitreous cortex and 
ILM. Opticin (OPTC which binds to collagen fibrils of the vitreous humour), hyaluron 
synthase (produced during tissue repair) and hyaluronan and proteoglycan-binding link 
protein were also included in the final candidate gene list. Number of selected and tested 
candidate gene SNPs are given in Table 2.2. (* selected that passed iSelect design, ** 
















Number of selected tagging 
SNPs in  the gene (Number 
successfully tested) 
Candidate gene 
Number of selected tagging SNPs in  the gene 
(Number successfully tested) 
COL11A1 34 (14) 
LAMA1 
161 (67) 
COL18A1 58 (29) 
LAMB1 
54 (24) 
COL2A1 54 (21) 
LAMC1 
41 (13) 






















Table 2.2.Number of selected* and tested** tag SNPs for candidate genes selected for follow-up in the 












2.2.4. Imputation of the genotyped SNPs 
 
2.2.4.1. RRD data preparation 
 
870 of the 912 genotyped RRD individuals on the Illumina CNV370v3-Quad array were 
imputed against CEU reference panel using the MACH software. After the QC with the 
following parameters (MAF<0.01, HWE<10-6, call rate >0.98) 870 individuals and 
324256 markers remained.  SNPs with bad genotype clustering (identified in Illumina's 
Genome Studio during genotype call check of the candidates following the association 
analysis using genotyped data) were removed (only 3 SNPs from the whole list were 
actually present in the QCed data) which left 324253 SNPs. Additionally all the SNPs 
with AT, TA, GC, CG genotypes were removed (due to possible flips between Illlumina 
strand designation and MACH references haplotypes) which left 323180 SNPs for 
imputation. The population-matched controls used for this analysis are from the Scottish 
Colorectal Cancer Study (SOCCS). Imputed genotypes for the SOCCS individuals were 
available for this analysis and had used the same reference. Identical individuals 
between case and control groups and close relatives within or between case and control 
groups were removed as already described (2.2.2.1.).   
 
 
2.2.4.2. RRD data imputation 
 
Imputation was done for over 2 million SNPs (on 22 autosomal chromosomes) with 
reference to the CEU population (HapMap2 build 36 release 22). Imputation is run in 
two stages. The first step is to compare our samples to the phased haplotype data in the 
reference panel (HapMap CEU) to generate recombination and error maps. Error map 
includes estimates of the "error" rate for each marker (it captures both genotyping error, 
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discrepancies between our platform and the reference panel, and recurrent mutation), 
while recombination map includes "crossover" rates for each interval (a parameter that 
describes breakpoints in haplotype spans shared between our samples and the reference 
panel). The second step uses the parameters estimated in the first step to impute all SNPs 
represented in the reference panel (from phased HapMap data) in our sample of 
individuals. Approximately 2.5 million SNPs can be imputed to sufficient quality with 
this method. Imputation data for the Scottish controls was performed previously. 




2.2.5. Statistical analysis 
 
2.2.5.1. Association testing 
 
The genome-wide scan was performed using a regression model with age and sex as 
covariates and fitting an additive SNP effect, using the egscore function of the 
“GenABEL” R package (Aulechenko et al. 2007) which takes into account possible 
population stratification (Price at al. 2006). QQplots of observed versus expected 
ordered test statistics were drawn using the “snpMatrix” R package (Clayton 2007). The 
grey area represents the area between the 2.5% and 97.5% probability bounds of non-
departure to the null hypothesis. Five analyses were performed, all RRD Scottish cases 
versus all SOCCS Scottish controls, RRD cases with known high myopes (Spherical 
equivalent refraction ≤ -5) removed , SOCCS controls with cancer cases removed and 
gender separate analysis. This part of the analysis was done by V.V. The top ranking 
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associated SNP from each analysis (p-value< 10-3) were listed to be taken forward in the 
second stage of the discovery.  
 
In the second stage of the discovery phase, association between RRD with SNP 
genotypes was tested using logistic regression including sex and age as covariates and 
using the PLINKv1.07 software (Purcell et al. 2007). Both additive and dominant 
models were tested. For additive model depending on the number of copies of the minor 
allele genotypes were coded 0 (minor allele homozygote), 1 (heterozygote) or 2 (major 
allele homozygote). The direction of the regression coefficient (β) represents the 
addition of one extra minor allele. Odds ratios (OR) greater than 1 indicate that minor 
allele increases risk of the disease relative to major allele. For dominant model 
genotypes are coded 0 (major allele homozygote) and 1 (heterozygote and minor allele 
homozygote; combines these two genotypes into 1 category), while the regression 
coefficient compares the effect of the heterozygote and minor allele homozygote 
genotype to the major allele homozygote one. Since the genetic model coding is done 
relative to the minor allele and the recessive model tests minor allele homozygote 
against heterozygote and major allele homozygote, the recessive model gives many low 
counts for low MAF which often leads to inflated test results; or no counts and analysis 
cannot be performed for a substantial number of markers. For these reasons it was 
decided not to pursue testing of the recessive model. 
 
Association analyses were done for each cohort separately and the results from all 
cohorts (with the Scottish discovery step 1 rerun using the PLINKv1.07 implementation 
of the logistic regression adjusting for age sex and 3 ancestry principal components) 
combined in an inverse variance weighted fixed effect meta-analysis using the statistical 
package METAL (Willer et al. 2010).  The fixed effect model assumes that all studies 
are estimating the same effect size, and the weights (for all these studies) are assigned 
based on the amount of information captured by each study (a study with greater number 
of samples is given a bigger weight compared to a smaller study). METAL assigns a 
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reference allele to each SNP (all studies are aligned to the same reference allele) and its 
z -statistic is calculated. Based on this an overall z-statistic and p-value are calculated for 
each SNP from a weighted sum of the individual statistics. Standard errors were used to 
calculate the effect size weights (inverse variance weights). Forrest plots and 
heterogeneity measures for the most significant SNPs were obtained using the “meta” R 
package (Swarzer, 2012).  
βi- effect size estimate for study i 
sei- standard error for study i 
 
wi=1/se2i  (weight assigned to each study) 
se=√1/∑ 𝑤𝑖𝑖  (the standard error of the combined effect ) 
 
 weighted effect size  β=∑ 𝛽𝑖𝑤𝑖𝑖 /∑ 𝑤𝑖𝑖  
z-score Z=β/se 
Overall P-value ;  P=2Φ(|−Z|) 
(Φ is the standard normal cumulative distribution function) 
 
 
Given the low sample size of our replication cohorts and that inclusion of covariates in 
case-control association studies has been shown to reduce their power in this scenario 
and with low disease prevalence (Pirinen et al. 2012) we carried out analysis in the 
replication phase without the inclusion of covariates. Results from both discovery stages 




2.2.5.2. P value threshold 
 
In order to correct for multiple testing in the initial genome wide scan, we used a 
multiple testing correction method that takes into account the correlation structure 
among the GWAS genotyped SNPs due to linkage disequilibrium using “SimpleM” R 
library (Gao et al. 2010). It uses composite linkage disequilibrium correlation, which is 
44 
 
calculated directly from SNP genotypes to create the correlation matrix of SNPs. This 
correlation matrix is then used to compute the eigenvalues for the principal components 
analysis which then generates an effective number of independent (non-correlated) 
SNPs. Imputation of the missing genotypes was carried out using k Nearest Neighbors 
using the “scrime” R package (Schwender 2012), since SimpleM does not allow for 
missing values. The calculated effective number of independent SNPs, n=197628, was 
then used to correct for multiple testing using the standard Bonferroni procedure. The 
discovery stage significance threshold was additionally corrected for the testing of two 
genetic models (additive and dominant). The genome wide significance threshold was 
therefore set at 1.27x10-7 (=0.05/(197628x2)). Despite following up only a subset of 
SNPs used in the first step of the discovery phase into the second step, the same genome 
wide significance threshold was used for the meta-analysis of the two steps to be 
conservative. The overall meta-analysis (combining discovery stage and replication 
stage data) used the conventional 5x10-8 significance threshold, additionally corrected 






2.2.5.3. Permutation procedures 
 
We calculated empirical significance levels for the association analysis in all of the 
cohorts, and used these empirical significance levels for further meta-analysis. Adaptive 
permutation testing was carried out in PLINKv1.07 (Purcell et al. 2007).  Firstly labels 
between cases and controls are swapped and a new dataset (which is then tested for 
association) that is sampled under the null hypothesis is created. This dataset is then 
permuted using the adaptive permutation approach which permutes non-significant 





2.2.6. Genetic risk score 
 
Multilocus genetic risk scores were calculated for each individual and included 5 risk 
variants (most significant results from meta-analysis of discovery steps 1 and 2 that had 
significant associations in all of the cohorts; p<0.05; rs12960119, rs267738, rs2045084, 
rs8132771, rs955943). Simple allele counting was used to calculate the genetic risk 
score. The simple count uses the total sum of the risk allele present in an individual. 
Genetic risk scores were calculated using PLINK’s v1.07 “score” option. Individuals 
with one or more missing genotypes were not included in the analysis. Odds ratios were 
calculated relative to the median number of risk alleles among controls in SPSS 
(subjects with 5 or more risk alleles were combined due to the low number of 




2.2.7. Disease liability’s genetic variance explained 
 
GCTA (Genome Wide Complex Trait Analysis; Yang et al. 2010) software was used to 
estimate the proportion of variation in disease liability capture by the genotyped SNPs in 
the study population of discovery stage 1 (Scottish RRD cases and SOCCS controls). 
GCTA enables this estimation in the samples of unrelated individuals (Lee et al. 2011). 
Transformation of a disease trait (0-1) to an underlying scale of liability is performed 
using a probit transformation. Heritability is estimated by fitting a linear mixed model 
and using restricted maximum likelihood and with a random SNP effect on the 
transformed trait. This estimation is then corrected for the incomplete linkage 
disequilibrium (LD) between the tag SNP and the causal variant. The program uses LD 
between genotyped SNPs as a guide to LD between causal variants and genotyped 
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SNPs. In case-control studies individuals are selected from the tails of the distribution of 
liability, thus the proportion of cases is usually larger than the prevalence in the general 
populations. This ascertainment can be corrected for when calculating the heritability 
estimates in case–controls study with GCTA. Very stringent QC procedures (Lee et al. 
2011) were implemented using plink on the genotyped data to avoid experimental biases 
causing false case-control differences in relatedness. SNPs with MAF <0.03 and missing 
rates >0.05, and individuals with missing rates >0.01 were excluded from the analysis. 
Additionally, very stringent threshold for Hardy-Weinberg equilibrium and differences 
between the missing genotype rates between cases and control were applied (SNPs with 
p<0.05 were excluded). Closely related individuals were removed to make sure only 
distant relationships are taken into account (kinship coefficient threshold was set at 0.05 
as implemented within the GCTA software). As further check, the control cohort 
(SOCCS without colorectal cancer cases) was split into two groups and the procedure 





2.2.8. Pathway analysis 
 
The top 6 SNPs from the discovery stage 1 and 2 meta-analysis were selected for a first 
pathway analysis. Identification of all possible genes underlying these SNPs was done 
using “seed” output from GRAIL (Gene Relationships Among Implicated Loci). For 
each input SNP GRAIL finds SNPs in LD (r2>0.5, CEU HapMap) with it in the 3′ and 5′ 
direction, and locates the nearest recombination hotspot to the furthest SNPs in both 
directions. The interval between these two hotspots is then chosen to locate the genes 
associated with the SNP of interest (because our top SNPs could be tagging a stronger 
SNP signal from another variant in the region, particularly because we genotyped only a 
subset of SNPs from the initial GWAS in the majority of cases). When there are no 
genes within this region, the interval is extended for 250 kb in each direction. All genes 
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located in this interval were considered in the subsequent pathway analysis using IPA 
software (Ingenuity Pathway Analysis; Ingenuity ®Systems, www.ingenuity.com ). IPA 
uses an internal manually maintained database to identify networks that maximize 
specific connectivity of the entered genes. It searches through networks (in its database) 
in which the genes from the entered list are included and searches how they associated 
with other genes (looking for experimentally demonstrated relationships among genes 
that are associated with distinct known pathways). It then creates a novel network 
including some or/all genes of interest together with other interacting genes which 
maximizes its connectivity. When running the analysis in IPA, endogenous chemicals 
were excluded from the search and only the direct interactions were taken into account.  
After the analysis of the 6 most significant hits from the meta-analysis, additional 
analysis using all SNPs with  association p-value <10-4 (22 SNPs in total, Table 2.8) was 
performed in order to test whether possible direct biological interactions exist between 
our top SNPs. Parameters were set identically to the first analysis. Based on this 
extended pathway analysis we identified three direct interactions and further literature 
search confirmed their biological grounds for one identified interaction (TIAM1-
NTRK2). SNP (rs913444) associated with NTRK2 gene (using the GRAIL criteria) was 
therefore included in the stage 3 of our analysis (SNP associated with TIAM1 was 
already among top 6 SNPs from the meta-analysis). 
 
MAGENTA (Meta-Analysis Gene-set Enrichment of variaNT Associations) software 
was also used to explore the enrichment of our genetic associations in predefined 
biological pathways. Since MAGENTA only takes genome-wide data, only the results 
from the first step of the discovery stage data was used in this analysis. The input data 
comprises SNP association p-values and the location of the variants. Firstly, SNPs are 
mapped onto genes after which each gene is assigned a gene association score that is a 
function of its regional SNP association p-values (is assigned a set of SNPs that lie 
within 110 kb upstream and 40 kb downstream of the gene’s most extreme transcript 
boundaries is assigned to each gene in the genome).  Then the confounding effects on 
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gene association scores are identified and corrected for (linear regression-based 
approach that adjusts for the effects of multiple confounders on the gene score is used; 
number of SNPs per kb, number of independent SNPs per kb, recombination spots per 
kb, linkage disequilibrium units per kb, genetic distance across the gene). Each mapped 
gene in the genome is ranked by this corrected gene score.  Finally, a Gene Set 
Enrichment Analysis (GSEA)-like statistical test is used in order to check whether any 
gene sets (predefined biologically relevant gene sets from several public databases) are 
enriched for significant gene association scores (compared to randomly selected gene 
sets). The observed number of gene scores in a given pathway, above a chosen 
significance threshold (95th or 75th percentiles of all gene scores) is calculated and 
compared with 1 000 000 randomly permuted pathways of identical size giving the 
empirical GSEA P-value for each pathway. 2572 pathways from Gene Ontology, 
PANTHER, KEGG and Ingenuity were tested. A pathway is considered significant if 














2.3.1. Association analysis –discovery stage step 1 –analysis of genotyped 
data 
 
A genome-wide association study (GWAS) was carried out with 867 RRD cases and 
1953 controls from Scotland, using 299 737 genotyped SNPs, after applying stringent 
quality controls. GWAS results show a very slight excess of low p-values compared to 
the null hypothesis of no association (Figure 2.3; A,B). One SNP (rs10510663) reached 
genome wide significance after correcting for multiple testing (significance threshold set 
at 1.27x10-7 as described in the methods; p=1.88x10-9). This marker is located on 
chromosome 3p22.3, upstream of ARPP21 gene (analysis done previously by V.V.). 
  
Figure 2.3.  A. Manhattan plot (A) and Quantile-quantile (B) plot for the discovery phaseI genome wide 
scan. Statistics from a logistic regression adjusting for age sex and co-ancestry performed on 867 Scottish 
RRD cases and 1953 SOCCS participants using 299,737 genotyped SNPs passing quality control checks 
are plotted (-log10 (P-value) on the x axis, chromosomal location on the y axis for the Manhattan plot.-





2.3.2. Association analysis –discovery stage step 1 - analysis of the 
imputed data 
 
The ProbABEL software was used to carry out the association analysis. The analysis 
resulted in numerous genome-wide significant hits located all around the genome when 
standard post-analysis QC criteria were applied (markers with imputation quality score 
Rsq less than 0.3 and low minor allele frequency variants, MAF of <0.02, removed) too 
significant and too ubiquitous to be true positives. Therefore various more stringent QC 
criteria were applied, but the distribution of the significant SNPs did not change 
dramatically. Finally a very stringent QC criteria was applied, removing SNPs with Rsq 
of <0.98 and MAF of <0.05 in both cases and controls, leaving 38 SNPs with p-value ≤ 
10-5 in total (Table 2.3). Excess of significant result is observed on the QQ plot (λ=1.09) 








Figure 2.4.  Observed and expected chi-square values were 
used for the QQ –plot. Excess of significant test statistic is 
observed after SNPs with Rsq<0.98 and MAF<0.05 are 







 Table 2.3 Most significant GWAS results of the imputed data after very stringent QC; for each SNP 
MAF for case and controls is given, imputed MAF frequencies for RRD cases and controls. P-value, OR 
with 95% confidence intervals are also reported. Imputation quality score measurement Rsq is also given 
for each SNP. SNPs having MAF difference when compared to CEU population in both cases and controls 
are highlighted in bold.  
 
Deviation from CEU's allele frequencies in both cases (RRD) and controls (SOCCS) 
were calculated for top 38 hits. 37% SNPs in cases and 53% in controls had MAF 
difference between CEU and RRD greater than 5 %. These inconsistencies suggest that 
association test is detecting MAF difference between cases and controls that are most 









freq) Rsq_soccs Rsq_RRD OR Lower 95% CI Upper 95% CI p 
rs7816179 8 26832051 0.86 0.93 0.94 (0.91) 0.9998 0.9955 0.46 0.37 0.57 4.78E-13 
rs16846471 2 1.42E+08 0.04 0.09 0.036 (0.033) 0.9926 0.9839 0.38 0.28 0.51 1.77E-10 
rs7816187 8 26832063 0.83 0.90 0.94 (0.89) 0.9993 0.9961 0.57 0.47 0.68 1.7E-09 
rs12677733 8 26833426 0.17 0.10 0.08 (0.11) 0.9992 0.9936 1.76 1.46 2.12 1.99E-09 
rs10124811 9 7609582 0.69 0.75 0.75 (0.75) 0.9885 0.9843 0.69 0.59 0.79 2.32E-07 
rs4670165 2 36795770 0.64 0.57 0.55 (0.54) 0.9849 0.9971 1.41 1.24 1.61 2.9E-07 
rs978591 4 10227767 0.84 0.77 0.88 (0.76) 0.9969 0.9904 1.53 1.30 1.79 3.59E-07 
rs2531196 4 10228045 0.16 0.23 0.13 (0.24) 0.9964 0.9905 0.66 0.56 0.77 3.67E-07 
rs7672373 4 60856165 0.04 0.09 0.05 (0.09) 0.9990 0.9862 0.48 0.36 0.64 3.84E-07 
rs2531197 4 10228287 0.84 0.77 0.85 (0.76) 0.9952 0.9911 1.52 1.30 1.79 3.86E-07 
rs13140301 4 60850026 0.04 0.09 0.0 (0.09) 0.9989 0.9867 0.48 0.36 0.64 3.87E-07 
rs11727316 4 60856708 0.96 0.91 0.97 (0.91) 0.9989 0.9860 2.07 1.56 2.74 3.88E-07 
rs13113866 4 60857530 0.96 0.91 0.96 (0.91) 0.9988 0.9859 2.07 1.56 2.74 3.95E-07 
rs2531200 4 10230190 0.84 0.77 0.9 (0.76) 0.9944 0.9909 1.52 1.29 1.79 3.97E-07 
rs2531192 4 10226798 0.84 0.77 0.88 (0.76) 0.9967 0.9896 1.52 1.29 1.79 4.07E-07 
rs2720359 4 10232389 0.16 0.23 0.125 (0.24) 0.9929 0.9904 0.66 0.56 0.77 4.08E-07 
rs2720372 4 10226723 0.16 0.23 0.125 (0.24) 0.9969 0.9895 0.66 0.56 0.77 4.2E-07 
rs2720361 4 10234723 0.16 0.23 0.123 (0.24) 0.9847 0.9849 0.66 0.56 0.78 6.73E-07 
rs2720362 4 10234995 0.16 0.23 0.106 (0.24) 0.9846 0.9849 0.66 0.56 0.78 6.76E-07 
rs17383444 4 10230614 0.84 0.77 0.88 (0.77) 0.9894 0.9917 1.51 1.28 1.78 8.01E-07 
rs2720365 4 10237359 0.16 0.23 0.11 (0.24) 0.9821 0.9916 0.67 0.57 0.78 9.81E-07 
rs2531205 4 10239857 0.16 0.23 0.10 (0.24) 0.9822 0.9917 0.67 0.57 0.78 9.92E-07 
rs7615092 3 1.7E+08 0.33 0.27 0.275 (0.29) 0.9999 0.9873 1.39 1.21 1.59 1.97E-06 
rs12638698 3 1.7E+08 0.33 0.27 0.275 (0.29) 0.9999 0.9870 1.39 1.21 1.59 1.97E-06 
rs1362521 3 1.7E+08 0.67 0.73 0.725 (0.71) 1.0000 0.9856 0.72 0.63 0.82 1.97E-06 
rs13061789 3 1.7E+08 0.67 0.73 0.725 (0.71) 0.9996 0.9881 0.72 0.63 0.83 2.01E-06 
rs12633440 3 1.7E+08 0.67 0.73 0.725(0.71) 0.9983 0.9847 0.72 0.63 0.82 2.03E-06 
rs13094430 3 1.7E+08 0.67 0.73 0.725 (0.71) 0.9974 0.9843 0.72 0.63 0.83 2.07E-06 
rs7602707 2 1.42E+08 0.15 0.22 0.13 (0.15) 0.9974 0.9939 0.67 0.56 0.79 3.24E-06 
rs11789902 9 7608288 0.28 0.23 0.23 (0.23) 0.9946 0.9841 1.41 1.22 1.63 4.11E-06 
rs10815648 9 7607978 0.28 0.23 0.24 (0.23) 0.9987 0.9864 1.41 1.22 1.63 4.32E-06 
rs9518902 13 1.02E+08 0.09 0.13 0.067 (0.13) 0.9975 0.9877 0.61 0.50 0.76 6.26E-06 
rs9518901 13 1.02E+08 0.09 0.13 0.075 (0.13) 0.9985 0.9885 0.61 0.50 0.76 6.28E-06 
rs10520735 15 91874783 0.82 0.75 0.77 (0.77) 0.9945 0.9857 1.44 1.23 1.69 6.68E-06 
rs283552 6 51071956 0.48 0.46 0.43 (0. 49) 0.9985 0.9984 0.75 0.66 0.85 7.12E-06 
rs7209554 17 5487877 0.41 0.34 0.40 (0.38) 0.9992 0.9873 1.35 1.18 1.54 9.09E-06 
rs6458751 6 51079672 0.48 0.46 0.45 (0.49) 0.9950 0.9975 0.75 0.66 0.85 9.64E-06 
rs7224241 17 5487689 0.41 0.34 0.42 ( 0.38) 0.9979 0.9874 1.35 1.18 1.53 9.68E-06 
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likely the result of imputation errors, considering such big discrepancies in allele 
frequencies with the reference population for the imputation. This scenario is more 
likely when allele frequency discrepancies are observed for the controls. For RRD cases 
it is more difficult to make this assumption, since their allele frequencies may genuinely 
differ from CEU if they present a true positive result. For the RRD samples, these large 
discrepancies flagged checking of the genotype clusters of the original data (regions on 
chromosomes 3, 8 and 9). However genotyping clusters did not reveal issues in the 
genotyping clustering.  In addition, frequencies of the alleles in SOCCS were compared 
to another Scottish sample (Lothian Birth Cohort) to confirm the possibility of 
imputation errors. SNPs showing large allele frequency differences between SOCCS and 
CEU also presented a considerable difference in frequencies when LBC data was 
compared. The exception was the region on chromosome 4p16.1 within the CLNK gene 
(cytokine-dependent hematopoietic cell linker), with in role in the regulation of 
immunoreceptor signalling. 
 
In addition when MAF difference between directly genotyped and imputed SNPs were 
checked, only two markers (rs4670165 and rs10520735) were represented in the set with 
the QC criteria of Rsq>0.98. Therefore these discrepancies were checked for markers 
having Rsq values greater than 0.9 in both RRD cases and SOCCS controls (in total 11 
SNP frequencies were compared). Differences greater than 2.5% were detected among 4 
out of those 11 SNPs (36%). The proportion of SNPs with MAF difference between the 
genotyped and imputed sets was greater after more relaxed QC criteria were applied. 
This observation in addition to the observed SOCCS MAF difference (when compared 
to CEU’s and LBC’s) indicates imputation errors that partly contribute to the abundance 
of highly significant results when SNPs with lower quality scores were included. Marker 
with the highest p-value when cut-off of Rsq<0.9 was applied (rs13095640, p=1.76x10-
12) presented a difference of 5.4% between the imputed and directly genotyped MAF. 
Unfortunately, marker on chr8 showing highest p-value (rs7816179; Rsq<0.98) has not 
been genotyped and it was no possible to check for these discrepancy To see whether 
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there is a greater difference in MAF between directly genotyped and imputed SNPs in 
the RRD cases sample than in another imputed dataset (ORCADES) where GWAS have 
been routinely carried without report of excess type 1 error rate, the difference in MAF 
between genotyped and imputed SNPs was inspected for all relevant markers on one 
chromosome (chromosome 22). 1.13% of SNPs had MAF difference greater than 2.5 % 
in the RRD individuals, which is similar to the number of SNPs on Chr22 with the same 
difference in MAF in Orkney individuals (1.5% of SNPs have difference in MAF >2.5% 
between directly genotyped and imputed SNPs; tested on the similar number of SNPs, 
4940 for Orkney and 5303 for RRD cases). Suggesting the quality of imputation of the 
RRD dataset was in line with the standards for imputation data, and that the excess of 
positive results problem probably lies in the comparison of the imputed data from two 
datasets genotyped on different genotyping platforms (and imputed separately). Many of 
the checks described here were done after the time of selecting markers for the iSelect 
platform follow-up at which time it was decided too risky to follow up results from the 
imputation analysis. The issue of extra care when convenience controls are used in case-
controls analysis of imputed data has also been documented since I started this analysis. 
(Sinnot and Kraft, 2011). And although in a standard setting (case and controls genotype 
together), imputation methodology has been proven to be very accurate and reliable, 
working with cases and controls genotyped independently requires extra care and 
stringent QC. 
 
2.3.3. Association analysis –discovery stage Step 2 
 
The most significant SNPs associated with RRD by GWAS of genotyped data, plus 
some selected candidate gene markers were then genotyped on a custom-made Illumina 
iSelect array in an additional 1,000 RRD cases (Discovery stage 2; 252 Dutch and 748 
UK individuals). The meta-analysis of the SNP association data from these two steps 
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constituted the discovery phase and involved analyses of three distinct case-control 
cohorts (of Scottish, English and Dutch ancestry). A stringent genome wide significance 
threshold based on the number of SNPs tested in the initial whole genome scan 
(1.27x10-7; see Methods section) was applied in this meta-analysis. Index SNPs with 
association p-value less than 10-4 are displayed in Table 2.4.A for an additive model of 
allelic effect and in Table 2.4.B for a dominant model. The marker reaching genome 
wide significance in the GWAS of Scottish cases (rs10510663) did not remain 
significant in the meta-analysis (non-significant associations in both UK (p=0.86 
additive; p=0.92 dominant model) and Dutch cohorts (p=0.24 additive; p=0.27 dominant 
model) and its association p-value after meta-analysis of discovery studies increased to 
greater than 10-4.  
 






















rs12960119 G 18 21868701 0.075 1.46(1.26-1.67) 1.58E-07 +++ 0.67 
rs267738 C 1 149207249 0.275 0.79(0.71-0.87)  6.7E-06 --- 0.65 
rs955943 A 4 16123506 0.067 1.54(1.27-1.87)  9.9E-06 +++ 0.67 
rs7097067 A 10 71676508 0.075 1.65(1.32-2.07) 1.28E-05 -++ 0.99 
rs1074463 A 5 22671126 0.092 1.31(1.16-1.48) 1.28E-05 +++ 0.73 
rs2045084 G 8 144764982 0.425 1.21(1.11-1.31) 1.54E-05 +++ 0.25 
rs8132771 A 21 31921294 0.075 1.43(1.21-1.69) 1.96E-05 +++ 0.21 
rs11259960 A 15 81379707 0.200 1.35(1.17-1.54) 2.36E-05 +-+ 0.41 
rs2368106 A 2 180815911 0.125 1.35(1.17-1.54) 2.58E-05 -++ 0.76 
rs7234959 A 18 21816517 0.083 1.34(1.17-1.53) 2.68E-05 +++ 0.77 
rs6070015 A 20 55192062 0.067 1.67(1.31-2.13) 2.91E-05 +++ 0.91 
rs913444 A 9 87051470 0.250 1.22(1.11-1.34) 3.00E-05 +++ 0.94 
rs4893905 A 2 180867194 0.100 1.33(1.16-1.52) 3.32E-05 +++ 0.59 
rs1477441 A 5 22569230 0.124 1.31(1.15-1.49) 4.03E-05 +++ 0.87 
rs12193473 G 6 121301788 0.375 1.20(1.10-1.31) 4.25E-05 +++ 0.32 
rs218843 A 6 121388196 0.375 1.20(1.10-1.31) 4.40E-05 +++ 0.30 
rs4715056 G 6 47977103 0.275 0.81(0.73-0.90) 4.94E-05 +-- 0.59 
rs2817896 G 1 22988636 0.242 1.24(1.12-1.37) 5.35E-05 -++ 0.82 
rs10515162 C 5 73090012 0.050 0.72(0.61-0.85) 6.48E-05 --- 0.95 
rs11181447 A 12 41026298 0.150 1.28(1.13-1.45) 6.68E-05 +++ 0.85 
rs12202993 A 6 121330001 0.375 1.20(1.10-1.31) 7.48E-05 +++ 0.30 
rs564351 A 6 47927523 0.208 0.79(0.70-0.89) 7.49E-05 +-- 0.91 
rs6035211 C 20 19008513 0.117 1.30(1.14-1.47) 8.66E-05 +++ 0.99 
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B dominant model 




OR (95%CI) p-value Direction HetPVal 
rs12960119 G 0.075 1.47(1.27-1.71) 4.45E-07 +++ 0.531 
rs267738 C 0.275 0.74(0.65-0.84) 1.55E-06 --- 0.4144 
rs955943 A 0.067 1.54(1.26-1.88) 2.40E-05 +++ 0.5753 
rs7097067 A 0.075 1.55(1.26-1.91) 3.18E-05 -++ 0.1682 
rs1074463 A 0.092 1.32(1.16-1.50) 3.24E-05 +++ 0.8182 
rs8132771 A 0.075 1.43(1.20-1.69) 4.04E-05 +++ 0.4098 
rs6035211 C 0.117 1.32(1.16-1.51) 4.45E-05 -++ 0.4106 
rs9956700 A 0.267 0.71(0.60-0.84) 4.94E-05 +?- 0.03752 
rs7234959 A 0.083 1.36(1.17-1.58) 5.09E-05 +++ 0.7646 
rs267733 G 0.133 0.76(0.67-0.87) 5.29E-05 --- 0.9093 
rs2368106 A 0.125 1.33(1.16-1.53) 5.86E-05 +++ 0.382 
rs11637235 G 0.225 1.40(1.19-1.65) 6.73E-05 ++? 0.01017 
rs11181447 A 0.150 1.31(1.14-1.49) 8.73E-05 +++ 0.6992 
Table 2.4.Highest ranking RRD association signals in the meta-analysis of the 3 discovery studies. 
A additive model; B dominant model .Odds ratios with 95% confidence intervals, association p-
values, direction of the effect for respectively the populations Netherlands, UK and Scotland and 
heterogeneity metrics for all markers showing suggestive p-values (< 10-4). 
 
The most significantly associated marker after this stage was rs12960119, with an 
association p-value of 1.58x10-7(additive model), just below the genome wide 
significance threshold. This marker is located on chromosome 18q11.2 within an intron 
of the SS18 gene (OR=1.46; 1.26-1.67 95%CI). The magnitude and direction of the 
signals were consistent across all three populations, translating into a low heterogeneity 
score across studies (I2=0; p=0.67). Cases showed an excess of the rs12960119 minor 
allele G compared to controls in all three cohorts (Table 2.5.).  
 








Scottish 0.115/0.086 1.42 (1.16-1.75) 1.40(1.30 -1.73) 0.0009/0.003 
UK 0.104/0.077 1.41(1.13-1.76) 1.46(1.17-1.82) 0.002/0.0008 
Dutch 0.117/0.075 1.76(1.13-2.76) 1.90(1.17-3.1) 0.013/0.009 
Table 3.4. rs12960119 minor allele (G) effect across the three discovery cohorts .rs12960119 







Another marker (rs7234959), located upstream of the SS18 gene, displayed a 
suggestive p-value in the meta-analysis (p=2.68x10-5), strengthening the 
validity of an association signal in this region. A regional plot if the SNPs in 
the region of 500kb of the rs12960119 is presented in Figure 2.5. 
Figure 2.5. Regional SNP association plots for SNP rs12960119 by the combined population meta-
analysis of association signals in discover stage populations (Scottish, UK and Dutch). A region of  500 kb 
around the association signals is displayed. The degree of LD between the top genotyped SNP and other 9 
SNP tested in the meta-analysis is indicated by colours (red indicating high LD, purple indicated no LD). 
Recombination rate is displayed by a blue line with scale on the right-hand axis. Genes are displayed in 
the bottom part of the figure, with the arrow showing the direction of transcription. 
 
 
rs12960119 is in high LD with an evolutionarily highly conserved SNP, usually 
suggesting functional importance (rs765529; Figure 2.6.). This SNP was not 
successfully typed in the step two of the discovery stage and therefore not included in 
the previous regional plot. This was observed once the results from the genome scan 






Figure 2.6. Regional plot of genome scan results (discovery step one) showing rs12960119 is in high LD 
with a SNP in an evolutionary conserved region (rs765529), annotated with an  symbol in Locus Zoom 
(tool to plot regional association results). 
  
 




Figure 2.7. Graphical representation of the evolutionary conserved regions (ECR) within the SS18 gene 
using ECR browser (Ovcharenko et al. 2004). ECRs are detected by aligning the sequence of the base 
genome (human in this case) with others in a pairwise fashion. The human sequence (the base genome) is 
represented on the bottom axis. The height of the conservation peaks represents the number of nucleotides 
conserved in a windows of 100 nucleotides centred on that position. Blue color correspond to positions of 
coding exons, yellow to UTRs. Peaks within the conservation profile that do not correspond to transcribed 
sequences are in red (intergenic) or salmon (within an intron). Green regions relate to transposable 
elements and simple repeats. Vertical axis represents genomes of different species the base genome is 
aligned/compared to. Conserved UTR region is highlighted. 
 
Most suggestive SNPs (p<10-4) also showed comparable directions of effect across all 
three populations (Table 2.5.). Sex separate analysis was also performed but yielded no 
genome wide significant results (results in Appendix I). Since some of the study 
populations had very low number of cases (Dutch), splitting them based on sex produced 
study groups containing very small number of cases and significantly reduced power to 






2.3.4. Association analysis – replication  stage  
 
In the replication stage, we followed up the six most significant markers with low 
heterogeneity across studies (rs12960119, rs267738, rs955943, rs8132771, rs2045084, 
rs1074463) from the discovery stage results and an additional marker (rs913444) 
identified in the pathway analysis, with direct experimental evidence supporting protein-
protein interactions between NTRK2 (assigned to rs913444) and TIAM1 (assigned to 
rs8132771 ) (Miyamoto et al. 2006).  A brief description of the genes included in or 

















SNP Gene in LD r2>0.8 with index SNP 
rs12960119 PSMA8  - encodes for proteasome subunit, alpha type, 8. The proteasome 
is a multicatalytic proteinase complex, which cleaves peptides with Arg, 
Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly 
basic pH. It is expresses in the mouse retinal tissue (Freeman et al. 2011). 
 
SS18 - encodes for the human synovial sarcoma translocated to 
chromosome X protein. This gene plays a role in cell adhesion processes 
(Kim et al. 2009). It is expressed in many adult tissues and, in mouse, the 
protein was detected in all cell types of the retina (Kim et al. 2009). 
rs267738 
 
CERS2  encodes the protein ceramide synthase 2 (CerS2), the most 
abundantly and ubiquitously expressed member of the ceramide synthase 
family. Ceramide-enriched membranes domains amplify diverse signals 
and are critically involved in inducing apoptosis (Schenck et al. 2007).It is 
expressed in mouse retina (Freeman et al. 2011). 
 
rs955943 LDB2 encodes LIM domain binding transcription cofactor. LIM domains 
are present in many proteins that have diverse cellular roles as regulators 
of gene expression, cytoarchitecture, cell adhesion, cell motility and signal 
transduction(Kadrmas et al. 2004). Expressed in rat retinal ganglion cells 
(Wang et al. 2009).  LDB2 has been shown to interact with SLK which 
plays a role in actin dependent  apoptosis and adhesion dynamics 
(Storbeck et al. 2009)  
rs1074463 CDH12 encodes cadherin 12, a member of a family of cadherin 
molecules. Cadherins are integral membrane proteins that mediate 
calcium-dependent cell-cell adhesion. Cadherin 12 appears to be 
expressed specifically in the brain. Expressed in the developing mouse 
retina (Faulkner-Jones et al. 2009). 
 
rs2045084 TSTA3  encodes the enzyme GDP-L-fucose-synthetase, which catalyses 
the conversion of GDP-4-dehydro-6-deoxy-D-mannose to GDP-fucose in 
the de-novo-synthesis of GDP-fucose.  Expressed in human retinal 




SOD1 encodes superoxide dismutase 1 , enzyme that catalyzes th 
dismutation ofsuperoxide into oxygen and hydrogen peroxide. SOD1-/- 
mice present oxidative damage of retinal pigment epithelial cells. 
Expressed in mouse retina (Imamura et al. 2006). 
 
SCAF4  encodes for an RNA binding protein. It is the human ortholog of 
rat rA4 protein that interacts with the C-terminal domain of RNA 
polymerase II. May act to physically and functionally link transcription 
and pre-mRNA processing (Yurjev et al. 1996). 
 
rs913444 TRKB encodes neurotrophic tyrosine receptor kinase type B. It is located 
within the membrane, and signalling pathway involving this kinase leads 
to cell differentiation, proliferation and survival (Numakawa et al. 2010). 
TrkB protein is expressed in the inner plexiform layer (IPL) and retinal 
pigment epithelium in mouse retina (Grishanin et al. 2008). It plays a role 
in the development of synaptic networks in the inner retina. 
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Table 2.6 Function of the genes within or flanking association signals followed-up in the 
replication phase. A brief description of the genes included in or flanking the corresponding 
association signals are described. 
 
The seven selected markers were typed in 846 cases from London and 120 cases from 
Croatia. Only one SNP (rs12960119) was successfully typed in the Croatian cohort.  All 
markers displayed comparable direction of effect to the discovery analysis, and one 
reached the Bonferroni corrected significance threshold of 0.0035 (7 SNPs; two genetic 
models). Results of the replication stage analysis are given in tables 2.7.A and 2.7.B. 
 
A London Croatia 








rs2045084 0.0009 1.31 1.12 1.54 NA NA NA NA 
rs267738 0.0075 0.81 0.69 0.94 NA NA NA NA 
rs8132771 0.0552 1.22 1.00 1.49 NA NA NA NA 
rs955943 0.2027 1.19 0.91 1.57 NA NA NA NA 
rs12960119 0.4167 1.07 0.91 1.27 0.45 1.23 0.72 2.10 
rs1074463 0.7500 0.96 0.73 1.25 NA NA NA NA 
rs913444 0.6640 1.03 0.88 1.21 NA NA NA NA 
 
B London Croatia 








rs267738 0.0071 0.83 0.72 0.95 NA NA NA NA 
rs2045084 0.0278 1.13 1.01 1.26 NA NA NA NA 
rs8132771 0.1050 1.20 0.96 1.49 NA NA NA NA 
rs955943 0.2919 1.15 0.88 1.50 NA NA NA NA 
rs1074463 0.6203 0.96 0.83 1.12 NA NA NA NA 
rs12960119 0.3704 1.07 0.92 1.25 0.36 1.23 0.79 1.91 
rs913444 0.1080 1.10 0.97 1.25 NA NA NA NA 
Table 2.7. Replication phase association results using a dominant (A) and additive (B) effect 
model for the SNP minor allele Odds ratios with 95% confidence intervals are given for each SNP 






This marker, rs2045084, is located on chromosome 8q24.3, 949bp 3’ of TSTA3 and 
7.8kb 5’ of PYCRL gene and displayed a statistically significant association under a 
dominant model (p=9x10-4, OR=1.31) and nominally significant association under an 
additive model (p=0.028, OR=1.13). The next best associated marker, rs267738, is 
located on chromosome 1q21.3 within an exon of the CERS2 gene and displayed a 
nominally significant association under both additive and dominant models (additive 
p=7.1x10-3, OR=0.83). rs12960119, which almost reached genome wide significance in 
the discovery phase, did not replicate in the London cohort (p=0.37 additive effect). The 
minor allele of this marker (allele G, frequency=0.092) was however associated with 
increased risk, as in the previous analysis, but the effect was smaller in size (OR additive 
model=1.07, OR dominant model=1.07). This reflected the frequency of the G allele of 
rs12960119 in the WTCCC NBS controls used in this replication analysis being higher 
(MAF=0.087) than that of the CEU HapMap population (MAF=0.075) or the WTCCC 
1958BC control sample used in the discovery stage (MAF=0.078), whereas the minor 
allele frequencies were comparable in cases. This marker was successfully genotyped in 
109 cases and 265 controls from Croatia. It did not reach statistical significance (p=0.36) 
in this sample due to the small sample size but the direction and size of the effect 
(OR=1.23; 0.79-1.91 95%CI) were comparable to those in the discovery cohorts, with 
the minor allele frequency of the risk allele higher in cases (MAF=0.14) compared to the 
controls (MAF=0.11).  
 
Genotyping was unsuccessful for the remaining 6 SNPs in the samples from Croatia. 
Less than 90% of the samples were successfully typed in the cases (45% rs2045084, 
51% 267738, 68% rs913444, 51% rs8132771, 45% rs955943) and therefore not included 
in the replication analysis. 
 
A few genotyping steps were involved in typing rs12960119. First attempt of Taqman 
genotyping resulted in missing results for 53 individuals (71 subjects were successfully 
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genotyped). Genotyping of these individuals were repeated, which resulted in additional 
genotyping of 24 individuals. Sequencing was attempted for the remaining subjects. 
PCR did not work for 11 of those individual so sequencing could not be attempted. 18 
samples were sequenced, and results obtained for only 2 subjects. Additionally, 13 
subjects were re-recruited and blood samples were drawn in a new set of vacutainer 
blood tubes. DNA extraction and genotyping were successful for all of the samples, and 
it was concluded that that blood tubes used in the original group of cases must have past 
their expiry dates, since effectively when few samples were redrawn no issue were 
observed.   Given this long and costly process of genotyping rs12960119, the same was 
not attempted for the rest of the SNPs included in the replication stage. 
  
 
2.3.5. Overall meta-analysis 
 
Results for the seven SNPs analysed through both discovery and replication steps were 
combined into an overall meta-analysis (Table 2.8.) and this yielded one variant 
(rs267738) reaching the conventional genome-wide significance threshold and the next 
most significant SNP (rs2045084) falling just below our initial GWAS threshold 
(dominant model p-value=2.59×10-7; threshold set at 1.27x10-7). SNP rs267738, within 
the CERS2 gene, showed the strongest association signal under a dominant effect model 
(p=2.11x10-8). The SNP effect size was consistent in both direction and magnitude 
across all four populations (Figure 2.8.), with cases showing an excess of the major 





Figure 2.8.Forrest plots for the SNPs with the strongest association signals in the combined analysis 
under a dominant model for the minor allele effect. Population odds ratio with respect to the minor allele 
and its 95% CI is represented by a grey box and horizontal line. The bottom rhombus shows the weighted 
estimate of the odds ratio overall studies.   
 
 
The signal in this region was further supported by an additional SNP (rs267733) 
showing suggestive significance in the discovery phase meta-analysis (p=5.29x10-5). 
This marker is located within the gene ANXA9, which is 5’ of CERS2. 
 
The next most significant SNP association in the combined meta-analysis (rs2045084) is 
located 3’ of the TSTA3 gene, and showed some heterogeneity between studies (I2=32.8, 
p=0.22). The association was not significant in the UK discovery cohort (p=0.55, 
OR=1.09 (0.85-1.40 95%CI). The rs12960119 SNP, located in the SS18 gene, which 
reached genome wide significance at the discovery phase, did not replicate in the 
London cohort and did not reach genome wide significance in the overall meta-analysis 
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(p=2.04x10-6, dominant model; p=2.49x10-6 additive model).  Heterogeneity in the 
overall meta-analysis was high under both models (I2=50.2, p=0.09, under a dominant 
model; I2=49.6, p=0.09, under an additive model) and contrasted with the homogeneity 
of association signal in the discovery phase, where three diverse study populations had 
been used.  
 
 
Additive model Dominant model 











rs267738 0.81 0.75 0.88 1.43E-07 ----? 0.78 0.71 0.85 2.11E-08 ----? 
rs2045084 1.16 1.09 1.24 2.85E-06 ++++? 1.25 1.15 1.36 2.59E-07 ++++? 
rs12960119 1.26 1.14 1.39 2.49E-06 +++++ 1.27 1.15 1.41 2.04E-06 
++++
+ 
rs955943 1.41 1.21 1.64 5.45E-06 ++++? 1.42 1.21 1.66 1.51E-05 -+++? 
rs8132771 1.31 1.16 1.48 1.65E-05 ++++? 1.31 1.16 1.49 1.64E-05 ++++? 
rs913444 1.17 1.09 1.26 2.09E-05 ++++? 1.17 1.08 1.29 3.38E-04 ++++? 
rs1074463 1.15 1.05 1.26 2.59E-03 +++-? 1.21 1.09 1.35 2.90E-04 +++-? 
Table 2.8. Combined discovery and replication phases meta-analysis results Odds ratios with 95% 
confidence intervals and direction of effect with respect to the SNP minor allele. Directions of the 
effect are given for respectively the Netherlands, UK, Scotland, London and Croatia studies. 






2.3.6. Genetic risk score  
 
Each of these markers contributed only a modest amount to individual risk of RRD. In 
order to assess the combined effect of our top ranked markers, we prioritized five of the 
SNPs that were followed up at the replication phase and combined them in a genetic risk 
score by using a simple allele counting approach. The difference in mean number of risk 
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alleles between cases and controls was statistically significant in all studies using the 
Mann-Whitney test (discovery Dutch p=2.05x10-5; discovery Scottish p=2.19x10-11; 
discovery UK p=4.1x10-6; replication London p=2.4x10-3). Figure 2.9. illustrates the 
distribution of the risk alleles in our four independent studies, displaying, in each study, 
a higher proportion of cases compared to controls amongst individuals carrying four or 
more risk alleles. 
 
Figure 2.9. Distribution of the number of identified risk alleles in cases (dark grey) and controls (light 
grey) in four different populations. The horizontal axis represents the number of RRD risk alleles and the 







The risk for RRD was estimated for each number of risk alleles, relative to the median 
number of risk alleles in the control populations (3 risk alleles). Individuals with no and 
one allele were grouped together, as well as individuals with 5 or more alleles. ORs were 
calculated for each population separately.  ORs ranged from 0.70 (95% CI 0.53-0.93) in 
Scottish population for 0-1 risk alleles to an odds ratio of 6.05 (95% CI 3.31-11.02) for 5 
or more risk alleles in Dutch study group. A significant increase of RRD risk (OR>1) for 
the individuals with five or more risk alleles was detected in all four populations: with 
odds ratios of at least two in the discovery cohorts and >1.22 in the London replication 
cohort (Figure 2.10.). Confidence intervals around risk estimates for 4 or more risk 
alleles were very wide due to small numbers of individuals. 
 
Figure 2.10. ORs and 95% CI for the 5 risk alleles used to build a genetic risk score. The vertical axis 
represents the OR and the horizontal axis represents number of RRD risk alleles. ORs are calculated 
relative to the carriers of median number of risk allele in the control population for each of the four 
populations separately. Individuals with five of more risk alleles were grouped together due to the small 







2.3.7. Variation in disease liability explained 
 
Following stringent QC (Lee et al. 2011) and using the method of Yang et al. (Yang et 
al. 2010) implemented in the GCTA software, 27.4% of the variance in underlying 
disease liability could be assigned to the combined effect of the markers tagged by the 
primary genome wide scan SNPs. The proportion of the variance explained remained 
comparable when different minor allele frequencies and missing genotype cut-offs were 
used (Table 2.9.). The signal was not due to population structure within Scottish cases 
and controls since it was not found when the Scottish (SOCCS) control group was 
artificially split into cases and controls, (liability transformed estimate=0.000001, 
SE=0.23). These GCTA estimates further supported the evidence of a modest polygenic 











MAF >0.01         
SNP missingness 
0.05 257 095  0.3587 (0.1206) 0.4479(0.1498) 0.275 (0.092) 
SNP missingness 
0.005 255 704 0.3573 (0.1207) 0.4467 (0.1502)  0.274   (0.092) 
MAF>0.05         
SNP missingness 
0.05 250 817 0.3701 (0.1192)  0.4612 (0.1480)  0.283 (0.091) 
SNP missingness 
0.005 249 439 0.3687 (0.1194) 0.4601 ( 0.1484)  0.282 (0.091) 
Table 2.8.Variation in RRD liability explained by the combined GWAS SNPs using different parameters. 
Estimated proportion of the variance in disease liability on the observed  scale (Estimate), corrected for 
imperfect LD between SNPs and causal variants (Adjusted estimate) and liability scale (Liability 
transformed estimate), explained by the consensus panel of SNPs typed on both the Illumina CNV370v3-







2.3.8. Pathway analysis 
 
2.3.8.1. Ingenuity Pathway Analysis (IPA)   
 
The genes putatively underlying the association signals were identified using a protocol 
implemented in GRAIL (Raychaudhuri et al.2009) (several genes were assigned to one 
association signal - Table 3.9). Genes underlie top 6 SNPs from the discovery stage 
meta-analysis were selected for the first step of pathway analysis.  This analysis revealed 
one highly significant network (p=10-62) involving 35 molecules in total, 21 of which 
were present in the top six signals (Figure 2.11.). This network showed enrichment for 
molecules involved in cell death, DNA replication, recombination and repair, and 




Figure 2.11. IPA network obtained with all genes possibly involved in the six top association signals from 
the discovery phase. Molecules colored in grey represent the genes products input. The number assigned 
to such entry represents one of the six SNPs signals (rs12960119-1, rs267738-2, rs955943-3, rs1074463-4, 
rs8132771-5, rs2045084-6) they are attached to. 
 
Additional pathway analysis was carried out using the 23 top results (p <10-4) from the 
discovery meta-analysis additive model (Table 2.10).  Four direct interactions were 
identified in this extended pathway analysis (MCL1-RAE1, rs267738-rs6070015; BMP7-
SETDB1, rs6070015-rs267738; SETDB1-PPA1, rs267738-rs7097067: TIAM1-TrkB, 
rs81232771-rs913444) (Figure 2.12.). The latter is strongly supported by experimental 
evidence of a protein-protein interaction (Myamoto et al. 2006). The SNP rs913444 was 




Figure 2.12. IPA network obtained with all genes possibly involved in the top 23 association 















GRAIL input genes Genes in LD block 
r2>0.8 with index SNP 
rs12960119 PSMA8, TAF4B, SS18 SS18, PSAM8 
rs267738 GOLPH3L, CTSK, FAM63A, SETBD1, CTSS, 
MCL1, CERS2, ANXA9, PRUNE, ARNT, 
HORMAD1, ADAMTSL4, ENSA 
CERS2 
rs955943 LDB2 LDB2 
rs7097067 PPA1, NPFFR1,TYSND1, AIMF2, SAR1A *PPA1,NPFFR1 
rs1074463 CDH12 CDH12 
rs2045084 TSTA3 TSTA3 
rs8132771 TIAM1, SOD1, SFRS15 SOD1, SFRS15 
rs11259960 HOMER2 HOMER2 
rs2368106 CW22 *CW22,UB2E3 
rs7234959 TAF4B,PSMA8, SS18 SS18, PSMA8 
rs6070015 RAE1, SPO11, BMP7, RBM38 BMP7 
rs913444 TRKB *TRKB,AGTBPBP1 
rs4893905 CW22 *CW22,UB2E3 
rs1477441 CDH12 CDH12 
rs12193473 C6orf170 *MAN1A,C6orf170 
rs218843 C6orf170 *MAN1A,C6orf170 
rs4715056 GPR115, OPN5,CD2AP,GPR111 C6orf38 
rs2817896 EPHB2 EPHB2 
rs10515162 RGNEF RGNEF 
rs11181447 GLT8D3, YAF2, ZCRB1, PPHLN1, PRICKLE1 ZCRB1, PPHLN1, 
PRICKLE1 
rs12202993 C6orf170 *MAN1A,C6orf170 
rs564351 GPR115, OPN5,CD2AP,GPR111 *OPN5, PTCHD4 
rs6035211 SLC24A3 *C20orf79,SLC24A3 
Table 2.10. List of genes underlying most significant (p<10-4) SNPs from discovery stage 
meta-analysis  (additive model). List identified by GRAIL is given as well as the list of 




2.3.8.2. MAGENTA analysis 
 
In order to test for enrichment of GWAS results with a different pathway analysis 
tool, MAGENTA pathways analysis was performed. However the analysis 
revealed no significant enrichment of any biological pathways in the GWAS 
results from discovery stage step 1 analysis. No pathway reached the set 
significance threshold (FDR <0.05). Top ranking pathways were pathways 
involved in nuclear transport, mRNA transcription and phagocytosis. Top 50 





To my knowledge, this is the first genome wide association study ever performed for 
rhegmatogenous retinal detachment, a condition which continues to result in significant 
vision loss. Genetic component to RRD has been suggested by the familial aggregation 
studies reporting two to three fold increased frequency of RRD in siblings of affected 
subjects compared with siblings of unaffected subjects in Scottish (λ=2.1) and Dutch 
(λ=2.6) populations ( Mitry et al. 2011, Go et al. 2005). This result is similar to the type 
2 diabetes sibling risk (λ~3; Lyssenko et al. 2005) and much lower than the sibling risk 
in type 1 diabetes (λ =15; Davies et al. 1994). Here the results supporting a polygenic 
component for this condition is confirmed, and several contributing common risk 





2.4.1. Functional relevance of best associated SNPs 
 
A genome-wide significant signal of association with RRD was found for the marker 
rs267738. This is a missense (Glu to Ala) coding SNP located within the CERS2 gene, in 
a gene rich region. The index SNP has been associated with the expression level of 
CERS2 in lymphoblastoid cell lines (exon eQTL for CERS2) (Montogomery et al. 2010) 
making the regulation of CERS2 expression a strong functional candidate for the RRD 
association. CERS2 is expressed in mouse retina (Freeman et al. 2011) and encodes the 
protein ceramide synthase 2 (CerS2), the most abundantly and ubiquitously expressed 
member of the ceramide synthase family (Laviad et al. 2008). Ceramide-enriched 
membranes domains amplify diverse signals and are critically involved in inducing 
apoptosis (Schenck et al. 2007).  Ablation of CerS2 in mice causes changes in 
biophysical properties of the cell membrane, due to the lack of long chain ceramides 
(Sylva et al. 2012). In vitro, ceramides have been shown to mediate apoptosis of 
mammalian photoreceptors (German et al. 2006, Sanvicens et al. 2006) and retinal 
pigment epithelium cell lines (Kannan et al. 2004, Tomita et al. 2000, Sreekumar et al. 
2009). In a mouse model of retinitis pigmentosa, inhibition of ceramide synthesis slowed 
disease progression (Strettoi et al. 2010) and mutation in the ceramide kinase like gene 
CERKL has been implicated in a recessive form of retinitis pigmentosa in humans 
(Tuson et al. 2004). Increased cellular ceramide levels were found in brains of patients 
with Batten’s disease (Puranam et al. 1997) and in retinas of patients with Farber’s 
diseas (Zarbin et al. 1988). A feature of both diseases is blindness, although this is due to 
retinal degeneration rather than detachment. An association signal with RRD in this 
region is supported by an additional association of SNP rs267733 (p=5.3x10-5, dominant 
model) located 11kb from CERS2. A variant in high LD (rs267734; r2=1) with this SNP 





The second strongest association signal is located on chromosome 8q24.3 between two 
genes (PYCRL and TSTA3) but the block of high LD with the index SNP comprises only 
the TSTA3 (tissue specific transplantation antigen P35B) gene (Figure 2.13.). TSTA3 
encodes the enzyme GDP-L-fucose-synthetase, which catalyses the conversion of GDP-
4-dehydro-6-deoxy-D-mannose to GDP-fucose in the de-novo-synthesis of GDP-fucose. 
GDP-fucose is a substrate in the posttranslational fucosilation reactions. Mice with 
induced null mutation in the TSTA3 gene show a complete deficiency in cellular 
fucosylation (N-fucosylation, O-fucosylation and E-/P-/Lselectin activities) (Smith et al. 
2002). This enzyme has been shown to play an important role in the post-translational 
fucosylation of selectin ligands (Smith et al. 2002). Selectins are cell adhesion molecules 
which bind to specific carbohydrate determinants of molecules on opposing cells, and 
play an important part in the inflammation processes (Ley, 2003). It has been 
demonstrated that GDP-L-fucose-synthetase controls adhesion of colorectal cancer cell 
to endothelial cells (Zipin et al. 2004). Furthermore, the de novo synthesis of GDP-
fucose plays an important role in the flagellar adhesion in Trypanosomabrucei (Turnock 
et al. 2007). Given this evidence, GDP-L-fucosesynthetase could potentially play a role 





Figure 2.13. Regional LD plot around rs2045084 is presented. A region of 500 kb around the SNP is 
displayed. Recombination rate is displayed by a blue line with scale on the right-hand axis and the R-
squared scale on the left-hand side. Genes are displayed in the bottom part of the figure, with the arrow 




Finally, marker rs12960119 which reached genome wide significance in the discovery 
step, but  failed in the replication step, is located within the SS18 gene. This remains, 
however, a particularly strong candidate gene for association with RRD because of the 
role of SS18 in cell adhesion. SS18 is expressed in many adult tissues and, in mouse, the 
protein was detected in all cell types of the retina (Kim et al. 2009). Integrins are 
transmembrane heterodimer glycoproteins that play an important role in cell signalling. 
They are the main receptor proteins for both binding and responding to the extracellular 
matrix and various matrix proteins are recognized by multiple integrins. Integrins bind 
the extracellular matrix to the actin cytoskeleton, which activates signaling cascade 
involved in cytoskeletal reorganization and cell adhesion processes. Cytosolic SS18 has 
been shown to bind F-actin and to play an essential role in the formation of stress fibers 
and focal adhesion (Eid et al. 2003). Ablation of SS18 in cultured human cells led to 
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compromised adhesion on specific extracellular matrix substrates (fibronectin and 
laminin-111 but not on collagen type I and IV) (Kim et al. 2009) prompting the authors 
to propose cytosolic SS18 as a sensor of extra cellular signals. In chicks and rats retina, 
β1 integrin and fibronectin had been localized exclusively at the basal membrane of 
RPE, chroriocapillaries and at the vitreo-retinal border (Philip et al. 2007). A type of 
integrin molecule (αvβ5-Integrins) that may play a role in the binding of RPE to the 
interphotoreceptor matrix (Fineman et al. 1997, Finneman et al. 2003) have been found 
at the apical part of the retinal pigment epithelium (RPE-photoreceptor interface) in 
human and rats (Finneman et al. 2007). However the role of SS18 in activating this 
specific class of integrin is unknown, and retinal detachment occurs on the basal part of 
RPE.   
 
The region of association with RRD is in high LD with an evolutionarily highly 
conserved sequence in the 3’ UTR region of the SS18 gene, suggesting a functional role. 
While the association signal in this region was not replicated in a large UK sample using 
NBSC controls, the minor allele frequency difference for the index marker was high at 
3% between cases and controls in the Croatian replication sample. However it did not 




2.4.2. Pathway analysis 
 
 
The non-randomness of the top association signals in our discovery phase analysis was 
tested through their connectivity in “in-silico” pathway networks occurring more often 
than by chance. A highly significant network was created based on the six most 
significant association signals and included 21 of our 22 entries, in a network of 35 
molecules, which is an unusual result (Figure 2.11.). However when a different approach 
was used that tests for enrichment of the top signals in the known pathways, and does 
78 
 
not create a new “in silico” networks, no significant results were revealed.  IPA analysis 
was expanded to include more signals (index SNP with association p-value <10-4). In the 
resulting network, direct protein-protein interaction annotations were detected. For 
example, an interaction between TrkB (encoded by NTRK2 gene) and TIAM1. TIAM1 
encodes a guanine nucleotide exchange factor which activates a small GTPase of the rho 
family and modulates changes in cytoskeleton downstream of membrane receptor 
stimulation. These receptors include TrkB (Miyamoto et al. 2006) a receptor for brain 
derived neurotrophic factors, but also adhesion molecules such as β1 integrins 
(Hamelers et al. 2005, O’Toole et al. 2011). The former, TrkB, and β1 integrin links 
functionally with the SS18 product.  TIAM1 signalling is also required in E-cadherin 
mediated cell-cell adhesion (Malliri et al. 2004). In mouse retina, TrkB protein is 
detected in the inner plexiform layer (IPL) and RPE (Grishanin et al. 2008) and while it 
plays a role in the development of synaptic networks in the inner retina, a role in the 
RPE has not been established. The TrkB-TIAM1 interactions, and the interaction of 
SS18 to actin filaments and activation of integrin, suggest a significant role for these 
players in the regulation of actin cytoskeletal organisation in the pathogenesis of RRD. 
They may also participate in the strength of the apical RPE filopodia – photoreceptor 
outer segments’ inter-digitation and adhesion. Our pathway analysis did not demonstrate 
an enrichment of highly significant results in any of the known pathways (MAGENTA 
analysis), however this analysis only utilized results from the genome-wide scan and 
therefore omitting some significant results obtained from the later meta-analysis of the 
discovery stage populations. This problem is also present in the IPA analysis as only top 
signals were chosen.  
 
 
2.4.3. Risk conferred by combined variants 
 
While single marker associations were weak, association with RRD jointly using the five 
markers showing the most significant and consistent association was significant in all 
four studies (Scottish discovery, Dutch discovery, UK discovery, London replication) so 
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that the combined genetic score was a potentially useful predictor of disease. Using all 
the genotyped SNP additive effects from the discovery genome-wide scan jointly, 
explained 27.4% of the underlying liability to RRD, supporting a moderate polygenic 
contribution to disease status (solely due to the common variants tested in this scan). 
This method have been successful in explaining the proportion of genetic variance in 
other complex diseases and traits with previously identified risk loci (Chron’s disease 
23%, bipolar disorder 39%, type I diabetes 30%, (Lee et al. 2011)), as well as in traits 
where no single risk variants have been identified in genetic association analysis 
(cognitive ability change from childhood to old age; account for 24% of the variation 
(Deary et al. 2012)). It has been suggested that estimating the proportion of variance 
explained that is due to all SNPs jointly may be inflated due to the confounding effect of 
population structure (Browning and Browning 2011). However, I believe that this should 
not be a strong contributory factor in our discovery cohort as the variance explained in 
the controls alone, randomly labeled as cases and controls, was negligible. The ancestry 
clusters drawn in RRD cases and Scottish controls were overlapping (Figure 2.2.) and 
care was taken to remove systematic differences between RRD cases and controls due to 
the different genotyping platforms used (Mitry et al. 2011).  
 
 
2.4.4. Issues regarding imputation of cases-control data  
 
Analysis of the imputed data was not successful. An overabundance of highly significant 
associations when standard QC restrictions were applied highlighted the known issue of 
Type 1 error inflation in the analysis of case-control data imputed from different 
genotyping platforms. After more stringent QC criteria were applied, the number of 
highly significant SNPs dropped. However, even with this rigorous criteria 37-53% of 
highly significant SNPs (p<10-5) in cases and controls presented allele frequency 
difference greater than 5% when compared to CEU’s frequencies. In addition, when 
highly significant marker’s frequencies were compared between the control set 
(SOCCS) and another Scottish cohort (LBC), similar inconsistencies were observed 
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except for one region on chromosome 4. Since the data are imputed against the HapMap 
CEU population, when MAF in cases (or controls) differs considerably from the CEU, 
the end result is a very different MAF for that particular SNP between cases and 
controls, which drives highly significant associations. Based on these allele frequency 
difference it can be suggested that association signals could come as a result of the 
imputation process and are artifacts of data imputation errors (and not as a result of true 
associations).  This differential measurement error introduced when case-control data are 
imputed from different genotyping platforms has now been well known and documented 
(Sinott and Kraft, 2011). This problem is improved but not completely resolved if cases 
and controls from different platforms are imputed together as one population (Sinott and 
Kraft, 2011), and therefore re-imputing the merged case-control data was not attempted. 
It has been demonstrated that for SNPs with low MAF, even a small error in genotyped 
calling produces an inflation of Type 1 error (Moskvina et al. 2006). Finally, re-
genotyping a number of controls alongside cases in order to exclude SNPs with 
problematic gene calling was proposed, and it was shown to reduce Type 1 error (Sinott 
and Kraft, 2011), however it also requires that a substantial number of SNPs be excluded 
from the final analysis. This was not attempted in this analysis, due to the financial 
restrictions of the study. Finally it is important to point out that studies looking into issue 
of case-control imputation suggest genotyping cases and controls at the same time as the 
best possible strategy, which was not possible for this particular study. Imputation 
analysis results were not included in the subsequent steps, but will be worth further 
investigations in the future.  
 
 
2.4.5. Study limitations 
 
In addition to the data imputation issues, there were a number of other limitations to this 
study. As we followed up only a subset of the variants tested in the GWAS discovery 
step, variants which displayed a non-statistically significant association at this first stage 
may have been missed and yet could have been statistically significant in the larger 
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sample size of the combined datasets (false negatives due to lack of power). 
Furthermore, there was a substantial failure rate (14%) of the SNPs tested on the 
customized iSelect Illumina platform in the follow-up discovery step. We tried to 
minimize the effect of this by (re)genotyping the most significant markers not 
represented by a proxy SNP, however true associations could still have been missed. A 
further limitation was the use of controls from studies or repositories that were 
genotyped independently using different genotyping platforms. This can create 
confounding but true associations should remain consistent across the case-control sets 
assembled. The controls were unselected with regard to phenotype therefore a number of 
RRD cases might be expected within the control series given the relatively high 
prevalence of RRD (0.8%) (Mitry et al. 2011). Since the number of affected RRDs may 
have fluctuated across control series by chance, this may partly explain the heterogeneity 
across studies. Furthermore, significant population structure has been reported in two of 
the WTCCC control cohorts, 1958 BC and NBS (Browning and Browning 2011), that 
we used in the discovery and replication stages respectively, making it a possible 
explanation for the non-replication of the SS18 locus. NBS controls had a 1.2% higher 
allele frequency for rs12960119 compared to that in the HapMap CEU population, and a 
0.9 % higher allele frequency than that in the other control group used in the discovery 
step (1958 Birth Cohort). The fact that only a subset of SNPs had been typed in the RRD 
cases used after the stage 1 discovery prevented us from correcting for population 
structure for the matched RRD cases and controls in the usual manner (by adjusting for 
ancestry principal components). Heterogeneity of the RRD phenotype is an additional 
concern as other underlying pathologies usually precede its development, e.g. posterior 
vitreous detachment, high myopia, lattice degeneration. Larger studies will be useful to 
tease apart the possible differences between these two pathologies. Results from the 
published GWAS on high myopia (Kieferet al. 2013, Verhoven et al. 2013) and lattice 
degeneration (Meguro et al. 2012) did not show any overlap with our most significant 
associations and neither the SS18, CERS2, or TIAM1 signal strengths were affected by 
removing high myopes from the RRD cases in the primary analysis (Appendix III) 
although the TSTA3, TrkB and CDH12 associations may be influenced by myopia.  This 
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study was not designed to explore the association of rare variants with RRD, and given 
the fraction of underlying disease liability not accounted for by the common variants 
tested in this study, the search for rare variants influencing RRD is warranted. Finally, 
given our sample size, we had limited power to detect and replicate variants of moderate 





Despite these limitations, this first genetic association study of RRD supports a 
polygenic component underlying RRD risk, and identified several common variants of 
moderate effect contributing to risk. Additional studies will be required to confirm the 
individual variants highlighted in this study and additional genotyping and increased 
sample size will be needed to extend this first exploration of the genetic basis of RRD. 
Since the pathogenesis of RRD is not fully understood, the identification of genes 
influencing it should make an important contribution to furthering our understanding of 



















This chapter aims to provide detailed information about retinal fundus image analysis, 
the various traits derived from the images and the trait selection procedures used in this 
study. Semi-automatic computerized methods for the analysis of quantitative traits 
derived from retinal photographs are detailed, and the most commonly used traits in the 
analysis of the retinal vessel architecture are also examined.  The VAMPIRE software 
used in this work had been recently updated at the start of this project, hence this chapter 
provides information on the validation procedures essential for any newly developed 
software. Finally the selection process for the traits used in the subsequent genetic 
analyses is explained. 
 
 
3.2. Retinal fundus image 
 
The medical term “fundus” refers to the base of an organ. For the eye, this term is used 
for the portion of the inner eye visible though the ophthalmoscope or the fundus camera. 
It represents the retinal layer of the eye captured by the external camera. The retina is 
photographed directly though the pupil, which is used as both an entrance and an exit for 
the fundus camera's illuminating and imaging light rays. An external source of light 
illuminates the retinal surface, which is then reflected in order to capture a 2-
dimensional image of the 3-dimensional retinal tissue surface. This 2-dimensional image 
84 
 
of the retinal surface is termed a retinal fundus image. A typical fundus camera views 
between 30 and 50 degrees of the retinal surface, and magnifies it 2.5 times.  
 
Figure 3.1. Top left panel represents a schematic 
picture of the creation of fundus image with different 
angles of the camera. Remaining panels represent 
fundus images with the 40, 20 and 60 degree angles of 






The main physiological features of the retinal fundus image include the optic disc, the 
optic cup, retinal vessels, fovea and macula. Fundus images can be centred on different 
retinal features, depending on the purpose. The most commonly used ones (due to the 
medical purpose of each) are: optic disc cantered images (glaucoma), macula cantered 
images (macular degeneration) and images cantered between the optic disc and the 
macula(diabetic retinopathy). Most large scale retinal vessel analysis studies use images 
cantered around the optic disc or between optic disc and the macula. These two image 
fields provide the most details of the retinal microvasculature, as they capture the area 
where the circulation enters and leaves the retina. Specialised computer software has 








 3.3. Fundus photography and digital imaging 
 
A Canon digital fundus camera which digital back was used to capture non-mydriatic 
retinal photographs centred between the macula and optic disc for the ORCADES and 
the Croatia-Korcula study participants. The first step in digital imaging is image capture. 
The image is composed of an array of pixels of varying intensity across the image. This 
intensity corresponds to the level of "greyness" (or red, green and blue for a colour 
image) at a specific point on the image. Modern digital imaging cameras give high-
resolution images (camera used in this study is a 12Mpixel) that can later be digitally 
analysed. Image processing operations transform the "greyness" (or RGB) values of 
pixels.  
 
Image quality is a major issue in retinal image capture, and image enhancement can 
develop or improve an image to a point more suitable for subsequent use (image is 
improved for viewing, processing or analysis). Image restoration helps to reverse 
damage generated by known causes. The major challenge in the processing and analysis 
of digital image is the effect of the magnification, due to differences in refraction, axial 
length, and distance and angle between the camera and the eye (Patton et al. 2006). This 
challenge can be overcome by taking into the account the optics of the eye and the 
position of the camera, however, in studies that collect large numbers of individuals this 
can be difficult to achieve. Therefore many studies have turned to dimensionless or 
magnification-independent measures to nullify any magnification effect. Such 
dimensionless traits are arteriovenus ratio (AVR), bifurcation angles, vascular tortuosity 
and fractal dimensions. These measures overcome the magnifying effect, but can also 
mean a loss of pertinent information. For example, AVR is a ratio between arterial and 
venular widths, and many studies showed that different conditions relate specifically to 
arterioles or venules. Many studies chose to ignore magnifying effect in order to capture 
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more information. Researchers in the field of retinal image analysis have acknowledged 
magnification bias, but it still remains an issue in the field of retinal vessel research.  
 
 
3.4. Computer assisted methods for retinal vessel analysis 
 
Measuring retinal vessel topography by hand is time consuming and laborious activity 
that effectively precludes the assessment of large number of individuals and hinders the 
detection of small differences. Hence, computerised approaches have been developed to 
increase the number of images that can be assessed. Further, the process itself is 
objective compared to the more subjective manual measurements. Two different types of 
software were used for the quantitative retinal vessel analysis: VAMPIRE and SIVA. 
 
VAMPIRE 
VAMPIRE was developed by Dr Tom MacGillivray at the University of Edinburgh 
(Wellcome Trust Clinical Research Facility) in collaboration with School of Computing, 
University of Dundee (Prof Emanuel Trucco and Adria Perez). The software employs a 
high-performance supervised classification Gabor wavelet algorithm (Soares et al. 2006) 
as a pre-processing step to segment the retinal vasculature in fundus images (and to 
divide pixels into vessel and non vessel classes). The image is filtered at different scales 
to highlight vessels of different sizes. Processing is performed on the green channel of 
the colour fundus images as this typically exhibits the greatest contrast between vessel 
and background. All algorithms were implemented in Matlab (The Mathworks Inc., 
USA). The green channel is first inverted so that vessels appear brighter than the 
background, and then filtered. The pixels of a fundus image are considered to be objects 
represented by feature vectors which allow the application of statistical classifiers to 
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segment the image into two classes, vessel and non-vessel. Training sets for the 
classifier were constructed from manual segmentations of the images by trained 
researchers. 
 
All vessels captured by the fundus image are automatically tracked, with branching 
points automatically selected by the program (Figure 3.2.). Optic disc grid placement is 
done manually by the grader, and is required for the initialization of the tracking 
procedures.  
 
Figure 3.2. A model image analysed 
automatically by the VAMPIRE software 
(from the ORCADES study). Fractal 
geometrical analysis (analysis of the 
complexity of the microvasculature) and 
detection of vascular bifurcation points 





The program uses information from all tracked vessel from each image to calculate 
fractal dimensions of a given vascular tree. The user can decide whether to use all or to 
select specific tracked branching angles in the given output of the image analysis. 
Separate protocols for analysing branching angles was devised and followed during the 







Semi-automated computer-assisted image program SIVA (Singapore I Vessel 
Assessment) was the second software used in this project (Cheung et al. 2010). It was 
developed at the School of Computing, National University of Singapore. Their 
approach includes “techniques from wavelet analysis, texture analysis, and curvature 
ridge/trench analysis, to attain the desired clinical sensitivity” (SIVA Brochure, Exploit 
technologies). The software supports automatic optic disc grid placement with an 
additional manual placing option (when the automated assignment needs to be 
corrected). Vessels located 0.5 - 2 disc diameters away from the optic disc are tracked 
automatically, if wider than 40µm. Vessel type (venules or arterioles) is also 
automatically detected by the software. Tracking of the vessels and vessel typing 
(venules/arterioles) is subsequently improved manually by the grader, as the software 
does not detect or track all the vessels correctly (Figure 3.3.). 
 
Figure 3.3. Example of the 
automated tracking of the 
retinal vessel completed by the 
SIVA software. Blue vessels 
represent automatically 
detected venules and the red 
ones automatically detected 
arterioles. The majority of the 
vessels are not tracked or 
typed in the correct way, and 
manual correction is needed 
for each image analyzed. 






The software automatically generates series of transverse stripes (referred to as ‘covers’ 
in SIVA) measuring the distances between pixels at the edges of the vessel, later used to 
generate vessel width measurements (described later in the text). These stripes are 
perpendicular to a tracked vessel wall and appear at regular intervals down the length of 
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the vessel. In the final step of the image analysis by SIVA, these lines have to be 
checked and manually corrected by the grader (Figure 3.4.). 
 
Figure 3.4. Lines perpendicular to the vessel are generated by the software, and later manually corrected 
by the grader. Lines under/over estimating the width of a vessel (in yellow)  are removed and are not used 




Two different areas of the fundus image are used to derive vessel traits; areas are 
between 0.5 and 1 disc diameter, and between 0.5 and 2 disc diameters (Figure 3.5.).  
Once the tracking process is completed, measurements are automatically exported. 
Quantitative vessel traits derived by the SIVA software are: vessel caliber 




Table 3.5. Example of a 
retinal fundus images 
analyzed with SIVA 
software. SIVA is semi-
automated retinal vasculature 
measurement program- with 
automatic optic disc 
detection placement - 
measures peripheral vessels 
up to 2 disc diameters away 
from optic disc. Zones B and 
C are highlighted in the 





The grading protocol developed in the Singapore Eye Research Centre was followed 
during the grading process (Appendix V) and required relatively extensive manual 
editing as it had been set for scoring of Asian eyes. 
 
 
3.5. Quantitative retinal vessel traits 
 
3.5.1. Vessel widths 
 
The retinal vessel calibre measured from the colour fundus images was believed to 
measure the width of the streaming column of reflective erythrocytes (central red blood 
cell column), and does not include the surrounding plasma zone and the vessel wall, 
which are transparent to the fundus photography. This is based on the notion that 
erythrocytes flow in the centre of the retinal vessel, just like in other vessels, while the 
outer segment, that flows at a slower pace, consist mainly of plasma. However, one 
recent study found only very slight differences between width measurements from 
fundus images and fluorescein angiographs (Pakter et al. 2011). As fluorescein 
angiography is the method of choice for blood column visualisation, the authors of this 
study have concluded that the overall lumen (erythrocytes and plasma) is also measured 
by the fundus photography. Assessment of the retinal vessel’s diameters from a digital 
colour fundus applies a micro-densitometric approach which uses intensity profiles of a 
grey-scale image. Grey scale digital images consist of many pixels, and each one has a 
spatial co-ordinate and an intensity value, also known as its grey value. Each pixel point 
in a line perpendicular to the retinal vessel will have various intensity levels, 
subsequently producing a distinct double Gaussian distribution curve against the 
background intensity of the surrounding retina (Patton et al.2005; Figure 3.6). This 
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double Gaussian curve is then used in the image analysis for the estimation of the vessel 
width, most commonly by estimating it at half height of the peak of the intensity profile 
of the Gaussian curve (half-height method). Image analysis software automatically 
generates a series of perpendicular lines to a retinal vessel in a predefined zone, 
information gathered by the tracking algorithm is then summarized using formulae to 
obtain values representing the average arteriolar and venular calibre of that particular 
eye.     
                     
a.                                                                                                        b.                                                                                                                              
 
Figure 3.6. a. Example of the tracking procedure used by the software used for tracking the vessels 
(Orkney image) , b. Information gathered by the tracking algorithm is then used to calculate vessel widths 
(Patton et al. 2005). 
 
The most commonly used measures used for describing arteriole and venule widths are 
CRAE (central retinal artery equivalent) and CRVE (central retinal vein equivalent). 
These measures were developed to standardise the way in which retinal vessel calibres 
are reported, and to summarize the average widths of vessels surrounding the optic disc. 
The CRAE measurement was devised by Parr and Spears (1974) and improved by 
Hubbard et al. (1999). The CRVE was developed by Hubbard et al. 1992 based on the 
Parr and Spears CRAE formula. Both of these formulae were derived by examining 
numerous vascular junctions in retinal images of young healthy normotensive 
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individuals. The relationships between the trunk vessel and its respective branches, for 
numerous vessels in a predefined zone around the optic disc, were calculated using a 
least root mean square deviation model that best fit the observed data. Hubbard et al. 
further developed the measure by combining the largest vessel with the smallest one, the 
second largest with the second smallest one, until all vessels are combined. Knudtson et 
al. (2003) developed a revised measure based on the six largest arterioles and venules 
passing through the predefined zone, making this measurement independent of the 
number of vessel measured in each image. They used the same iterative process of 
pairing the largest and the smallest vessels (there are only 5 iterations because only six 
vessels are being measured). In this method a “branching coefficient” is measured which 
gives the ratio of the branch and trunk vessels: 
 
Branching coefficient= (w21+w22)/W2 
 
Where W is the width of the trunk vessel and w1 and w2 are the widths of the two 
branch vessels. They measured 187 arterial and 151 venular junctions in a sample of 44 
young healthy individuals. By placing the values calculated from these images in the 
above formula, they calculated that: 
 
CRAE: Wa=0.88√(w12+w22)    - arterioles  
CRVE: Wv=0.95√(w12+w22)    -  venules 
By using the pairing method (combining smallest and largest vessel in each pairing), 
CRAE and CRVE are then calculated. In SIVA these measurements are done for the 
standard (0.5-1 OD diameter) and the extended (0.5-2 OD diameter) zones (the measures 
of vessel widths were not available in the VAMPIRE software). The computation of the 
retinal vascular calibre in the extended zone additionally includes the width of the first 




The most commonly used dimensionless measure is AVR, the arteriolar-venular ratio. 
AVR=CRAE/CRVE (smaller AVR signals relatively smaller arterial diameter or wider 
venous diameter). A limitation of the AVR measures is that arterioles and venules can 
have different responses to different pathological mechanisms, and therefore the 
independent use of CRAE and CRVE can possibly provide more information.  
 
 
3.5.2. Bifurcation parameters 
 
Branching angles 
The bifurcation angle refers to the angle between the two daughter vessels, branching 
from the parent vessel. It provides information about the architecture of the vessel 
network, which determines the efficiency of the circulation. In a healthy state, the 
vascular network tends to conform to some fluid dynamic principals of the optimal 
structure in order to minimise the shear stress and work and in turn maximises 
efficiency. Murray (1926) calculated that if the blood flow across the vessel network is 
proportional to the cubed power of the vessel radius it achieves the most efficient 
circulation (Murray’s law). In addition to this, an optimal angle between the two 
daughter vessels at a vascular junction was calculated to be 75˚ in order to minimize the 
principle work across the vascular network (Murray 1926).  
When measuring branching angles, the software generates a skeleton from a binary (i.e. 
segmented) map of the vasculature and it locates the intersecting junction points of 3 
vessels. A set number of points are extracted from each branch and a straight line fitted. 
For each junction, the 3 straight lines are used to find an improved junction point in a 
least squares manner. The improved junction point in conjunction with the previously 
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extracted vessel branch points are fitted with another straight line this time anchored at 
the new bifurcation point. These fits are used to calculate the branching angle.  
 




The measurement of the branching coefficient is based on vessel widths between the 
parent and two daughter vessels. In addition to the branching angle, it is also an 
important factor determining retinal vascular architecture. And changes in these 
measurements have implications in the distribution of shear stress (defined as a stress 
which is applied parallel or tangential to a surface of a material) across the network. 
Theoretical predictions estimated its optimal value to be 1.26.  Branching coefficients 
are used for the calculation of "revised" CRAE and CRVE measurement, a method 










The tortuosity is a measure of the degree of curvature of a vessel. Degree of tortuosity of 
a vessel can be defined as the ratio between the distance a vessel travels from A to B and 
the shortest distance between the points A and B drawn by a straight line. It is a 
diagnostic parameter assessed by ophthalmologists on the basis of examples and 
experience; however no quantitative model is specified in clinical practice. Image 
analysis techniques implemented in the SIVA software measure two types of tortuosity: 
simple and curvature. Simple tortuosity is estimated as the difference between the 
lengths of the vessel segment measured by vessel tracking and the straight line length of 
the same segment divided by the straight line length. This is a simple measure and it 
does not distinguish the curve bowing from multiple points of inflection (Figure 8). The 
second measurement, curvature tortuosity, is defined as the integral of the curvature 
square along the path of the vessel, normalized by the total path length and provides a 
more accurate measure of the vessel’s curvature (Figure 3.8).  
            a                                                                               b 
 
Figure 3.8. a) Difference between simple and curvature tortuosity measurements with respect to curving 
and inflection points (image from Witt et al. 2006). b) Tortuosity measurements are obtained from the 




3.5.4. Fractal analysis 
 
Retinal vasculature is a complex branching structure and difficult to describe using only 
the simple Euclidian geometry, thus the individual measures described above do not 
provide a global measure of the vasculature as a whole. Fractal analysis denotes one type 
of analysis used to describe geometrical patterns that defy Euclidian concepts. Any type 
of fractal analysis is based on fractal dimensions, which are a measure of the geometric 
complexity of a spatial object (e.g. the vascular tree). Fractal dimensions describe how 
well a pattern fills two-dimensional space, described as a form of symmetry (Master, 
2004). In retinal image analysis it attempts to describe the branching patterns of the 
vascular system, and is based on the concept of self-similarity of spatial geometrical 
patterns (fractals are self similar objects).   
 
The first step in a fractal analysis is the determination of its fractal dimensions (D). 
There are several methods for determining fractal dimension; box counting, mass-radius 
relation and pair correlation function method. The most commonly used in retinal image 
analysis is the box counting method. In this method a binary image is covered with 
square boxes of the length L. The number of boxes covering the images is counted (N). 
The size of the box is then increased and the process repeated. A log-log plot of numbers 
(N) vs box length (L) is plotted and the slope of the plot calculated by least square 
regression. The slope of the plot is –D, and D is the box-counting fractal dimension. 
This is a monofractal analysis and it yields a single fractal dimension, which is a 
dimensionless quantity that measures the degree of branching complexity for the 
structure. However, retinal blood vessels may have different properties in different 
regions of the retina, and so different characteristics can be found depending on the 
location or scale of the measurement considered.  A multifractal approach calculates 
multiple fractal dimensions from numerous (~1000) randomly chosen starting points on 
the vessel tree. Based on the fact that this measure takes into account the retinal vascular 
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system as a whole and at different scales, it could be expected that it will prove to be the 
best quantitative measure of overall vascular architecture. (MacGillivray et al. 2007). 
  
Figure 3.9. Fractal analysis areas measure by VAMPIRE(a) and SIVA (b) (using two different images) 
 
The VAMPIRE software utilises both mono and multiracial analysis and captures the 
vasculature from the entire retinal fundus image (Figure 3.9. a). In contrast to SIVA, the 
fractal dimension is only measured in the extended zone (0.5-2 OD diameters; Figure 
9b) and returns a monofractal value, using a curvature based segmentation (Cossato et 
al. 2010). On the other hand, it offers separate fractal measurement for arteriolar and 
venular networks separately, in addition to the measurement of the complete vasculature.  
 
 
3.6. Quantitative traits derived from the optic disc and their assessment 
 
Alongside retinal vessel traits, traits derived from the optic nerve or optic disc are most 
commonly analysed from the retinal fundus images.  Three major traits were typically 
analysed from the fundus images are optic disc area, an optic cup area and a cup to disc 
ratio (CDR). These traits play a very important role in the diagnosis of glaucoma. 
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Images from the ORCADES participants were sent to Singapore to be automatically 
analysed by the AGLAYA software. This system automatically detects glaucoma from 
multiple image features of retinal images.  As the optic disc region is very small 
compared to the rest of the fundus image, the first step is to extract the region of interest 
via pixel intensity analysis. This is followed by the segmentation of the optic disc using 
a variational level-set algorithm and boundary smoothing of the detected disc. The same 
procedure is repeated for the optic cup. Due to the decreased visibility of the boundary 
between the optic cup and the surrounding optic disc region and the vessels, this is more 
challenging. Therefore, a multi modal approach is used combining several different 
algorithms (level-set algorithm and colour intensity method). After extracting the disc 
and the cup are, CDR is calculated from the vertical extents of the cup and disc. 
Complete analysis of the ORCADES images was done conducted in Singapore and the 
results were sent in the Excel spreadsheet. 
 
 
3.7. Measuring retinal vessel vasculature parameters 
 
Retinal fundus images were obtained at a 45° angle using a high resolution digital 
camera (Canon CR-DGi non mydriatic retinal fundus camera). All images were stored in 
JPEG or TIFF format (high resolution digital images), depending on the study. Retinal 
photographs were centred between optic disc and macula. Images centred overly 
towards the macula, with optic disc on the side of the field, were not used in the further 
image analysis as they would not allow grading of the vascular network in the extended 
zone (if more than half of one quadrant of the extended zone was missing, the image was 
considered ungradable). Furthermore, only retinal image with at least four major arteries 
and venules present in the zone of grading were followed up. Images of very poor 
quality (e.g out of focus, overexposing of the lens) or with known pathologies 
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influencing image quality (e.g cataract, asteroid hyalosis) were not used in the further 
image analysis. 
   
a.                                                    b.                                                             c.  
Figure 3.10. Examples of images removed before the image analysis.an a- cataract; b-asteroid hyalosis; c-
more than half quadrant missing 
 
Measurements were obtained on one eye for each subject. If both images were of the 
same quality, the right eye was chosen, otherwise the eye with the better photographic 
quality was chosen. The analysis of the ORCADES and CROATIA-Korcula images was 
conducted by the me. The Lothian Birth Cohort (LBC) images were graded by the me 
and two other graders. Retinal images from ORCADES, CROATIA-Korcula and 
Lothian Birth Cohort included in the study were analysed by semi-automated computer 
image analysis software SIVA and VAMPIRE.  VAMPIRE was used for branching 
parameter (ORCADES) and fractal analysis measurements (ORCADES, Korcula, LBC). 
Images graded by SIVA include measurements for vessel calibres, tortuosity, branching 
parameters and fractal dimensions. A detailed list is given in Table 3.1. 











Vessel calibre (standard and extended zone) 
Simple tortuosity  
Curvature tortuosity 
Monofractal analysis (complete vasculature, arterial 
vasculature and venular vasculature in extended zone C) 
Branching angles 
Branching coefficient 
Length to width parameter 
Table 3.1. Retinal vascular parameters measure by VAMPIRE and SIVA softwares. 
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 In total 820 images from Orkney, 420 from Korcula and 397 LBC images were 
analysed by SIVA and VAMPIRE. 
 
 
3.8. Validation of the branching angles analysis with VAMPIRE 
 
Prior to the use of a computerized image software analysis in a large study, the 
method/sytem requires to be tested and validated. The SIVA licence was purchased from 
the Singapore Eye Research Institute and tested and validated by them, with a very 
detailed grading protocol. Extensive onsite training of the author was also required, 
which was necessary for comprehensive and accurate usage of the program. VAMPIRE 
was developed by the University of Edinburgh in collaboration with University of 
Dundee and, at the start of this PhD study, was still under development. These 
developments to improve software available in Edinburgh meant that measurements of 
bifurcation branching angles had to be tested before use in the ORCADES study. The 
agreement between human and computer measurements was assessed using 20 retinal 
images. On each image we aimed to measure 5 venule and 5 arteriole branching points. 
Due to the different retinal patterns and varying image quality, it was not always 
possible to identify these and so the number of measures for each image varied between 
2 and 5. Images were manually analyzed by two different graders using the angle 
measurement tool in ImageJ (http://rsbweb.nih.gov/ij/) and compared. Subsequently, 
human measurements were compared to the results obtained from a semi-automated 
computer method. Results are shown in Figure 3.11. 
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Figure 3.11. Bland-Altman plots of human vs human and human vs computer measurements 
 
A Bland-Altman plot describes the agreement between two quantitative sets of 
measurements. In the plot the difference between the paired sets is plotted against the 
average of the two measurements. The agreement between two quantitative methods is 
considered to be good if 95% confidence intervals include 95% of differences between 
the two measurement methods. The first plot in Figure 11 shows the mean difference 
between two human raters was 4.3° with 95% Confidence Interval (CI) of -13.9° to 
22.4° while the second shows the mean difference between human and computer was 
5.8° with 95% CI of -17.5° to 29°. Thus we were confident that the computational 
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technique is returning valid branching angle measurements, and it could be used on the 
ORCADES images. 
 
The same procedure was repeated for branching coefficient measurements, on the same 
branching points. Here, only human versus computer measurements were possible 






Figure 3.12. Bland-Altman 
plots human vs computer 






After the validation of the technique for measuring branching angles and coefficients, 
VAMPIRE was used to analyse branching points of the ORCADES images. Before 
starting the measurements, a measurement protocol was established and followed when 
each image was analysed. The protocol is given in the appendix (Appendix IV). Fractal 
analysis of the retinal vascular network with VAMPIRE software was validated prior to 
the start of this study. 
 
















Branching coefficient- Human vs Computer
mean  
-0.015  
+1.96 sd  
0.713  




3.9. Selection of the retinal fundus image phenotype for the genetic 
analysis 
 
Both left and right eye fundus images were obtained for each subject included in the 
study. However due to the laborious process involved (average of 20 minutes spent on 
one image) in the image analysis with semi-automated software, only one eye could be 
measured for each study subject. A good correlation between left and right eye 
phenotypes is needed in order to ensure that a randomly selected eye represent an overall 
eye phenotype. Correlation between the two eyes is expected to be high due to the 
sharing of the same environment and genes. This has been reported for human limb 
bones (Choi et al. 1997), retinal vessel diameters (Leung et al. 2003, Ikram et al. 2006) 
and retinal nerve fibre layer measurements (Budenz 2008). In addition, in their study of 
small vessel disease and retinal vessel diameters Ikram et al. (2006) did not find 
statistical significant differences between measured diameters in left and right eyes in a 
random subsample of 100 individuals. Investigating the correlations between the left and 
the right eye measures was therefore the first step in the analysis of the traits available.  
 
First, branching parameters estimated by VAMPIRE program were tested. Both 
bifurcation angles and coefficient were tested in a set of 40 eyes, and both median and 
mean values of the total measurements for the eye (between 3 and 6) with the results 
given below Table 3.2. 
 Vessel  type arterioles  venules  
 mean median mean median 
branching angles 0.31 0.26 0.44 0.40 
bifurcation coefficients 0.04 -0.16 -0.04 0.08 
Table 3.2. Pearson’s Correlation coefficients between left and right eye for mean and median values of 
branching angles and branching coefficients measured by VAMPIRE software (of 3 to 6 angles, 




 Correlation between the two eyes of the same individuals were low for branching 
angles, and very poor for branching coefficients, signalling a problem either in the 
measurement procedure or suggesting a poor correlation of these traits between both 
eyes.  One likely reason is the inability of the software to detect all the branching points 
on the image, with a consequent  bias in the selection of the angles chosen for the 
derivation of the final trait (mean or median of maximally 6 bifurcation points). This is 
introducing bias due to the high variance in the number of measured bifurcation angles 
within each eye. Further, the consensus is that angles of the first, second and third 
branching point from the optic disc are used for the measurements. They are not always 
randomly distributed across the image and are often masked by the neighbouring 
vessels. 
 
Monofractal and multifractal dimensions of the retinal vasculature were also tested for 
left and right eye correlation. In total, 130 images were tested. Correlation values were 
higher compared to the branching parameters measured by VAMPIRE. Left-right eye 
correlations were 0.78 for monofractal dimensions and 0.50 for multifractal dimensions. 
These results are more in line with data published on retinal vessel calibres (Leung et al. 
2003, Joachim et al. 2012) increasing confidence in using these measures for further 
analyses. 
 
Next, correlations were assessed for the parameters obtained from the retinal image 
analysis with SIVA. 30 ORCADES subjects and their left and right retinal images were 
used. Subjects were chosen if they had good quality images for both eyes.  Results are 








 CRAE zoneB 0.68 (5x10-5) 
CRVE zoneB 0.78(7.5x10-7) 
 AVR zoneB 0.56(0.002) 
 CRAE zoneC 0.86(2.4x10-9) 
 CRVE zone C 0.78(4.6x10-7) 
AVR zoneC 0.78(6.6x10-7) 
 Fractal Dimensions zone C –complete vasculature 0.66(1x10-4) 
 Fractal Dimensions zone C –arteriol vasculature 0.24(0.139) 
 Fractal Dimensions zone C –venular vasculature 0.59(0.001) 
Simple tortuosity arteries 0.69(3x10-5) 
Curvature tortuosity arteries 0.90(1.8x10-11) 
 Branching coefficient – arteries -0.48(0.001) 
 Branching angles – arteries 0.34(0.66) 
 Angle of first daughter vessel – arteries 0.08(0.653) 
Angle of second daughter vessel – arteries 0.16(0.41) 
 LDR- length to diameter ratio –arteries 0.055(0.778) 
Simple tortuosity venules 0.59(0.001) 
Curvature tortuosity venules 0.66(1x10-4) 
 Branching coefficient – venules -0.03(0.885) 
 Branching angles – venules -0.11(0.563) 
 Angle of first daughter vessel – venules 0.06(0.76) 
Angle of second daughter vessel – venules 0.17(0.37) 
 LDR- length to diameter ratio – venules 0.04(0.842) 
Simple tortuosity – complete vasculature 0.70(2.5x10-5) 
Curvature tortuosity – complete vasculature 0.82(4.5x10-8) 
 Branching coefficient - complete vasculature -0.43(0.18) 
 Branching angles - complete vasculature 0.14(0.476) 
 Angle of first daughter vessel - complete vasculature 0.20(0.292) 
Angle of second daughter vessel - complete vasculature 0.22(0.253) 
 LDR- length to diameter ratio - complete vasculature 0.21(0.286) 
Table 3.4. Pearson’s correlation and the significance p-values are given for parameters measure by SIVA. 
Measure with r2>0.5 are highlighted in bold. 
 
Retinal vascular network branching parameters presented generally low correlation 
values with both programmes for retinal vessel image analysis. Therefore it was decided 
not to include them in the subsequent analysis as there was not enough evidence that 
these phenotypes measure in one eye would accurately represent the phenotype. 
Remaining traits measure by VAMPIRE and SIVA showed an inter-eye correlation of 




Finally, traits pertaining to the optic nerve were assessed. Left and right retinal images 
(of good quality for both eyes) of 100 subjects were sent for the analysis to Singapore. 
Correlation values were low, compared to published data of the inter-eye correlation of 
the retinal nerve fiber layer (Budenz 2008); 0.22 for the optic disc are, 0.26 for the optic 
cup are and 0.18 for cup to disc ratio. A proportion of ORCADES subjects also 
underwent Heidelberg retinal tomography (HRT) measurements of the optic nerve layer. 
135 subjects had CDR results from both of these measurements, however the correlation 
between these results was also extremely poor (r2=-0.0089), suggesting a larger issue 
with software measurements of optic disc parameters from retinal fundus images. It was 
therefore decided not to pursue these parameters in the subsequent analysis.  
 
In summary, quantitative traits derived from the retinal fundus images selected for the 
subsequent genetic and epidemiological analysis were: vessel calibre traits, tortuosity 
traits and fractal analysis traits.  
 
 
3.10. Grader variability of the retinal vessel measurements 
 
Estimation of the reliability of a quantitative measurement is essential for its use in 
future research. Reliability enables us to assess the consistency (repeatability) of our 
measurement technique. In the case of semi-automated computer software where human 
input accounts for a substantial part of the measurement procedure, evaluation of 
reliability is essential. Principal measure of reliability is the intraclass correlation 
coefficient (ICC). It represents correlation when variables are different measurements of 
the same construct (agreements between two or more individuals measuring the same set 
of traits). The general purpose of ICC is to determine the proportion of variation in a 
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measure that is due to being a member of a particular group. The benefit of ICC is that it 
is adjusted for the effects of the scale of measurements as opposed to the correlation 
coefficient, and that it can represent agreements between more than two raters.  First, a 
two-way analysis of variance is carried out, and if the between column mean sum 
squares (between raters) is not significantly greater than the residual error, then 
concordance can be concluded.   The intraclass correlation coefficient provides a 
measure of agreement or concordance between all the methods (0-0.2 indicates poor 
agreement; 0.3-0.4 indicates fair agreement; 0.5-0.6 indicates moderate agreement; 0.7-
0.8 indicates strong agreement; and >0.8 indicates almost perfect agreement).  
Several large epidemiological studies reported moderate to strong reliability for the 
retinal vessel calibre measures for both inter and intra-grader reliability measurements  
(Hubbard et al. 1999, Liew et al. 2008, Wang et al. 2004, Ikram et al 2004). Despite the 
different reliability measurements used by these studies, (Pearsons’s correlation 
coeficient, ICC, kappa), high repeatability values were consistently reported.  High 
reliability was also reported for the measurements of fractal dimensions (Doubal et al. 
2010, Lim et al. 2009, Sng et al. 2010) and tortuosity (Koch et al. 2010, Sasongko et al. 
2010).  
 
Intra-grader and inter-grader reliability for all the selected traits were evaluated. A set of 
60 images from a Singapore Research Eye Study (SERI) were used to calculate inter-
grader reliability (i.e two different graders analysing the same sets of images), and for 
intra-observer reliability assessment (i.e. the same grader at different times) 60 images 
from the ORCADES study were used. SERI images were previously analysed by an 
experience grader (L.J.). Results obtained by these replicated grading exercises are 
presented in Table 3.5. They confirm previously published results of high reliability of 
quantitative retinal vessel traits.  Due to the higher level of automatisation in the grading 
process, reliability was higher compared to the previously published results (older retinal 
image software required more human input).  
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Traits Intraclass correlation coefficient 
Intra-grader repeatability      Inter-grader repeatability 
CRAE zone B 0.95                                              0.90 
CRVE zone B 0.97                                              0.95 
AVR zone B 0.98                                              0.90 
CRAE zone C 0.99                                              0.95 
CRVE zone C 0.98                                              0.98 
AVR zone C 0.98                                              0.93 
Fractal dimension zone C 0.97                                              0.92 
Arterial curvature tortuosity  0.99                                              0.88 
Venular curvature tortuosity 0.97                                              0.94 
Table 3.5. Reliability estimates for retinal vascular traits analysed by SIVA software. Both inter (right 







This chapter has shown that while the recent improvements in retinal image analysis 
software has led to a quicker and more reliable analysis of the traits derived for the 
retinal fundus images, limitations remain. Traits available from the two softwares, 
VAMPIRE and SIVA, were therefore evaluated for further use. One selection process 
was the assessment of the phenotypic stability of each trait, by estimating the correlation 
between the two eyes in a subset of our study subjects. This was essential since only one 
eye was selected to represent a retinal vessel phenotype for each study subject, and even 
if both eyes were available traits with the high variation between left and right eyes are 
not likely to have significant genetic basis.  Some of the traits (branching angles and 
derived group of traits) showed particularly low left to right eye correlation with both 
image analysis programs used. A more in depth analysis of the reasons for this was 
beyond the scope of this thesis, and the causes are therefore not possible to deduce. 
 
 However, since the area of the retina analyzed by the software is dependent on the area 
of the retina photographed by the camera (this area often differs between two eyes), 
number and type of the angles analyzed in the left and the right eye may not be the same. 
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The standard practice is to measure first, second and third degree angles (numbering is 
given depending on the distance of the bifurcation from the main retinal artery or vein), 
and the total number of each type measured is often different between the two eyes 
(left/right). Furthermore the total number of the measured bifurcation points is often 
different between the two eyes, adding to the inconsistency. Another potential reason 
could be the inability of the algorithm to correctly and consistently detect the branching 
angles. The inability of the VAMPIRE software to automatically detect all of the 
branching points, and the limitation of the SIVA grading protocol which only appoints 
tracking of the vessels that the program automatically detects (with a few exceptions) are 
most likely the main reasons for the lack of phenotypic consistency of the branching 
angle measurements.  
 
It is crucial that any trait used in the following epidemiological or genetic analysis is 
accurate and reproducible. Estimating the reliability of the computer assisted methods 
used in the previous step was therefore the next phase of the selection process. As 
mentioned previously, the estimation of reliability is essential when human input is 
substantial, which was the case in our image analysis. Both intra and inter grader 
reliability of the measurements chosen in the previous step was very high, which was not 
surprising due to the high level of automatisation of the SIVA software and the removal 
of the traits with poor left eye-right eye correlations. However it is important to 
acknowledge several factors that can influence the accuracy of the retinal vessel 
measurements despite good correlations, since in some cases it is not possible to fully 
account or correct for them. All images taken by the fundus camera go through the 
image magnification process, which in turn affects the precision of the absolute value of 
the vessel caliber measurements (CRAE, CRVE).  The scale depends on the distance 
from the camera to the eye and on the eye’s refractive error. To partially correct for 
these magnification differences a calibration factor was used (ratio of micrometers per 
pixel). The calibration factor is obtained by measuring the average vertical height of the 
optic disc (in pixels) in 10% of the retinal images in a given population, and dividing the 
assumed average of the disc diameter (1800µm, average disc diameter measured for the 
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Caucasian subjects by Varma et al. 1994) with the population’s average value. The 
relationship between refractive error and the axial length of the eye with retinal vascular 
caliber has been explored in several studies. Associations between smaller retinal vessel 
diameters and longer axial length and more myopic refraction were reported (Patton et 
al. 2005, Wong et al. 2004, Lim et al. 2011).  
 
However, these associations have been explained as both the artifacts of the 
magnification effect and as the result of a true biological process. Axial length and the 
refractive error were found not be associated with vascular caliber after the correction 
for the refractive error using the Bengstsson formula (Bengstsson et al. 1992) in the 
Singapore myopia study (Cheung et al. 2007) and in the Blue Mountain Eye Study 
(Wong et al 2004). On the other hand, underlying biological relationship is supported by 
the studies of decreased ocular pulse and retinal blood flow with myopia (Perkins 1981, 
Benavente et al. 2010). Tortuosity (a dimensionless retinal vessel trait) was also found to 
be correlated with axial length and spherical equivalent (Lim et al. 2011). However it is 
important to point out that the correction for refraction had no impact on the association 
between blood pressure and retinal vessel diameters (Wong et al. 2004, Tan et al. 2004), 
suggesting that the overall impact of axial length and refraction error on the retinal 
vessel morphology is not large enough to skew associations with systemic disease.  
Another issue concerning the retinal vessel width measurements is its variability with 
regards to the cardiac cycle (Knudtson et al. 2004), degree of nervous stimulation 
(Lanigan et al. 1988) and the pigmentation of the fundus. The variation caused by the 
cardiac pulse has been shown to be small and random, and it appears not to bias known 
associations (Sun et al. 2009). Several studies reported difference in the vessel calibre 
between ethnicities (Rotchinina et al. 2008, Cheung et al. 2007) suggesting that retinal 
pigmentation could introduce a source of bias in studies with subjects with different 
ethnic backgrounds and should be accounted for. Finally, any study that attempts to 
quantify retinal vascular morphology should take into account factors directly affecting 
retinal microcirculation such as age, sex, BMI, blood pressure, diabetes, etc. However 
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the difficulty of accounting for all possible systemic, ocular and environmental 
confounding effects has to be acknowledged.   
 
In summary, this part of the study provided evidence of good correlation between eyes 
for the measurements of several retinal vessel traits (diameters, tortuosity and fractal 
dimensions), and excellent reliability for all measurement selected for further analysis. 
The evidence from the published data and those obtained in this study allowed selection 
of retinal vascular morphological traits best suited for further genetic and 

























This chapter evaluates the genetic component of the retinal vessel traits.  Estimation of 
the extent to which genetic variation contributes to these quantitative retinal vessel 
traits’ variances and the amount of genetic correlation between these traits is the main 
focus. A few studies so far estimated the heritability of retinal vessel width parameters, 
and the majority of them were derived from twin studies, which tend to overestimate the 
actual heritability (due to difficulty of teasing out the shared environmental component).  
 
All retinal vessel traits used in the study are essentially describing the architecture of the 
retinal vasculature in different ways (each quantifying one of the aspects of the vessel 
morphology). In order to investigate the degree to which these various retinal vessel 
traits are influenced by the same genes, genetic correlations between the traits were 
tested. Some reports of correlation between calibre measurements are published, but no 
study systematically estimated genetic correlation between various retinal vascular traits. 
Thus, estimation of heritabilities and correlation between retinal vascular is the first step 









4.2. Heritability estimates of the retinal vessel traits 
 
4.2.1. Definition and measurements of heritability 
 
The variance of a quantitative trait can be decomposed into several components. In its 
simple form, phenotypic variance is decomposed into a genetic and environmental  
components.  
  
V(phenotypic) = 𝑉(genetic) + 𝑉(environmental) 
 
The broad sense heritability is then defined as the ratio of genetic variance over the 
overall phenotypic variance; i.e it measures the proportion of the total variance of the 





However, the genetic variation contains contribution from additive and dominant effects, 
and those can be further modulated by epistasis, gene by environment interactions, 
maternal and paternal effects. Only the additive effects are transmitted to descendants 
and the fraction of the phenotypic variance attributable to the additive genetic variance is 
defined as the narrow sense heritability. It is the one usually referred to when measuring 





Estimates of heritability in human populations are based on correlation between 
phenotypic measures of related individuals and their expected sharing of genetic 
material inherited by descent, and therefore a particular trait is considered to be heritable 
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if the similarity between relatives arises from shared genotypes. The most commonly 
used study designs have been the twin study and parent-offspring regression, which use 
data on the observed and expected resemblance between relatives to estimate 
heritabilities. However these estimates rely on assumptions that are often violated (e.g 
shared environment component assumed  to be the same in mono and dizygotic twins, or 
environmental component similar in parent and offspring generations) and estimating 
heritabilities from a mix of relationships has been advocated (Visscher et al. 2008). 
 
In the case of population-based studies, phenotypic measures are available from 
individuals with a mixture of relationships and multiple generations, estimates of 
additive genetic variance are calculated by fitting  the so-called “animal model”: a linear 
mixed-effects model (one containing both fixed (e.g. SNP) and random (polygenic) 
effects). This polygenic model of inheritance is considered the model of choice in 
studying heritability of quantitative traits, in settings where phenotypic values can be 
correlated between pairs of individuals of multiple different types of relationships 
(Almasy and Blangero 1998). The model describes the vector of an observed 
quantitative trait as: 
Y = µ+ΣβjCj+A+e   
where μ is the intercept, Cj the design vector for the jth covariate, Bj its associated effect 
(coefficient of regression),  A is the matrix of polygenic additive contribution, and e is 
the matrix of random residual contribution (Lynch and Walsh, 1998). A, the additive 
polygenic component, describes the contribution from multiple independently 
segregating genes all having a small additive effect onto the trait (infinitesimal model) 
and its distribution in a pedigree can be described as multivariate normal with variance-
covariance matrix proportional to the relationship matrix Φ and the variance of additive 
effects (σA2)  : A ∼ MVN(0,ΦσA2). It is assumed that  residuals, from each of the 
individuals in a pedigree, are independent  between the pedigree members, and the joint 
distribution of residuals in the pedigree can be modelled using multivariate normal 
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distribution with variance-covariance matrix proportional to the identity matrix I and 
residual variance (σe2); e ∼ MVN(0,Iσe2).  
 
Covariances between individuals are used to estimate the additive genetic component 
given the coefficients of coancestry based on the family pedigree or genetic markers:  
 
Cov(yi,yj)~2 ɸijσA2 
ɸij expected kinship (co-ancestry) coefficient between individual yi and yj 
 
Maximum likelihood and restricted maximum likelihood methods are used to estimate 
fixed effects and variance components in the mixed model and for significance testing. 
Likelihood of obtaining the observed data given the family structure and the scale of 
parameters to be estimated (the genetic and environmental variance components) is 
calculated. The model then finds the values of these unknown parameters which 
maximises the likelihood function.  Estimated parameters are used to calculate 
heritability. Heritability estimated in this manner takes into account all the informative 
relationships within the population (e.g. parent offspring, full-sib, half-sib, avuncular, 
first cousin and the more distant ones), which in turn improves the power of the 
estimates as all the data from all informative relationships are used. In addition this 
model allows the estimation of different components of environmental variance. Isolated 
populations represent populations with large complex pedigrees and with relatively 
stable and uniform diet, climate and living conditions. However, reduction of the genetic 
diversity and more uniform shared environmental influences may give estimates that are 
not representative of other populations. Two such isolated populations (Orkney and 







4.2.2. Reported heritability measurements from the literature 
 
 
Estimates of the heritability of retinal vessel traits have been investigated in only a few 
studies to date. All of the studies reported substantial genetic effect on these traits, 
however most of them applied either a twin or parent-offspring study design known for 
possible biased estimates. No studies to my knowledge have reported data from large 
population-based samples.  
 
Retinal vessel widths were the most extensively studied trait. Three twin studies 
(Taarnhoj et al. 2006, Sun et al. 2009, Fahy et al. 2011) reported heritabilities between 
0.56-0.70 for CRAE (central retinal arteriolar equivalent) and 0.62-0.83 for CRVE 
(central retinal venular equivalent). One familial aggregation study (Lee et al. 2004) 
estimated heritability by doubling the parent–child correlations and reported lower but 
still substantial heritability estimates; 0.48 for CRAE and 0.54 for CRVE.  Finally, one 
smaller population based study (413 participants from 70 families from a Flemish 
population; Liu et al. 2013) reported lower heritability estimates of 0.21 for CRAE and 
0.34 for CRVE.  
 
A Danish study (Taarnhooj et al. 2008) estimated heritability for retinal arterial 
tortuosity at 0.82 in a sample of 57 monozygotic and 52 dizygotic same-sex healthy twin 
pairs. Estimates of other parameters of retinal vessel architecture have not been 










4.2.3. Material and Methods - heritability estimates of retinal vessel traits in 
the population isolates of Orkney and Korcula 
 
4.2.3.1. Study populations  
 
The retinal vascular traits described previously were chosen to estimate heritability in 
two isolated populations from Scotland (Orkney islands- ORCADES study) and Croatia 
(Korcula island).   
 
 
The Orkney islands -ORCADES 
Orkney is an archipelago in northern Scotland of around seventy islands (of which 17 
are inhabited) situated on average ~30 kilometres north of the coast of Caithness. The 
total populationis ~20,000 people. The advantage of the Orkney islands is their 
geographic isolation and the fact that family trees can be tracked back as many as eight 
generations. The North Isles of Orkney, the focus of this study, consist of ten inhabited 
islands: Westray, Papa Westray, North Ronaldsay, Rousay, Egilsay, Wyre, Stronsay, 
Sanday, Eday and Shapinsay.  
The Orkney Complex Disease Study (ORCADES) is an ongoing family-based study 
which aims to identify common and rare genetic variants influencing the risk factors for 
common complex disease which are important in Scotland.  The ORCADES study 
collected data for 6 years and has a resource of ~2100 richly phenotyped and densely 
genotyped subjects (46% male; mean age at recruitment 53 years, range 18 - 100), 
including data on numerous quantitative traits associated with cardiovascular, metabolic 
and other diseases, detailed family history data and 6 generation pedigrees.  Illumina 
genome-wide scans were available for 889 participants (after the merge of two sets of 




Good quality retinal images were available for 811 genotyped individuals. All of the 
images from Orkney were graded by one grader (M.K.).  
  
KORCULA 
The island of Korcula is located in the southern Croatian coastal region of Dalmatia. 
According to the 2001 Census, the total island population was 16,182 inhabitants, 
distributed in five larger districts: Korcula, Lumbarda, Smokvica, Blatoand Vela luka. 
The target population comprised inhabitants of the Eastern part of the island (6,544 
registered inhabitants). The study aimed to recruit healthy volunteers from the town of 
Korčula and villages of Lumbarda, Žrnovo and Račišće.  A total of 944 subjects were 
included in this study and most underwent complete eye examination.  Family history 
data and pedigrees were not available for the recruited subjects. Data on numerous 
quantitative traits associated with cardiovascular, metabolic and other diseases was also 
collected as a part of the study. 
The eye examination included fundus image photography. However, only 421 images 
were graded by the SIVA and the VAMPIRE software. Most of the ungradable images 
were rejected as they were excessively centered towards the macula, with optic disc on 
the side of the field. These images do not allow grading of the vascular network in the 
extended zone C. All the images were grade by one grader (M.K). 
 
 
4.2.3.2. Genotyping and quality control 
 
DNA was extracted from peripheral blood. Extraction was done by Nucleon kits by 
WTCRF (Wellcome Trust Clinical Research Facility, Western General Hospital, 
Edinburgh) for ORCADES and at the Medical School, University of Split for Korcula 
participants. Participants were genotyped using a dense SNP arrays; a mix of HumanHap 
300v2 and 370CNV-Quad for ORCADES (data integration is described in chapter 6), 
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370CNV-Quad for Korčula, following the manufacturer’s standard recommendations. 
Genotypes were determined using Illumina BeadStudio software. 
Genotyping rates for both SNPs and individuals are checked using the GenABEL 
package implemented in R. Individuals with less than 97% genotyping rate were 
removed from further analysis (to ensure poor quality data are not used). SNPs with call 
rate below 98%, minor allele frequency (MAF) below 2% and P-value for Fisher's exact 
test of Hardy–Weinberg equilibrium (HWE) below 10–10 are also removed to remove 
low-quality SNPs. In addition, samples with excess autosomal heterozygosity or gender 
inconsistency (based on the sex chromosomes genotypes) are removed due to possible 
sample mix-up. Ethnic outliers are removed based on principal components analysis of 
genotypic data. After this quality control step, the number of individuals available with 
ocular measures and genotypes was 811 for Orcades and 387 for Korcula 
 
 
4.2.3.3. Statistical analysis – heritability estimates 
 
Heritability estimates were calculated using the GenABEL package in R (Aulchenko et 
al. 2007) which implements a maximum likelihood method for the animal model 
parameters’ estimates. The first step of the analysis is the calculation of a realised 
kinship matrix from the genome-wide data to account for covariances between 
individual genomes, using the gkin function of the statistical package GenABEL. This 
way of estimating the relationship between individuals is superior to the one derived 
from classic pedigrees as this solution does not rely on the completeness and quality of 
pedigrees. Furthermore pedigree-based kinships provide only the expected average 
amount of material shared IBD between pairs of individual genomes, whereas genomic-
based kinship measures the realised sharing and is expected to lead to better estimates of 
polygenic model parameters. Estimator of the kinship matrix can be obtained by 
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calculating the kinship coefficients between individuals i and j  (Astle and Balding 
2009): 
 
 L - the number of loci,  
pl - the allelic frequency at l-th locus 
gl,j - the genotype of j-th person at the l-th locus, coded as 0, 1∕2, and 1, corresponding to the 
homozygous, heterozygous, and other type of homozygous genotype 
 




The next step is fitting a polygenic model using a maximum likelihood function. 
GenABEL implements the method developed by E. A. Thompson group (Thompson and 
Shaw 1992).  
 
polygenic(trait~covariates, kinship.matrix, data, trait.type="gaussian") 
 
 
Additive genetic and residual variance components that maximise the polygenic model 
are estimated and used to calculate narrow sense heritability. Maximal likelihood 
estimates (MLEs) are given in the GenABEL output (mean, estimates of effect size for 
covariates, heritability, and polygenic + residual variance estimates) as well as the value 
of twice negative maximum log-likelihood.  
 
The significance of the explanatory covariates was tested via a likelihood ratio test 
(LRT).  The LRT is used to compare the fit of two models; it compares obtained 
likelihood for the full model (model with the covariates) to the likelihood of the nested 





𝐷 = −2ln �
𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑 𝑓𝑜𝑟 𝑛𝑢𝑙𝑙 𝑚𝑜𝑑𝑒𝑙
𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑 𝑓𝑜𝑟 𝑎𝑙𝑡𝑒𝑟𝑛𝑎𝑡𝑖𝑣𝑒 𝑚𝑜𝑑𝑒𝑙� 
 
The probability distribution of the test statistic is approximately a chi-squared 
distribution with degrees of freedom equal to the difference in the number for 
parameters included in two models. Significance of the heritability estimates was tested 
by comparing the full and the null model of heritability using the following option in 
GenABEL:  
 
herritability<-polygenic(trait~covariates, kinship.matrix, data, trait.type="gaussian") 
 heritability_nullmodel<-polygenic(trait~covariates, kinship.matrix, data, trait.type="gaussian", 
fixh2=0) 
 
and by comparing the likelihood estimates of those two model, as described above.  
 
 
 Goodness of fit of a polygenic model was tested using the Akaike information criterion 
(AIC);  
2k-2ln(L) 
 where k is the numbers of parameters in the model  and L the maximum likelihood of 
the model (Akaike 1974) . This criterion introduces a penalty for extra covariates used. 
Each extra covariate included in the model was tested this way and the optimal model 
for each trait was chosen as the one with the lowest AIC  value.  
 
Normality of the distribution for each trait was tested using the Kolmogorov-Smirnov 
normality test (lillie.test) implemented in nortest package in R (Gross 2012), in addition 
to the graphical representation of the distribution of each traits. Traits for which the 
distribution deviated from normality were transformed using quantile normalisation with 
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the rank transformation function of GenABEL (Aulchenko et al. 2009).  Interquartile 
range was used to identify and remove outliers. An outlier was defined as any value that 
is bellow below Q1 – 1.5×IQR or above Q3 + 1.5×IQR. IQR is interquartile range and is 





4.2.4. Heritability estimates - Results 
 
4.2.4.1. Descriptive statistics 
 
The descriptive statistics for the 17 retinal vessel traits measured in the participants of 
Orkney and Korcula (for which both quality-controlled phenotypic and genotypic data 
were available) are displayed in Table 4.1. In total 811 (751 – for fractal dimension 
measures by VAMPIRE) individuals from Orkney and 387 (328 - fractal dimension 
measures by VAMPIRE) from Korcula were used in the analysis. 31.4% tested subjects 
were male in Korcula, and 46.1% in Orkney. Measures were comparable between the 
two populations, however measurements of vascular calibres in zone B were lower to 
those previously published (CRAE mean=136.1-168.8, CRVE mean=196.5-253.0). This 
can be explained by the average disc diameter used in the calculation of the conversion 
factor from pixels to µm. In the present study I used 1800 microns as the standard disc 
diameter (following the SIVA protocol), while most of the published study use 1850 
microns. Several studies reported monofractal dimension of the retinal vessel network, 
and results from Orkney and Korcula are in line with the published data (mean=1.42, 
SD=0.02 - Doubal et al. 2010, mean=1.41, SD=0.046 - Cheung et al. 2012, mean=1.44, 
SD=0.024 - Liew et al. 2011). Doubal et al. 2010 reported values for multifractal 
dimensions (mean=1.67, SD=0.03), which are again in line with the results reported in 
this study. Published means for retinal vessel tortuosity exist, however the methodology 
123 
 
of tortuosity measurement in these studies is different and the scales are not comparable 
to the results obtained from SIVA.  
 
 






Big6craeB 811 79.90 166.92 127.60 0.50 0.88 
Big6crveB 811 125.29 236.54 178.22 15.44 0.10 
Big6avrB 811 0.55 0.98 0.72 11.61 0.009 
Big6crae 811 79.41 168.20 128.33 16.13 0.64 
Big6crve 811 131.05 232.55 180.37 0.06 0.91 
Big6avr 811 0.54 0.912 0.71 11.04 0.03 
FractalDimC 811 1.19 1.51 1.40 15.37 0.001 
FractalDimCv 811 0.99 1.30 1.17 0.05 0.04 
sTORTa 811 1.05 1.23 1.10 0.045 <2.2x10
-16 
cTORTa 811 3x10-5 0.00015 6.63E-05 0.05 <2.2x10
-16 
sTORTv 811 1.06 1.24 1.10 0.05 1.1x10
-14 
cTORTv 811 3.8x10-5 0.0002 7.33x10-5 0.03 <2.2x10
-16 
sTORTt 811 1.06 1.20 1.1 0.00002 5.6x10
-11 
cTORTt 811 3.9x10-5 0.00015 6.97x10-5 0.02 <2.2x10
-16 
Dbox_scel 751 1.30 1.46 1.40 0.00002 2.88x10
-6 























Big6craeB 387 90.15 188.93 126.34 12.51 0.11 
Big6crveB 387 121.8 234.00 177.47 0.47 0.72 
Big6avrB 387 0.52 0.93 0.71 12.94 0.56 
Big6crae 387 92.91 186.57 126.60 17.35 0.054 
Big6crve 387 125.99 231.58 179.73 0.06 0.83 
Big6avr 387 0.56 0.93 0.71 12.50 0.05 
FractalDimC 387 1.22 1.47 1.37 16.97 0.36 
FractalDimCv 387 0.99 1.26 1.15 0.05 0.25 
sTORTa 387 1.06 1.24 1.10 0.06 <2.2x10
-16 
cTORTa 387 0.000036 0.00019 7.4x10-05 0.05 <2.2x10
-16 
sTORTv 387 1.06 1.37 1.098 0.03 <2.2x10
-16 
cTORTv 387 0.00004 0.00032 8.1x10-05 0.00002 <2.2x10
-16 
sTORTt 387 1.06 1.23 1.10 0.03 1.65x10
-9 
cTORTt 387 0.000045 0.00019 7.7E-05 0.00002 3.44x10
-10 
Dbox_scel 328 1.26 1.41 1.33 0.03 0.05 
D0_scel 328 1.51 1.76 1.64 0.04 0.60 
Table 4.1. Descriptive statistics of retinal vessel traits in two isolated populations. Departure from 




4.2.4.2. Effect of the covariates 
 
The majority of the studies published so far included only sex and age as covariates. In 
addition, we tested the following covariates: the 3 first principal components of ancestry, 
the average systolic blood pressure (mean of two measurements), the average diastolic 
blood pressure, the average difference between systolic and diastolic blood pressure 
(pulse pressure) and the body mass index (BMI). Numerous epidemiological studies 
showed significant correlations of retinal vessel traits with past, present and future blood 
pressure and obesity (detailed literature review in chapter 5), and therefore these 






Table 4.2. Variance of retinal vessel traits explained by 9 different covariates (age, sex, three first 
principal component, average systolic blood pressure, average diastolic blood pressure, difference between 
the systolic and diastolic blood pressure-average, body mass index). Effect of a single covariate was tested 
in a general linear model taking family structure into account. Significant results are highlighted, and 
significance level marked with ** for p-val < 0.01 and * for P-val < 0.05. 


















































































































































































































































































































































































































The effect of 9 different covariates on retinal vessel traits was tested singly in the both 
populations separately and expressed as % of the trait variance explained (Table 4.2). 
Age and average systolic blood pressure were covariates with greatest effects on retinal 
vessel traits. Average systolic blood pressure (avdbp) had the greatest effect on central 
arterial width in both zones B (8.64-11.7%) and C (9.96-15.48%), while age showed the 
strongest effect on several measurements of fractal dimensions (SIVA 8.9 -12.37%; 
VAMPIRE (16.47-25.4%). Overall age was the covariate with biggest effect on most 
retinal vessel traits. Average diastolic blood pressure (avdbp) also presented a strong 
effect on several traits; arterial diameter (zone B 8.58- 8.64%; zone C 9.95-11.84%) and 
AVR (zone B 4.05-5.66%; zoneC 5.82-8.91%). Avdp was the covariate with the biggest 
effect on AVR in both zones. Other covariates had much smaller effects. All three 
ancestry principal components had very small effects on the traits, which was anticipated 
since the polygenic effect is already fitted in the model. Body mass index (BMI) showed 
little effect on the traits (explaining up to a maximum of 1.73% of variance in 
monofractal dimensions in Orkney, but not significant in Korcula). Likewise sex had a 
very small effect on all of the traits tested; at most explaining 3.82% of variance in 
CRAE in zone C in Korcula (but not significant in Orkney). The traits most affected by 
any of the covariates were fractal dimensions measured by the VAMPIRE software; 
monofractal dimension measured in the Orkney sample showed a very strong effect of 
age (25.2%). The least affected trait by any of the covariates in both populations were 
venular tortuosity measurements (simple and curvature), withvery small and non-
significant effects. 
 
The effect of most covariates was stronger and more significant in the Orkney 
population than in Korcula, most likely due to the large difference in the subjects tested 
(811 Orkney, 387 Korcula).  
 
It has been reported that axial length and intra ocular pressure affect the retinal vessel 
measurements explored in this analysis, and would be obvious candidates for potential 
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covariates. However only 529 individuals available for heritability analysis in Orkney 
have these measurements taken, and it was therefore decided not to explore their effects 
due to the inevitable loss of power. The effects of combined multiple covariates was 
explored further in the next section with testing of the best fitting models.  
 
 
 4.2.4.3. Heritability estimates 
 
Several different covariates presented substantial and significant effect on retinal vessel 
traits, and therefore the subsequent step was to establish the best fitting model for the 
heritability analysis. The effects of various single and multiple explanatory covariates 
were tested, and the best possible model based on the Akaike criterion was selected for 
further analysis. Covariates with the individually strongest effects were considered in a 
multiple covariate model (age, BMI, average/systolic/diastolic/difference blood 
pressure, and age2 in addition to age when significant in case the effect of age on the 
trait is non-linear). The following protocol was followed in the selection of the best 
fitting model: the variable with the greatest and most significant effect was first tested 
for each trait as the base model (if there were no significant variables, the no covariate 
model was kept as the best model); then the next best covariate was fitted and tested 
based on the Akaike criterion to check if it gives a better fitting model, if not the 
previous model was used otherwise the next best covariate was fitted and testing 
repeated. As the effect of age squared in not usually tested alone but in addition to age, 
for traits in which it had significant effect, it was tested in addition to age in the model. 
The best fitting models (based on the Akaike criterion) were selected to calculate the 









trait Best model 
covariates 















AVR zone B Avdb -0.0619 
 
5.66% 0.26(2.7x10-4) 





CRVE zone C Age -0.2553 
 
5.57% 0.39(1.99x10-8) 











Bmi 0.0172 0.81% 0.22(0.14) 
Total curvature 
tortuosity 
Age -0.009 2.0% 0.44(0.001) 
Arterial simple 
tortuosity 





-0.003 0.4% 0.20(0.006) 
Total simple 
tortuosity 


















































trait Best model 
covariates 
Effect size % trait variance 
explained by 
covariates 
h2 best model 
(p-value) 




10.59% 0.35 (0.07) 
CRVE zone B avsbp -0.14 2.18% 0.59(0.005) 
AVR zone B avdbp -0.001 4.05% 0.275(0.04) 






CRVE zone C Avsbp -0.13 2.2% 0.54(0.02) 
AVR zone C Avdbp -0.023 5.83% 0.41 (0.07) 
Arterial curvature 





























diffbp -0.003 2.11% 1.08x10-8(0.39) 
Total simple 
tortuosity 









Zone c - veins 
avsbp -0.0001 1.85% 0.05(0.79) 
Monofractal 













Table 4.3 Heritability estimates and covariates effects for retinal vessel traits in Orkney and Korcula 
islands. Best models represent the best fitting models (obtained after following the described protocol) 
with significant covariates. Fixed effects are reported as regression coefficients expressed in unit of the 




A combination of age and average systolic blood pressure resulted in the best fitting 
models for several traits in Orkney (CRAE zone B and C, arterial curvature tortuosity, 
SIVA total fractal dimensions and venular fractal dimensions, VAMPIRE monofractal 
dimensions and multifractal dimensions) and Korcula (arterial curvature tortuosity, 
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monofractal dimensions (by VAMPIRE and SIVA) , and  VAMPIRE multifractal 
dimensions Vampire).  
 
 
Similar to the single covariates model, the trait with the largest effect of the combined 
covariates in both populations was monofractal dimension (Dbox); age and average 
systolic blood pressure explained 26.79% of Dbox variance in Orkney and 17.81% in 
Korcula. Heritability estimates for Dbox were 0.24 in Orkney and 0.79 in Korcula. 
Fractal dimension estimated by SIVA was also highly affected by the same covariates in 
both populations (avsbp and age explained 15% of variance in Orkney and 11.2% in 
Korcula). Heritability estimates for traits adjusted for covariates were more comparable 
for this trait between the two populations (0.28 for Orkney and 0.22 for Korcula). All 
tortuosity measurements were least affected by the combination of any explanatory 
variables. In both populations, venular simple tortuosity was the trait least affected by 
the covariates (age explaining 0.4% in Orkney and diffbp 2.11% of the traits variance in 
Korcula). 
 
The majority of the tested traits displayed moderate heritability values. Heritability 
estimates ranged from 0.11 for multifractal dimension to 0.55 for simple arterial 
tortuosity in Orkney. More extreme heritability estimates were recorded for several traits 
in Korcula (ranging from 1.08x10-8 for venular simple tortuosity to 0.79 for monofractal 
dimensions estimated by Vampire). Such a wide range of heritability estimates could be 
explained by the low number of subjects tested (N=387/N=328). Furthermore, 
heritability estimates for the majority of the traits in Korcula were not significant, again 








4.3. Genetic correlation of retinal vessel traits 
 
4.3.1. Definition and measurements of genetic correlation 
 
Phenotypic values of different traits are often correlated. The source of these correlations 
can be environmental and genetic, and similar to partitioning the traits variance into 
genetic and environmental, the same can be done for phenotypic correlation (rp).  It can 




The genetic correlation quantifies the amount of the genetic influence shared between 
two traits. The magnitude and direction of genetic correlation depends on the pleiotropic 
effects (alleles in one locus affecting more than one trait) of genes and linkage 
disequilibrium (non-random association of alleles at two or more loci). The genetic 
correlation can be negative or positive, with a magnitude from -1 to +1.  
Genetic covariance can be partitioned in the same manner as the genetic variance; into 
components of additive, dominant, epistatic and maternal and paternal effects. Therefore 
in order to estimate genetic correlation, genetic covariance and variance estimates are 
required. Additive genetic correlation is calculated as a ratio of the covariance between 
the additive genetic effects of two traits and the square root of the product of the 
variances for the additive genetic effects of the traits. 
 
Estimation of genetic correlation requires genetically informative samples, e.g twins, 
large pedigrees, isolated populations. The software used for the estimation of genetic 
correlation requires pedigree information and this was available only for the Orkney 
population. The genetic correlation estimates were therefore calculated only for the 
Orkney population. In addition, the small population size for Korcula was an additional 




Genetic correlations were calculated for traits that were observed to have significant 
additive genetic variance because rA is theoretically undefined when one trait has 
heritability equal to zero. Heritability analysis revealed substantial additive genetic 
variance for all tested traits in Orkney (therefore all traits were considered for the 
genetic correlation analysis). Best fitting model covariates identified in the heritability 
analysis were used. 
 
 
4.3.2. Methodology   
 
Genetic correlation estimates were assessed using the ASReml package (Gilmour et al. 
2002). ASReml is a statistical package that fits linear mixed models using Restricted 
Maximum Likelihood (REML). ASReml requires a known genetic pedigree to estimate 
a range of quantitative genetic parameters (only available for Orkney population). Since 
the heritability estimates are also given in the ASReml output, the two heritability 
estimates for each trait were compared.  
 
A multivariate animal model was used to estimate genetic correlations between selected 
traits. A multivariate model is used for correlation estimates as it allows for observation 
and analysis of more than one outcome variable at a time. Selection of fixed effects was 
based on the previous analysis of best fitting model. Multivariate models also allow for 
estimation of covariance components between traits. These include the (additive) genetic 
covariance COVA which is then rescaled to give the genetic correlation rG.  
 
Input files include standard pedigree information for each individual (individual’s ID 
along with maternal and paternal ID), and a second file consisting of phenotype 
information as well as the covariates used in the subsequent analysis. All the individuals 
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with the phenotypic data have to be included as offspring in the pedigree file. Following 
code was used:  
First the multivariate model is specified: 
Trait1   Trait2  ~  Trait   Trait.covariate   !r   Trait.ID  
                                                                         #Trait 1 and Trait 2 -represent traits tested for correlation 
                                                                        # Trait -represents the mean of each trait  
                                                                        # Trait.covariates- covariates used in the model 
                   #  !r - qualifier tells ASReml to fit the terms that appear after   
                                                                         this  qualifier as random effects (in this case additive genetic        
                                                                         effect). 
                  # Triat.ID –additive genetic effect 
 
Then the model of the variance structure is specified: 
 
1 2 1                                        #Variance header: 1 residual structure with two dimensions, and 1  
                                                           additional  random effects (additive genetic effect) 
 
Residual (R) structure defined as an unstructured covariance matrix: 
 
0 
Trait 0 US !S2== 1             # Starting values supplied as lower triangle 
0.1                                         # VR1, 
0.1 0.1                                   # COVR, VR2 
 
Random effect (G) structure defined as an unstructured covariance matrix: 
 
Trait.ID 2 
Trait 0 US 
1                                       # Starting values supplied as lower triangle 
0.1 1                                 # VA1 






After this model is run, the output results file are generated containing six variance 
components (residual and additive variances of both traits along with their covariances). 
Finally a post-processing file is used to estimates heritability and genetic correlation. 
Total phenotypic variance for each trait is computed and heritability calculated a ratio of 
phenotypic and additive variance.  Genetic correlation for the two traits is calculated a 
ratio of the covariance between the additive genetic effects of two traits and the square 
root of the product of the variances for the additive genetic effects of those traits. 
 
 
4.3.3. Results : genetic and phenotypic correlations between the traits 
 
Rank transformation of non-normally distributed traits was done prior to the correlation 
analysis. Covariate selection was based on the previous best fitting model analysis. In 
cases where two tested traits had different covariates, all covariates were fitted. Pairs of 
retinal vessel traits were selected based on the potential biological association between 
traits. In addition correlation between similar traits derived with different methodology 
(fractal dimensions) was also included in the analysis. In order to avoid redundant 
measurements, width measurements from only zone B and curvature tortuosity 
measurements were included in the analysis.  Both phenotypic and genetic correlations 
were estimated for all tested pairs of traits. Strong positive genetic and phenotypic 















CRAE and CRVE Age, avsbp 0.65 (0.11)** 0.55 (0.03)** 
CRAE and AVR Age, avsbp 0.27 (0.18) 0.45 (0.03)** 
CRVE and AVR Age, bmi -0.51 (0.14)** -0.50 (0.03)** 
CRAE and fractal dimension (SIVA) Age, avsbp 0.69(0.20)** 0.13 (0.03)** 
CRVE and fractal dimension (SIVA) Age, avsbp 0.41 (0.18)* 0.16(0.04)** 
CRVE and fractal dimension veins (SIVA) Age, bmi 0.90 (0.28)** 0.19 (0.03)** 
CRAE and curvature arterial tortuosity Age, avsbp 0.003 (0.14) 0.17 (0.04)** 
CRAE and curvature total tortuosity Age, avsbp 0.13 (0.17) 0.14 (0.04)** 
CRVE and curvature venular tortuosity Age, bmi 0.54(0.28) 0.07 (0.04) 
CRVE and curvature total tortuosity Age, bmi 0. 22(0.16) 0.13(0.04)** 
curvature arterial and curvature venular tortuosity Age, avsbp 0.69 (0.21)** 0.32 (0.03)** 
curvature arterial and curvature total tortuosity Age, avsbp 0.97 (0.03)** 0.84 (0.01)** 
Curvature vein and curvature total tortuosity Age, avsbp 0.84 (0.11)** 0.75 (0.02)** 
curvature arterial tortuosity and fractal dimension (SIVA) Age, avsbp 0. 43(0.15)** 0.29(0.03)** 
curvature venular tortuosity and fractal dimension (SIVA) Age, avsbp 0.27 (0.27) 0.25 (0.03)** 
curvature venular tortuosity and fractal dimension veins (SIVA) Age, avsbp 0.27 (0.36) 0.26 (0.03)** 
curvature total tortuosity and fractal dimension (SIVA) Age, avsbp 0.37 (0.17) 0.32(0.03)** 
CRAE and monofractal dimesion (VAMPIRE) Age, avsbp 0.69 (0.09)** 0.42 (0.03)** 
CRAE and multifractal dimesion (VAMPIRE) Age, avsbp 0. 45(0.14)** 0.25(0.03)** 
CRVE and monofractal dimesion (VAMPIRE) Age, avsbp 0.25 (0.17) 0.32 (0.04)** 
CRVE and multifractal dimesion (VAMPIRE) Age, avsbp 0.41 (0.18)* 0.34 (0.03)** 
curvature arterial tortuosity and monofractal dimesion (VAMPIRE) Age, avsbp 0.40 (0.11)** 0.23(0.04)** 
curvature total tortuosity and monofractal dimesion (VAMPIRE) Age,avsbp 0.39(0.12)** 0.25(0.04)** 
curvature arterial tortuosity and multifractal dimesion (VAMPIRE) Age, avsbp 0. 46(0.13)** 0.21(0.04)** 
curvature total tortuosity and multifractal dimesion (VAMPIRE) Age, avsbp 0.48 (0.15)** 0.25 (0.04)** 
monofractal dimesion (VAMPIRE)and fractal dimension (SIVA) Age, avsbp 0.95 (0.09)** 0.51(0.03)** 
multifractal dimesion (VAMPIRE) and fractal dimension (SIVA) Age, avsbp 0. 84(0.14)** 0.43(0.03)** 
multifractal dimesion (VAMPIRE) and monofractal dimension 
(VAMPIRE) 
Age, avsbp 0.89 (0.11)** 0.78 (0.02)** 
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Table 4.4 Genetic and phenotypic correlations between retinal vessel traits estimated by the bivariate genetic analysis. 
Correlation values with standard error are given for pairs of traits. Significance levels are marked with ** for p-
val < 0.01 and * for P-val < 0.05. 
 
 
The strongest correlations (both phenotypic and genetic) were found for pairs of fractal 
dimension traits, as expected. High phenotypic correlation (78%) between mono and 
multifractal dimensions measured by VAMPIRE demonstrates close relationship 
between these two measurements. When fractal measurements are compared between 
SIVA and VAMPIRE software, moderate phenotypic and very high genetic correlation 
is detected. Very high phenotypic and genetic correlations were also found between 
several tortuosity measurements. As expected, high correlation between total tortuosity 
and its components (arterial and venular tortuosity) is confirmed. However, more 
interestingly high genetic correlation is found between arterial and venular tortuosity 
measurements (ra=0.69, SE=0.21), as for the arterial and venular width measurements 
(ra=0.65, se=0.11) suggesting a common genetic factors underlying these retinal vessel 
structures. Surprisingly genetic correlations between arterial widths and tortuosity 
measurements were extremely low (ra=0.003, SE=0.14), which was not the case for the 
analogous venular measurements (ra=0.54, SE=0.28). A strong genetic relationship was 
also found between measurements of arterial widths and fractal dimensions (SIVA- 
ra=0.69, SE=0.20; VAMPIRE - ra=0.69, SE=0.09). 
 
In addition herrtiabilites obtained from ASReml and GenABEL were compared. Results 
are given in Table 4.5., and displaying consistencies between the two methods; one 
using genomic kinship matrix and the other constructed pedigree information in order to 














CRAE zone B 0.37** 0.40** 
CRVE zone B 0.45** 0.43** 
AVR zone B 0.30** 0.26** 
Arterial curvature 













Zone c – veins 
0.16 0.20** 
Monofractal 
dimension  Dbox 
0.24** 0.24* 
Multifractal 
dimesion – Do 
0.18* 0.11 
Table 4.5. Herritability estimates using two methods are presented. Significance of the herritability 





















Heritability estimates of retinal vessel traits found in the two isolated population of 
Croatia and Scotland showed substantial genetic contribution for the majority of the 
traits inter-individual variabilities. The results reported in this study were in agreement 
with published literature for vessel width traits. CRAE and CRVE reports from twin 
study were higher (CRAE 0.56-0.70; CRVE 0.62-0.83) than the ones reported here 
(CRAE Orkney 0.40, Korcula 0.35; CRVE Orkney 0.43, Korcula 0.59) as twin-based 
studies provide an upper limit for the heritability due to shared environments. However, 
when differences in heritabilities between the published measurements and the ones 
obtained in this study were tested (given their standard errors and tested by two sided 
test on z-scores (Jensen et al. 2003)), no significant differences were found. However 
our results are in agreement with the only published familial aggregation study (CRAE 
0.48, CRVE 0.54; Lee et al. 2004). A Belgian population based study (413 participants 
from 70 families from a Flemish population) reported lower heritability estimates 
(CRAE 0.21, CRVE 0.34), but the general trend is similar across various studies, 
displaying higher heritabilites for venular diameters, compared to arterial. Interestingly 
heritability estimates for AVR (ratio of arterial and vein diameters) demonstrates very 
similar estimates across studies (Orkney 0.26, Korcula 0.28, Beaver Dam familial 
aggregation study 0.32, Flemish population based study 0.27). This perhaps is not 
surprising, since AVR gives a ratio of the two widths, and therefore lowers the total 
variance of the traits (it combines information from both arms of the circulatory system). 
 
Only one study so far reported heritability estimates for arterial tortuosity measurements 
(Taarnhoj et al. 2008).  No other estimates of tortuosity traits have been published to my 
knowledge. Thus this study represents the first comprehensive study of additive genetic 
contribution to retinal vessel tortuosity, as well as phenotypic and genetic correlations 
between these and other retinal vessel traits. Taarnhoj et al. reported very high 
heritability of arteriolar tortuosity arterioles (h2=0.82), however as this was a twin study 
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including only 218 subjects the result is very likely to be inflated. Heritability of arterial 
curvature tortuosity was high and similar in both populations (h2=0.52 Orkney, h2=0.58 
Korcula), and is the trait with highest reported heritability across both populations. 
Venular tortuosity gave lower values in Orkney (curvature h2=0.22, simple h2=0.20). 
This is not surprising because of the anatomical difference between arterioles and 
venules. The arteriolar wall is thicker (because of the tunica media; a layer made up of 
smooth muscle cells and elastic tissue) and less compliant to the influences of different 
mediators of vasodilatation and vasoconstriction, and thus is subject to less contortion 
than is the venular wall. Venular tortuosity is therefore more likely to be shaped by 
environmental factors (hypertension, vasodilatation and vasoconstriction), and less of its 
variance can be attributable to the genetic factors. Very inconsistent values of venular 
tortuosity were documented in Korcula (curvature h2=0.64, simple h2=1.08x10-8). 
 
No reported data on the genetic contribution to the variance of fractal dimensions exist, 
and this study represents the first reports of the traits heritability. Heritability reports for 
fractal dimensions measured by SIVA were consistent between the two populations 
(0.24-0.29), however other fractal traits provide very different estimates between the two 
isolates.  In Orkney, monofractal measures from VAMPIRE and SIVA report very 
consistent values (0.24-0.28), confirming a good agreement between the two methods. 
Multifractal measurements from VAMPIRE report lower heritability (0.11). Values in 
Korcula vary from high (0.79) for monofractals (VAMPIRE) to very low (0.01) for 
multifractals (VAMPIRE). Overall the heritability measures were consistent between the 
two populations, with a few exceptions. Good agreement between the two isolates is 
reported for arterial tortuosity, the majority of the calibre measurements and the fractal 
dimensions measured by SIVA.  The most probable source of inconsistencies is the low 
sample size of Korcula population (N=387), which is less than half the number of 
Orkney subjects (N=809). In addition, lower number of informative familial 
relationships is available as a result of the lower number of individuals phenotyped in 
Korcula. Since the precision of the heritability measures depend on the sample size and 
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pedigree structure (among other sources of bias), unbalanced estimates of heritability 
obtained from Korcula sample are not surprising. 
 
Here we also report high phenotypic and genetic correlation between the calibre 
measurements CRAE and CRVE (ra=0.68, rp=0.52), in line with twin data estimates 
(ra=0.65-0.77, rp=0.55; Fachy et al. 2011) and higher than results reported in the 
Flemish study (ra=0.36). Flemish study only included 413 participants randomly 
selected from 70 families, presenting a less genetically informative sample than the 
isolated population of Orkney. Phenotypic correlations were in line with reported data 
(rp=0.55, Fachy et al. 2011). Correlations between other retinal vessel traits have not 
been published. Genetic correlations, representing a measure of the overlap in genetic 
effects between traits, conveyed moderate to high values, with the exception of the 
correlation between arterial widths and arterial tortuosity (ra=0.003, SE=0.14). A novel 
finding was of high genetic correlation between both arterial and venular tortuosity 
measurements (ra=0.69, SE=0.21)) and the arterial and venular width measurements 
(ra=0.65 se=0.11) suggesting a common genetic factors underlying these structures in 
both arterioles and veins. Moderate to high genetic correlations of most pairs of tested 
traits suggest the possibility that common genetic variants are influencing general retinal 
vascular morphology, and together with documented substantial heritabilites of those 
retinal vessel traits propose suggest this to be a fruitful area for further gene mapping 
analysis.  Phenotypic correlations between traits were also moderate to high in most 
pairs tested, with the exception of the pairs of vessel calibres -  vessel tortuosity and 
vessel calibres - fractal dimension traits measured by SIVA (ra=0.07-0.19). These results 
represent the first reports of phenotypic correlation between the retinal vessel traits other 
than vessel widths. 
 
Large effects of age, blood pressure values (systolic; diastolic in some studies) and a 
moderate BMI effect have been reported in numerous studies for retinal vessel widths 
(Leung et al 2003, Wong et al 2003, Wang et al. 2006, Kaushik et al. 2007, Taylor et al. 
2007, Gopinath et al. 2013, Klein et al. 2012, Li et al. 2012) tortuosity (Taarnhoj et al. 
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2008, Cheung et a.2011, Owen et al. 2011) and fractal dimensions (Liew et al. 2008, 
Kurniawan et al. 2012, Cheung et. al. 2012). In the two isolated populations examined in 
this study these covariates demonstrated moderate to large effect on retinal vessel traits.  
Age and average systolic blood pressure had the largest effects on fractal dimension 
measurements (age explaining 25.4% of monofractal dimensions variance in Orkney, 
and 19.39% in Korcula; avsbp explaining 15.1 % of variance in Orkney and 13.95% in 
Korcula of monofractal dimensions). Systolic blood pressure increase of 10mmHg was 
associated with 1.7 µm narrowing of retinal arterioles in Orkney and 1.5µm in Korcula, 
and 0.2 µm in Orkney and 0.9µm in Korcula narrowing of venules (adjusted for age and 
sex for comparison with published data), which was in agreement with reported effect 
sizes of systolic blood pressure on CRAE and CRVE in adult populations (1.1-1.9µm for 
CRAE , 0.2-0.5 µm for CRVE; lkram et al. 2004, Wong et al. 2006, Leung et al. 2003, 
Klein et al. 2012). Fewer studies reported effects of diastolic blood pressure, and data 
from Korcula (3.3 µm CRAE, 1.7 µm CRVE decrease per 10mmHg) and Orkney (2.7 
µm CRAE, 0.8 µm CRVE decrease per 10mmHg) were also in agreement with 
published reports (2.1-4.3 µm CRAE, 0.7-0.8 µm CRVE; Ikram et al. 2004, Leung et al. 
2003). Effect of bmi on retinal vessel traits was smaller compared to age and blood 
pressure traits (explaining at most 1.85% of the variance in simple venular tortuosity), 
however when compared to published results effect sizes were comparable in both 
Orkney and Korcula samples. Reduction in retinal arteriolar width was 0.003µm in 
Orkney and 0.08 µm in Korcula per kg/m2 , while venular calibres were 0.29µm wider in 
Orkney and 0.45µm in Korcula per kg/m2 (published reports; CRAE narrowing 0.07-
0.72, CRVE widening 0.03-0.44 ;Wang et al. 2006, Ikram et al. 2004, Hughes et al. 
2009). Identifying the sources of the phenotypic variation is a very important step in the 
heritability analysis, since it lowers the overall phenotypic variance and therefore allows 





In summary, the present study provides evidence of substantial additive genetic 
contribution to retinal vessel morphology and provides novel data on the heritability of 
various retinal vessel traits, as well as the genetic and phenotypic correlation between 
them. Furthermore, heritability estimates reported here are in agreement with the 
published reports (for calibre traits). Estimates reported here together with the evidence 
of common genetic variants influencing general retinal vascular morphology provide 
good basis for the following gene mapping analysis, even though heritability estimates 
are not always a good indicator of the success of GWAS. The choice of covariates 



















Chapter 5.  Retinal vessel traits: Association with 




The main focus of this chapter was to explore the relationship of retinal 
microvasculature with subclinical cerebrovascular, cardiovascular and metabolic 
outcomes (including some inflammatory biomarkers) measured in individuals from 
Orkney and Korcula (representing a cross-section of general population from those two 
islands). Since the retina presents the lone site in the human body where 
microcirculation can be assessed non-invasively, exploring associations between traits 
derived from its vasculature and subclinical markers of systemic disease developed into 
a standard way of studying manifestation of the human microvasculature. The 
associations of systemic risk factors with retinal vessel calibers have been explored in 
several epidemiological studies already, providing a comparison set when similar traits 
are tested. Additional systemic risk factors are tested here for the first time (e.g pulse 
wave analysis traits) as the ORCADES and CROATIA-Korcula studies included a deep 
array of phenotypes. All retinal vessel measures will be tested which include retinal 
vessel calibers, tortuosity and fractal dimension measurements. The analysis described 
in this chapter is exploratory, and the main purpose was to validate traits measured and 
aid future research into retinal vessel traits; to identify possible risk factors or 
confounding factors and guide the future epidemiological and genetic analysis of retinal 
vessel traits. It does not attempt to explore deeper analysis of joint effects of the 
systemic factors tested, and is purely designed to detect new and so far unknown 
associations of retinal vessel traits and systemic factors. Simple correlation between ten 




5.2. Literature review 
 
There are a great number of epidemiological studies focusing on quantitative traits 
related to retinal vessels diameters, and their association with systemic diseases (type 2 
diabetes, cerebrovascular disease, coronary heart disease). Nine major studies account 
for the majority of research in this field. Those studies are: Atherosclerotic Risk in 
Communities Study (ARIC), Blue Mountain Eye Study (BMES), The Beaver Dam Eye 
Study (BDES), Cardiovascular Health Study (CHS), The Wisconsin epidemiological 
study of diabetic retinopathy (WESDR), the Rotterdam study, Danish Twin Register 
study (DTRS), Singapore-Malay Eye Study (SMES) and Multi-Ethnic study of 
atherosclerosis (MESA). Majority of these studies have primarily focused on arterial and 
venous calibres and their association with systemic conditions and diseases. Details and 














Study name Sample size Type of study Reference 
Atherosclerotic Risk in 
Communities Study (ARIC) 
~17000 Prospective  http://www2.cscc.unc.edu/aric/ 
Blue Mountain Eye Study ~3500 Prospective, cross-
sectional 
http://www.cvr.org.au/bmes.htm 
The Beaver Dam Eye Study ~2500 Prospective, cross-
sectional 
http://www.bdeyestudy.org/ 




Fried et al. 1991 
The Wisconsin epidemiological 
study of diabetic retinopathy 
(WESDR) 
~1000 Prospective http://www.epi.ophth.wisc.edu/content/wesdr 
Rotterdam study ~8000 Prospective, cross-
sectional 
http://www.epib.nl/research/ergo.htm 
Singapore-Malay Eye Study ~3300 Prospective, cross-
sectional 
Rossman et al. 2012,  





Danish Twin Register study 
(DTRS) 
~100 Twin study Taarnhoj et al. 2006 
Table 5.1 Details of nine main epidemiological study included in the literature review. Sample size, type 
of study and the study reference is given. 
 
Generalised retinal arterial and venous narrowing have been associated with increasing 
age in four study populations (ARIC, DTRS, BMES, BDES). The main features of 
hypertension are increased peripheral vascular resistance and increased vascular 
stiffness. Even though it is still unknown whether arterial narrowing precedes and 
contributes to the development of hypertension, or is just a consequence of it, testing the 
association between the blood pressure and retinal microvascular features is an obvious 
line of inquiry in microvascular epidemiological research. In addition, pathological 
studies have shown that cerebral and retinal vasculatures change with increasing blood 
pressure (Hill 1970, Goto et al. 1975, Tso and Jampol, 1982). Retinal arterial narrowing 
have been shown to be associated with current high blood pressure (ARIC, DTRS, 
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BMES, BDES, Rotterdam study, CHS, SMES, MESA), past high blood pressure (ARIC, 
CHS, BMES) and future blood pressure (ARIC, BMES), whilst retinal venous dilation 
was associated with high current and future blood pressure (BMES).  
 
Since inflammation is considered to be one of the major underlying mechanisms of 
small and large vessel disease, associations with these factors and retinal calibres have 
also been tested. Several studies found association between venular dilation and markers 
of inflammation (C reactive protein-CRP, white blood cell count, interleukin-6; BDES, 
Rotterdam study, MESA). In addition, the Rotterdam study reported association of 
higher white blood cell counts and erythrocyte sedimentation rate with wider retinal 
venules.   
 
 Microvascular damage is one of the main pathological features of diabetes mellitus, and 
many studies explored associations between hyperglycaemia and retinal vessel calibres. 
Higher levels of serum glucose were reported to be associated with wider arterioles 
(MESA). In diabetic patients higher levels of HbA1c (glycated haemoglobin) were 
associated with both wider arterioles and venules (WESDR), and reported wider venular 
calibers than in a control group (BMES). Venous dilation alone has been shown to be 
associated with increased risk of diabetes mellitus (Rotterdam study, WESDR, ARIC). 
 
Several studies reported association of retinal vascular calibre and dyslipidaemia 
(MESA, ARIC, SMES) and obesity (BMES, Rotterdam study, MESA, SMES).  It is 
reported that dyslipidaemia is associated with wider venules (higher triglycerides – 
ARIC,MESA; lower HDL –BMES,MESA, Rotterdam studies).  Higher LDL levels were 
associated with venular dilation in MESA, but not in BMES. Obesity was associated 




In the ARIC study, arterial narrowing was found to share some risk factors with 
atherosclerosis (carotid arterial plaque and carotid arterial stiffness, but not with carotid 
intima-media thickness (CIMT)), but wasn't associated with clinical indicators of 
atherosclerosis. This was not confirmed in Rotterdam study, where lower AVR was 
associated with higher CIMT and carotid plaque score, nor in the CHS study which 
found no associations between AVR and measures of atherosclerosis. ARIC and 
Rotterdam studies found that both wider retinal venules and narrower arterioles are 
related to increased risk of stroke, but the Rotterdam study reported that venous dilation 
rather than arterial narrowing explained this association. The CHS study reported 
association between larger venous diameter and smaller arterial width increased 5-year 
risk of coronary heart disease (CHD), whilst the ARIC study reported association of 
lower AVR with increased risk of CHD and acute myocardial infarction in women but 
not in men. Both CHD and stroke mortality were found to be associated with larger 
venous and smaller arterial calibres (BDES, BMES). In addition, SMES reported 
association of retinal arterial narrowing with chronic kidney disease. The Sydney 
childhood eye study found association between narrower retinal arterioles and lower 










Vessel changes Association Study 
Narrower arterioles increasing age ARIC, DTRS, BMES, BDES 
Narrower arterioles current high blood pressure 
ARIC, DTRS, BMES, BDES, 
Rotterdam study, CHS, SMES 
Narrower arterioles past high blood pressure ARIC, CHS, BMES 
Narrower arterioles future high blood pressure ARIC, BMES 
Narrower arterioles increased risk of stroke ARIC 
Narrower arterioles 
increased risk of coronary heart disease 
and acute myocardial infarction in women ARIC 
Narrower arterioles 
increased incidence of coronary heart 
disease CHS 
Narrower arterioles stroke mortality BDES, BMES 
Narrower arterioles coronary heart disease mortality BDES, BMES 
Narrower arterioles chronic kidney disease SMES 
Narrower arterioles 
lower birth weight, shorter birth length and 
smaller head circumference Sydney childhood eye study 
Narrow venules increasing age ARIC, DTRS, BMES, BDES 
Venular dilation high blood pressure (present and future) BMES 
Venular dilation 
markers of inflammation (CRP, 
fibrinogen) (CRP, fibrinogen, interleukin 
6) 
Rotterdam study  
BDES, MESA 
Venular dilation hyperglycemia 
BDES, Rotterdam study, MESA, 
SMES 
Venular dilation obesity 
BMES, Rotterdam study, MESA, 
SMES 
Venular dilation increased risk of stroke ARIC, Rotterdam study 
Venular dilation coronary heart disease mortality BDES, BMES 
Venular dilation stroke mortality BDES, BMES 
Venular dilation increased risk of diabetes mellitus ARIC, Rotterdam study, WESDR 
Venular dilation dyslipidemia MESA, ARIC, SMES 
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Table 5.2. Association of retinal vessel diameters with different disease outcomes, markers and risk 
factors. 
 
Two major studies have focused on association of quantitative vessel traits and cognition 
(ARIC, and Lothian Birth Cohort (LBC) study). The ARIC study found that the presence 
of retinal abnormalities (retinopathy, micro aneurysms, retinal haemorrhages and 
exudates) was associated with small decrease in cognitive function, at the same time 
they reported no association between retinal arterial narrowing and cognitive function. 
In addition, LBC found no association of vascular width measurement (CRAE, CRVE, 
AVR) and cognition (Patton et al. 2007). However they found association of 
suboptimality of the retinal bifurcation junctional geometry (the root mean square of the 
difference of the median angle/branching coefficient from 75°/1.26) and cognitive 
decline. They reported associations of suboptimal angles with logical memory (GLM, 
p=0.03), and suboptimal branching coefficients with verbal fluency (GLM, p=0.01) and 
with cognitive ability score (GLM, p=0.02). However, they did not apply adjustments 
for multiple testing and so the effect, if real, is of questionable significance. 
 
Several studies reported associations of monofractal dimensions with systemic diseases. 
Grauslund et al. (2010) investigated association of retinal monofractal dimensions with 
vascular complications in long-term surviving type 1 diabetes patients, and found that 
patients with lower fractal dimension were more likely to have proliferative retinopathy 
and neuropathy. In addition they found that patients with lower fractal dimensions were 
older, which was confirmed in several additional studies (Liew et al. 2008, Cheung et al. 
2012, Azemin et al. 2012). SMES (Cheung et al. 2012) also reported association 
between lower monofractal dimensions and higher mean arterial blood pressure, which 
was confirmed in further studies (Sng et. al 2010, Kurniawan et al. 2012).Association 
between lower fractal monodimensions and diastolic blood pressure were also reported 
(Liew et al. 2008, Kurniawan et al 2012). Decreased fractal dimensions have also been 
associated with the incidence of stroke (Doubal et al. 2010, Kawasaki et al. 2011). 
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Patients with chronic kidney disease were associated with suboptimal fractal dimension 
(Sng et al. 2010). Reduced monofractal dimensions in children were reported to be 
associated with smaller head circumference (Gropinath et al. 2013). 
 
Vessel changes Association Study 
lower fractal dimensions 
proliferative retinopathy and neuropathy in 
long term surviving type 1 diabetes patients Grauslund et al. 2010 
lower fractal dimensions increasing age 
Grauslund et al. 2011, Cheung et al. 
2012, Azemin et. al 2012, liew et 
al. 2008 
lower fractal dimensions increased mean arterial blood pressure 
Cenung et al. 2011, Sng et al. 2013, 
Kurniawan et al. 2011 
lower fractal dimensions elevated diastolic blood pressure 
Kurniawan et al. 2011, Liew et al. 
2008 
lower fractal dimensions stroke 
Doubal et al. 2010, Kawasaki et al. 
2011 
suboptimal fractal dimensions chronic kidney disease Sng et al. 2010 
reduced arterioral tortuosity  older  age Cheung et al. 2011, 
Reduced  arterial tortuosity higher blood pressure 
Cheung et al. 2011, Hasan et al. 
2013, Taarnhoj et al 2008 
decreased tortuosity 
increased risk of death from ischemic heart 
disease  Witt et al. 2006 
Decreased arterial  tortuosity higher body mass index 
Taarnhoj et al 2009, Cheung et al. 
2008 
Decreased arterial tort increased Hb1c Sasongko et al. 20130 
Increased venular tortuoasity 
younger age, higher blood pressure, lower 
HDL Cheung et al. 2008 
   
Table 5.3. Association of fractal dimensions and tortuosity with different disease outcomes, markers and 
risk factors 
 
SMES study reported associations between reduced arteriolar tortuosity and older age, 
higher blood pressure and higher body mass index (BMI) (Cheung et al. 2011).  The 
same study also reported associations between greater venular tortuosity and younger 
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age, higher blood pressure and lower high-density lipoprotein (HDL) cholesterol level. 
Association between reduced arterial tortuosity and increased mean arterial blood 
pressure was reported in several other studies (Hasan et al. 2013, Taarnhoj et al 2008). 
In contrast, a study of 10-year old children reported positive associations between 
arteriolar tortuosity and systolic and diastolic blood pressure, levels of triglyceride, total 
and LDL cholesterol. Higher HbA1c was associated with increased arteriolar tortuosity 
(Sasongko et al. 2010), whilst less tortuous ones have been associated with increased 
risk of death from ischemic heart disease (Witt et al. 2006). Taarnhoj et al. (2008) have 
also reported in their twin study that less tortuous vessels are associated with increased 
body mass index.  
 
To summarise, out of all the retinal vessel traits retinal vessel width measurements have 
been studied to the greatest extent. There have been independent sources of evidence 
that retinal arterial narrowing and increased retinal vein diameter are associated with 
several cardiovascular disease outcomes and markers. Other quantitative vessel 
measurements haven’t been studied in such extent as vessel diameters. Research into 
fractal analysis and systemic disease have only started recently and the first results are 
looking very promising, and further research into this field is of great interest. Retinal 
vessel tortuosity still remains fairly unexplored area of research of retinal vasculature, 














5.3. Material and methods 
 
 
5.3.1 Selection of cardiovascular risk factors 
 
The selection of cardiovascular risk factors used in the correlation analysis was based on 
the following criteria; well established factors used in previously published retinal vessel 
research, and availability of the phenotypes in the two populations tested. Established 
guidelines from prior epidemiological studies on the associations of the systemic risk 
factors with retinal vessel calibers was complemented with one novel trait (from pulse 
wave analysis). Risk factors identified though literature could be divided into six distinct  
groups: blood pressure traits (systolic and asystolic blood pressure measurement), 
markers associated with hyperglycemia (glucose, Hb1c), markers of dyslipidemia 
(cholesterol, triglycerides, LDL, HDL), markers of obesity (bmi, waist to hip ratio),  
markers of atherosclerosis (CIMT) and markers of inflammation (CRP, fibrinogen). One 
novel traits tested has been recognized as a marker of systemic atherosclerosis (pulse 
wave analysis). Selected risk factors were used for the correlation analysis of all of 
retinal vessel traits available. 
 
5.3.2. Measurement of cardiovascular risk factors 
 
Blood was drawn directly into monovette tubes. Total and HDL cholesterol, 
triglycerides, HDL, CRP  and glucose were measured EDTA plasma, fibrinogen was 
measured in citrated plasma, and HbA1c was measured in whole blood in EDTA. LDL 
levels were calculated using the Friedewald equation. All analytes were determined by 




Ankle brachial pressure index is the ratio of the blood pressure in the lower legs to the 
blood pressure in the arms. The measurements used in the analysis were calculated as the 
lowest posterior tibial (ankle) systolic pressure divided by the highest brachial systolic 
pressure.  
 
Augmentation index, was one trait selected from the pulse wave analysis (PWA). PWA 
is used to estimate the degree of arterial and was performed after 1 hour of horizontal 
rest. Radial arterial tonometry was performed using the SphygmoCor Px system (AtCor 
Medical, NSW, Australia) with a Miller tonometer (Miller instruments, TX, USA), 
continuously for 30 seconds in a resting state and an average waveform was generated. 
Four reading were performed in total (two successful readings followed by 5 minutes 
rest followed by two further readings). Different PWA measurements were derived from 





                                                                                                                           
Figure 5.1. Example pulse wave 
describing key elements form which 






The augmentation index is a ratio calculated from the blood pressure waveform and one 
of the most commonly used non-invasive measures of arterial stiffness (a risk factor for 
cardiovascular events). It is defined as the ratio of augmentation pressure (AP) to pulse 
pressure (PP), or by how much the reflected pressure wave augments or raises the 
overall pulse pressure. The stiffer the arteries the more quickly the reflected pressure 




CIMT (carotid intima media thickness) was assessed by ultrasound examination of the 
common carotid artery 2 cm below the carotid bifurcation. The mean of the three 
measurements was used as a final trait in the analysis. This measure was only available 
in the ORCADES study. 
 
Systolic and diastolic blood pressures were measured twice using OMRON digital 
sphygmomanometers, and the mean of the two measurements was used. Smoking 
information was collected (categorized as current, former or never smoker) through the 
questionnaire.  Percentage of body fat was measured using bioimpedance with Tanita 
scales. BMI and waist to hip ratio was calculated accordingly to the following formulae: 
BMI = Weight in Kilograms / (Height in Meters x Height in Meters)  
Waist to hip ratio= The Circumference of the Waist/Circumference of the Hips 
 
 
5.3.3. Statistical analysis 
 
5.3.3.1. Testing distributional properties of the traits and adjusting for non-
normal distribution 
 
Normality of the distribution for each trait was tested using the Kolmogorov-Smirnov 
normality test (lillie.test) implemented in nortest package in R (J. Gross 2012). Traits for 
which the distribution deviated from normality were transformed using quantile 
normalisation with the rank transformation function (trait ~ age + sex), of GenABEL 
(Aulchenko et al. 2007). It ranks the Z-scored residuals of the regression of the traits on 
the relevant covariates and performs quantile normalization. 
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5.3.3.2. Correction for the relatedness of the individuals 
 
Since both Orkney and Korcula represent genetically isolated island populations and 
therefore contain substantial proportion of relatively closely related individuals, 
correcting for this relatedness was required. As a result of many close relationships 
between individuals, similarity between certain heritable traits could arise from these 
familial relationships and not from the true correlations between the retinal vessel traits 
and systemic risk factors. In order to correct for this, polygenic model of inheritance 
(explained in chapter 4) was used to obtain residuals, that have the estimated random 
polygenic effect and the effects of covariates (age, sex) factored out. Age and sex were 
the only covariates considered in this analysis, as a result of exploratory nature of the 
analysis. More complex selection of the covariates for each of the 180 pairs of trait 
tested was beyond the scope of this type of analysis. All of the cardiovascular risk traits, 
but waist to hip ratio, of interest were rank-transformed prior to the analysis, because of 
their departure from normal distribution. 
 
 
5.3.3.3. Correlation analysis 
 
Linear correlation between retinal vessel traits and cardiovascular risk factors were 
tested using bivariate Pearson’s correlation. Pearson's correlation coefficient between 
two variables is defined as the ratio of the covariance of the two variables divided and 
the product of their standard deviations. It ranges from -1  to 1 (correlation coefficient of 
1 and -1 implies a perfect linear relationship between two variable, and 0 implies no 
linear correlation). For all pairs of traits tested (both cardiovascular and retinal vessel 
traits), residuals obtained from the polygenic model were used to test the correlation. 
Zone B diameter measures and curvature tortuosity measurement were used (leaving out 
measurements in zone C and simple tortuosity) in order to minimize redundancy and 
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keep the analysis more clear. Statistical analyses were performed using statistical 





6.4.1. Descriptive statistics for cardiovascular risk factors 
 
Descriptive statistics for 18 different cardiovascular risk factors are displayed in Table 
5.4. Subjects form Korcula did not have the CIMT measurements taken, so the values 
for CIMT are missing from the table.  Values for majority of the traits were comparable 
between the two independent populations, however glycated hemoglobin levels and the 
pulse wave augmentation index presented slightly different mean values.  This is 
probably due to the lower numbers of individuals having these measures taken in 
Korcula (HbA1c and augmentation index) and Orkney (augmentation index). The 
normality of the distribution of all traits were tested, and rank transformed accordingly. 
In addition 22.5% in Korcula and 33.7% in Orkney are current smokers, while 48.2% in 









 Orkney  
N Minimum Maximum Mean Std. Deviation Kologorov-
Smirnov test 
ABPI 871 0.55 1.31 1.03 0.10 3.8x10
-4 
Avdbp 873 0 164 75.99 10.55 <2.2x10
-16 
Avsbp 873 58.5 212 130.88 19.12 5.07x10
-8 
Bmi 867 16.97 47.63 27.67 4.84 4.94x10
-13 
BodyFat 866 8.7 53.8 31.81 8.64 0.007 
CAGPHHR75mean 587 -28 47.5 15.60 14.41 4.88x10-
15 
Chol 889 2.7 12 5.45 1.15 4.1x10
-6 
CIMT 866 0.02 0.35 0.05 0.02 <2.2x10
-16 
CRP 882 0.15 90.1 2.55 5.06 <2.2x10
-16 
Fibrinogen 882 1.18 9.79 3.4 0.86 1.31x10
-11 
Glucose 889 3.9 17.1 5.43 0.99 <2.2x10
-16 
HbA1cIFCC 873 2.1 9.7 3.64 0.78 <2.2x10
-16 
HDL 889 0.7 4.9 1.55 0.43 3x10
-10 
LDL 889 0 9 3.36 1.07 <2.2x10
-16 
Triglyc 889 0.2 11.6 1.18 0.76 
<2.2x10-16 
waist_hip ratio 872 0.47 1.23 0.91 0.09 0.036 
       
 Korcula 
N Minimum Maximum Mean Std. Deviation Kologorov -
Smirnov test 
Abpi 860 0 2 0.99 0.15 6.22x10
-11 
Avdbp 878 58 113 81.29 9.31 1.19x10
-8 
Avsbp 879 93 215 138.95 21.02 1.1x10
-4 
Bmi 881 16.59 53.84 27.96 4.14 0.008 
Body_fat 856 14.47 50.33 36.23 6.51 4.75x10
-16 
Cholesterol 895 2.7 11.3 5.95 1.23 5.6x10
-7 
Crp 870 0.012 14.12 3.19 3.05 
               
<2.2X10-16 
Fibrinogen 801 2 11 4.56 1.51 <2.2X10
-16 
Glucose 895 3.8 17.5 5.81 1.55 <2.2X10
-16 
hba1c 456 5 13 5.79 0.765 <2.2X10
-16 
Hdl 892 0.76 2.7 1.46 0.35 
         8.16X10-10 
Ldl 889 1.3 8 3.82 1.04 5.8X10
-8 
Pulse-wave 486 -21.5 54.5 22.01 11.31 6.92x10-16 
triglycerides 895 0.3 21.84 1.49 1.26 <2.2X10
-16 
Waisthip 847 0.64 1.35 0.91 0.09 0.67 
Table 5.4. Descriptive statistics of selected cardiovascular risk traits in two isolated populations. 
Departure from normality of the traits distribution is reflected by the p-value obtained from the 





5.4.2 Correlation between retinal vessel traits and cardiovascular disease risk 
factors 
 
Correlation matrices representing correlation coefficients for all pairs of tested traits are 
given in table 5.5. Correlation coefficients between most pairs of traits were very low 
and non-significant in both populations. However some of the tested traits displayed 
consistent results in both of the populations tested. Correlation between arterial caliber 
in zone B and blood pressure measurements (both systolic and diastolic) showed the 
highest  significant correlation values in both Orkney and Korcula (Orkney – 0.24 
CRAE-avsbp p=4.3x10-12 , 0.238 CRAE-avdbp p=7.6x10-12; Korcula  0.242 - CRAE-
avsbp p=1.9x10-6 , 0.214 CRAE-avdbp p=2.8x10-5). Correlation between arterial 
diameter and blood pressure measures were negative in both population, confirming the 
widely previously reported associations between high blood pressure and arterial 
narrowing. AVR showed similar consistent values in both population for blood pressure 
measurements, as well as percentage of body fat (-0.14 in Orkney and -0.15 in Korcula). 
Fractal dimension measurements showed significant correlation values with blood 
pressure measurements in Orkney, but not in Korcula. Three different measurements of 
fractal dimension of the whole vasculature presented inverse correlation coefficients 
with both systolic and diastolic blood pressure (ranging from -0.09 to -0.15). In Korcula, 
measurement of multifractal dimensions presented the only significant negative 
correlation with diastolic blood pressure (-0.13). Pulse wave augmentation showed 
significant inverse correlation coefficient with AVR, of the similar size, in both 
populations (Orkney 0.10, Korcula 0.18). Puls wave augmentation index represents the 
only marker of atherosclerosis displaying consistent correlation values across both 
population for the same trait. CIMT was measured only in the subject form Orkney and 
showed significant correlation values with arterial curvature tortuosity (0.08).  ABPI did 
not display any significant correlation values with any of the retinal vascular trait in both 
of the tested populations. Traits showing significant correlation values with the most 
retinal vessel traits in Orkney were the total cholesterol level and LDL levels; displaying 
significant values with all of the tortuosity and fractal dimension measurements (ranging 
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from 0.07 to 0.09 from cholesterol, 0.08 to 0.11 for LDL). Current smoking displayed 
significant correlations with venular dilatation in both populations. 
Correlations between AVR adjusted for body fat, and average systolic blood pressure 
(and average diastolic blood pressure) also adjusted for body fat were calculated in order 
to see if the effects were independent or not. The same procedure was repeated to adjust 
for pulse wave augmentation. Lower correlation coefficients were observed between 
both blood pressure measurements in Orkney (AVR-avsbp r=-0.152, AVR-avdbp r=-
0.211 (adjusted for pulsewave augmentation); AVR-avsbp r=-0.160, AVR-avdbp r=-
0.23 adjusted for body fat percentage)) when traits were corrected for pulse wave 
augmentation and body fat percentage. This drop in the correlation was not nominally 
big, but given the high significance of the correlation coefficients it could be concluded 
that the associations between AVR and blood pressure measurements are not in large 
part due to confounding with body fat or pulse wave.  Results for Korcula did not show 
a similar trend (AVR-avsbp r=-0.172, AVR-avdbp r=-0.149 (adjusted for pulsewave 
augmentation); AVR-avsbp r=-0.210, AVR-avdbp r=-0.157 adjusted for body fat 
percentage)). This observation should be tested in a further independent cohort, in order 


















-0.006 -0.240** -.238** -0.036 -0.022 0.016 -0.002 0.048 -0.035 0.051 0.003 -0.015 0.013 -0.022 -0.023 -.114** -0.021 0.027 
CRVE 
0.080* -0.071* -0.012 .093** 0.027 0.059 0.067 0.048 0.018 0.038 0.045 -0.051 0.028 .071* 0.06 -0.022 0.041 .097** 
AVR 
-0.090* -0.178** -.241** -.136** -0.054 -0.045 -.073* 0.001 -0.053 0.019 -0.042 0.036 -0.014 -.095** -.089* -.103* -0.064 -.072* 
cTORTa 
-0.011 -0.056 -0.038 -0.03 0.01 -.082* 0.005 0.037 -0.014 0.023 .071* 0.03 .078* 0.048 -0.003 -0.003 -.069* -0.029 
cTORTv 
0.080* 0.019 0.003 .082* -0.033 0.026 0.034 .079* .077* 0.061 .091** 0.033 .091*
* 
0.03 -0.012 0.011 -0.016 -0.007 
cTORTt 
0.034 -0.014 -0.012 0.024 -0.019 -0.028 0.017 0.064 0.029 0.043 .093** 0.046 .093*
* 
0.048 -0.007 0.02 -0.055 -0.02 
FractlaDi
mc 
0.019 -0.142** -.089* 0.033 0.057 -0.053 0.042 .083* 0.055 -0.01 .086* -0.001 .080* 0.038 0.034 -0.032 0.002 0.014 
FractalDi
mv 
0.007 -0.023 0.026 0.048 0.048 -0.003 0.021 0.056 0.046 -0.008 .071* 0.019 0.059 0.037 0.037 0.027 0.001 0.002 
Dbox 0.037 -0.147** -.132** 0.043 -0.033 -0.04 0.014 0.04 0.049 0.014 .072* -0.057 .091* 0.042 0.043 -0.067 0.037 .088* 
D0 
0.031 -0.092* -.093* 0.03 -0.021 0.016 -0.016 0.042 0.069 0.023 .081* -0.045 .110*
* 
0.034 0.047 -0.022 -0.017 0.065 
 

















CRAE -0.07 -.242**  -.214** -0.06 0.08 0.09 -0.03 -0.002 -0.01 -0.06 -0.05 -0.05 0.01 .147** -0.10 0.07 .113* 
CRVE -.125* -0.10  -0.09 0.05 0.01 0.09 0.02 0.07 -0.04 0.09 0.06 0.06 0.05 .144** 0.08 0.10 .121* 




-.131** -0.05 0.01 -.185** -0.03 0.01 
cTORTa 0.01 0.001  0.03 -.160** -0.06 -0.06 -0.07 -0.03 0.08 -0.02 -0.002 -0.002 -0.04 0.03 -0.10 -0.03 0.04 
cTORTv -0.04 0.03  0.004 0.04 0.05 0.01 0.01 0.04 0.05 0.02 -0.03 0.02 0.03 0.06 -0.01 0.01 -0.002 
cTORTt -0.03 0.03  0.04 -0.08 0.01 -0.02 -0.04 -0.0004 0.09 -0.002 -0.02 -0.0004 -0.01 0.08 -0.03 -0.01 0.03 
FractalDim
C 
0.00 -0.05  -0.04 0.08 0.03 -.102* -0.03 0.04 -0.003 0.06 -0.01 0.07 0.05 -0.03 0.11 0.06 -0.04 
FractlaDim
v 
-0.02 0.01  0.03 0.04 -0.003 -0.04 -0.03 0.06 -0.05 0.06 0.01 0.05 0.06 -0.01 .173* 0.10 -0.001 
D0 -0.05 0.05  0.004 .151** -0.03 0.04 .139* 0.05 0.15 0.05 -0.06 0.06 0.00 0.08 0.06 0.03 .131* 
Dbox -0.10 -0.10  -.134* .129* 0.00 0.02 0.12 0.02 .165* 0.03 -0.05 0.05 0.02 0.04 0.02 0.07 0.08 
   
   Table 5.5 Correlation matices representing person’s correlation coefficient between retinal vessel traits and selected cardiovascular risk factors. *. Correlation is 





The results of the correlation analysis have confirmed previously known associations 
between retinal arterial diameters and blood pressure measurements. Several novel 
associations were detected with traits that have been tested in this analysis for the first 
time (pulse wave augmentation index). This study further extends previous work on 
associations of retinal vessel traits and systemic risk factors, which previously reported 
that the retinal vascular calibre and fractal dimensions of the retinal vascular network is 
influenced by blood pressure in adult populations (Liew et al. 2008, Sun et al. 2009, 
Kurniawa.n et al. 2012).  However we did not find significant correlations between 
retinal vessel tortuosity and blood pressure measurements as previously reported 
(Taarnhoj et al. 2009, Cheung et al. 2011, Hasan et al. 2013).  
 
Highest correlation coefficient values were reported for CRAE and both systolic and 
diastolic blood pressure, and these values were consistent across both populations, even 
though Korcula included only 389 subject with both phenotypes measured (compared to 
809 from Orkney), confirming the robustness of this association that has been reported 
in numerous retinal vascular research studies. Correlation coefficient between systolic 
blood pressure and venular diameter was significant in Orkney, but of a smaller size 
when compared to arterial association. Positive correlation between venular dialation 
and obesity has also been reported (Klein et al. 2006, Ikram et al. 2004, Wong et al. 
2004, Wong et al. 2006), and confirmed here in Orkney (r(CRVE-bmi)=0.08), but not in 
Korcula where it displayed inverse correlation with bmi; opposite to the published 
reports. This is most likely the result of low number of subjects tested in Korcula. In 
addition, association of venular dilation with dyslipidaemia, hyperglycaemia and 
inflammation markers reported in literature has not been replicated here. CRVE 
presented positive but non-significant associations with serum levels of glucose, 
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triglycerides, total cholesterol in both Orkney and Korcula and inverse correlation with 
HDL in Orkney. 
 
Lower fractal dimesion measurements have been shown to correlate with increased 
blood pressure measurements, which was also confirmed in the analysis of subjects from 
Orkney. Results were consistent between different monofractal and multifractal 
measurements, while in Korcula significant correlations were only reported between 
multifractal measurement and diastolic blood pressure. Blue Mountains Eye Study (Liew 
et al. 2008) reported correlation coefficient of -0.29 (after adjustment for age and sex) 
between systolic blood pressure and monofractal measurement of retinal vasculature 
which is sizably higher than reported here (0.147/0.142), however their study included 
only 300 participants compared to 809 included in the analysis of subjects from Orkney.  
 
Relationship between retinal vessel traits and markers of atherosclerosis has not been 
studied extensively and a few published reports showed no significant relationship 
between CRAE, except for the CIMT (Ikram et al. 2004, Torres et al. 2013). The same 
study reported association of CRVE with several markers of atherosclerosis. CIMT was 
reported to be associated with arterial narrowing (Ikram et al 2004, Torres et al. 2013) 
and venular diameter (Torres et al. 2013). Second atherosclerotic marker tested here 
(ABPI) showed no significant relationships between retinal vessel traits tested in both 
populations. Previous reports suggested a linear relationship of lower ABPI and larger 
venular diameters (Ikram et al. 2004), but it was not detected here. A novel finding was 
the significant correlation between arterial curvature tortuosity and CIMT (r=-0.08), 
suggesting a role of the atherosclerotic plaque in the tortuosity of arterioles and should 
be tested further in larger studies. A novel atherosclerotic marker (marker of arterial 
stiffness) tested here, pulse wave augmentation index, displayed significant correlations 
between CRAE (Orkney; -0.114) and AVR (Orkney -0.103; Korcula -0.185). This is the 
first report of this type of associations and warrants a further research into the 
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relationship between this and other traits derived from pulse wave analysis and retinal 
vessel diameters.  Augmentation index and central blood pressure are thought to 
measure different aspects of arterial stiffness. The low drop in the correlation 
coefficients between AVR and blood pressure measurements in Orkney (after adjusting 
both AVR and blood pressure measurements for pulse wave augmentation index) 
suggested they are acting independently on AVR. However the same drop in correlation 
coefficient was not observed in Korcula, and therefore it would be of interest to see 
whether this result replicates in other larger studies. 
  
Results obtained from this correlation analysis largely confirmed previously reported 
associations of some cardiovascular risk factors with retinal vessel diameters and fractal 
dimensions, validating our measurements. In addition some new significant correlations 
were reported that should guide the future epidemiological and genetic research, 
especially in terms of vessel diameters and pulse wave analysis traits. Data also showed 
the lack of significant correlation for a large number of pairs of traits tested, suggesting a 














Chapter 6.  Genome wide association studies of retinal 
vessel traits 
 
6.1.  Introduction 
 
This chapter describes the process of genome wide association studies of 10 traits 
derived from the retinal vessel vasculature. Each trait has been tested in the two 
populations from Orkney and Korcula and joint meta-analysis was performed. Two 
studies so far reported genome-wide association scans for retinal vessel calibers (CRVE 
(Ikram et al. 2010) and CRAE (Sim et al. 2013)) in 8 populations of European ancestry 
totaling 22010 individuals for CRVE and 7 populations totaling 22661 for CRAE 
analysis. These uncovered four genome-wide significant loci associated with CRVE and 
one with CRAE, allowing to look-up if these results replicate in our populations. Since 
two genetically isolated populations were used here, it is also possible that the allele 
frequency changes within these populations would enable the detection of genetic 
variants that have lesser allele frequencies in the larger population (used in the 
previously published GWAS). In addition, here we use very uniform phenotypes, 
acquired in identical manner in both populations, which has not been the case in the 
larger published GWAS where slightly different measurements of retinal widths were 
used between the many populations included. Finding potential novel associations not 
identified in the larger meta-analysis studies and finding potential association for traits 
never before tested for genetic association was the primary purpose of the work reported 
in this chapter. Directly genotyped data as well as imputed data were analysed for each 
trait, and replication was sought in an independent population form Scotland (Lothian 
Birth Cohort) for any potential genome-wide significant findings. Pathway analysis was 
also performed for the whole group of retinal traits results, selecting each GWAS SNPs 






6.2.1. ORCADES data preparation and quality control 
 
Prior to the start of this project 758 individuals from Orkney have been genotyped using 
an Illumina HumanHap300 v2 array and converted to a format for genome wide data 
analysis. A second batch of 162 individuals was genotyped just before the start of this 
project using the Illumina Human 370CNV Quad array and was available to be merged 
with the previously genotyped individuals. Genotypes clustering and calling was done 
using Illumina Genome Studio software by C.H.. Genotyping data for these 162 
individuals were then merged with the 758 individuals in plink using “–merge” option 
and converted to GenABEL format, using available GenABEL package option 
(convert.SNP.illumina). Before the quality control (QC) procedures there were 894 
individuals and 351251 SNPs (the combination of typed subjects and SNPs in the first 
and second genotyping stage).  
 
Appropriate quality control of the genotyped data is essential when executing 
association analysis of large-scale SNP data, primarily to avoid an abundance of false 
positive and false negative results arising from genotyping errors or population 
stratification (Cardon and Palmer 2003; Anderson et al. 2010). In addition a strict QC 
protocol is essential to allow for the most accurate data imputation of the genotyped 
data, which was done subsequently. 
 
293687 SNPs passed QC criteria (SNPs with call rate≤0.98, overall call rate per 
individual (perid.call) ≤ 0.97, minor allele frequency (maf) ≤ 0.02, Hardy Weinberg 
equilibrium (HWE) departure p.level ≤ 1.e-10, heterozygosity fdr ≤ 0.01 were removed). 
Before the QC there were 351251 markers in total. 10908 (3.105472%) markers 
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excluded as having low (<2%) minor allele frequency. 56299 (16.02814%) were 
markers excluded due to low (<98%) call rate and 258 (0.07345175%) markers were 
excluded because they were out of HWE (P <1e-10). 
 
Before QC in GenABEL, 2 individuals (ORCA1033, ORCA1142) were removed to a known 
sample mix-up. Six individuals in total failed QC. Three were removed due to the 
mismatch between reported gender and  chromosome X-linked markers genotypes. Even 
though X chromosome aneuploidy or gender reassignment could explain this mismatch, 
it is more likely that mislabeling of a DNA sample or another pre-analytical error has 
occurred. Genotyped call rate and average heterozygosity of an individual are used to 
detect individuals with poor quality genotype data. Two individuals were removed 
because of the low call rate, which can signify a low concentration or degraded DNA 
sample. One individual failed the heterozygosity test (HET >= 0.3641862) indicating 
possible sample contamination sample or a population admixture which also indicates 
the subject does not represent the population accurately. Relationships between the 
samples were tested by calculating the Identity by state (IBS) sharing levels, which 
enables the detection of twin or duplicated samples.. 1 individual was removed due to 
the very high IBS-sharing with another sample (IBS>=0.95), indicating a possible 
duplicate.  
 
We did not exclude any individuals after inspection of ancestry principal components 
plots based on IBS sharing distances (Figure 6.1.) as there were no significant outliers 
and inspection of pedigrees of multiple individuals from the extremes of principal 




Figure 6.1. Ancestry clustering for Orkney subjects passing QC measures. Clustering was achieved by 
multi-dimentional scaling of the matrix of pairwise genetic distances derived from the identity by state 




6.2.1.1. Data imputation 
 
889 genotyped individuals and 293,687 SNPS were then used for imputation to the CEU  
HapMap2 reference build 36 release22. Additionally all the SNPs with AT, TA, GC, CG 
genotypes were removed (due to possible discrepancies between Illlumina strand 
designation and reference haplotypes) which left 293,600 SNPs.  Imputation of the 
genotyped data was done using MACH software. This allowed 2.74 million genotypes to 
be estimated. Details on the imputation procedures are given in Chapter 2. The data was 
therefore ready for testing for association of common SNPs with quantitative retinal 




6.2.3. Korcula genotyping and quality control 
 
Details on the genotyping and subsequent QC procedure of the Korcula data are given in 
Chapter 4. Identical QC procedures as for Orkney were applied, which left 345555 SNPs 
and 898 individuals to use in the association analysis, and subsequent data imputation. 




6.2.4. Genome wide association analysis 
 
For genome wide association analysis of genotyped data, the GenABEL (Aulchenko et 
al. 2007) library implemented in the statistical program R was used. It provides facilities 
for storage and manipulation of large amounts of data, very fast tests for GWA analysis 
in particular tests accounting for relatedness, and special functions to analyse and 
graphically present the results of GWA analysis. As mentioned previously, individuals 
from Orkney and Korcula represent isolated population groups and as many participants 
of the study are related this source of positive confounding (extended pedigree works as 
a confounder) needs to be taken into account in the analysis.  We expect an inflation of 
significant results (pedigree inflates the resulting null distribution of chi-square test 
statistic by a constant λ) due to increased sharing of alleles between related individuals 
and familial covariance in the tested traits. In a genetically homogenous population, like 
the isolated populations, it can be shown that the constant λ is a function of a trait’s 
heritability and pedigree structure.  A mixed model accounting for a random polygenic 
inheritance is a standard approach to correct for this non-independence (as described in 
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more detail Chapter 4 p120) when heritability estimates procedures were explained). 
Various covariates can be included in the polygenic model, including genetic markers 
that need to be tested for association with a specific phenotype. However when large 
number of markers are tested, maximum likelihood(ML)/restricted maximum likelihood 
(REML) solutions (used for estimating the model parameters) may take very long time 
to run . Therefore fast approximate tests were developed for the purposes of GWA 
association analysis in samples of relatives. Two of fast approximations are available to 
use in GenABEL. FAmily-based Score Test for Association (FASTA, Chen & Abecasis, 
2007) and Genome-wide Rapid Analysis using Mixed Models And Score test 
(GRAMMAS, Amin et al. 2007). Both tests are based on the calculation of the polygenic 
model of inheritance and are run in two stages. 
 
The first step is that used for heritability estimation (Chapter 4). Briefly a mixed model 
is fitted that uses the genomic kinship matrix from genome-wide data and ML/REML 
method is used to estimate the random effects’ variances (the polygenic effect and error 
terms) together with relevant covariates effects fitted as fixed effects . The vector of 
residuals and the inverse of the variance-covariance matrix calculated in this stage are 
then used in the second step of the analysis, in which the FASTA score statistic is used 





Where (g - E[g]) is the additively coded observed genotype minus the expected average 
genotype based on allele frequency. Φ is the kinship matrix, σg2 the estimated polygenic 
variance, σe 2 the residual environmental variance and I the identity matrix. Y is the 
phenotype value and μ is the population mean. It can be shown that TF2 follows χ12 when 
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pedigree structure is correct. In an additive coding, effect for the homozygous for the 
effect allele is twice that of the effect of the heterozygous genotype. 
 
Imputed data were analysed with ProbABEL software (Aulchenko et al. 2010) is used. 
When dealing with imputed or high-throughput sequencing data, for many of loci there 
is uncertainty about the genotypic status of the person (we deal with probability 
distribution, based on the observed information). The degree of confidence about the 
real status of a genotype is measured with this probability distribution. To generate 
unbiased estimates of association parameters and to take into account the probability 
distributions, ProbABEL carries out association analysis by means of regression of the 
outcome of interest onto estimated allelic doses, which take a continuous value between 
0 and 2 . It is designed to carry out the regression analysis in fast and memory efficient 
ways, since it deals with millions of SNPs.  
 
Genome wide association analyses were done for each population separately, followed 
by a meta-analysis for each of the traits. Inverse variance weighted meta-analysis was 
applied (explained in detail in Chapter 2).  
 
The standard Bonferroni correction for multiple testing was applied. Results were 
considered significant if te p-value was less than 5x10-7 for genotyped data, and 5x10-8 
for imputed data. Haploview v4.0 software was used for the graphical representation of 
the genome-wide analysis results (Manhattan plots), and SNAP software version 2.2 
(Broad institute) was used for the creation of regional association plots. Using genotyped 
data allows us to usea greater p-value to declare genome-wide significance as less 
markers are tested, also insures better genotype call certainty (genotype clustering could 
be checked back to insure quality of the call) and in our case allows to test association 




Genome wide significant results were tested for replication in an independent population 
from Scotland (LBC). Lothian Birth Cohost study is a follow up cohort study totaling 





Here the genome wide analyses of 10 different quantitative retinal vessel traits are 
presented. The meta-analysis of genotyped data revealed one genome wide significant 
result, which however did not replicate in a small replication sample from Scotland. 
Several suggestive results are also reported and indicate the need for further studies 
involving larger number of subjects. Replication analysis of the already published trait-
locus associations are also presented. All the suggestive associations reported here 
represent novel findings. 
 
 
6.3.1. GWAS of retinal vessel caliber measurements 
 
A genome wide association study was performed for each of the retinal vessel caliber 
traits in zone B. Covariates used in this analysis were based on the best polygenic model 
identified in the heritability analysis, with the exception of AVR (Table 6.1). Covariates 
identified through correlations analysis were also included in two additional analysis of 
AVR (GWAS of genotyped data) in order to explore their effect on AVR and to 
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compare it to the effect of the standard covariates. Covariates identified in the subjects 
from Orkney were used in GWAS of both populations, in order to use the results of the 
same models in the subsequent meta-analysis.  




Best model covariates 
CRAE zone B Age 
avsbp 
CRAE zone B avsbp 
avdbp 
CRVE zone B Age 
BMI 
CRVE zone B avsbp 
AVR zone B avdb (bodyfat 
contenet , pulsewave 
augmentation index) 
AVR zone B avdbp (bodyfat content , 
pulsewave augmentation 
index) 




6.3.1.1. Central retinal arterial equivalent  
 
Genetic association analysis of retinal width was performed for the zone B, because of 
the high correlation with the width measurements in the zone C. Results of the 






Figure 6.1. Manhattan plot of P-values for the association of genotyped SNPs with CRAE in the meta-
analysis of ORCADES and CROATIA-Korcula studies. Horizontal lines represent the threshold of 





Table 6.2. Markers displaying the most significant association p-values (p<5x10-5) in genotyped data 
meta-analysis of CRAE adjusted for systolic blood pressure and age. Meta-analysis effect size estimates 
along with its standard errors are given for each SNP, as well as population specific values. Allele 
frequency of the allele for the effect is reported. List of genes underlying suggestive (p<5x10-5) SNPs 




Analysis of the genotyped data revealed one genome wide significant result when 
Korcula was analyzed separately, while the GWAS of the Orkney data did not reveal 
any SNPs reaching the genome wide threshold. The most significant result was reported 
for rs12366899 on chromosome 12 (p=8.82x10-9). However this SNPs was not 
genotyped in the Orkney samples, nor was it present in the imputed data. It was also 
detected as significant in the GWAS of Hb1c (C. Franklin thesis, 2010) as well as in 
several different traits analysed in Korcula,  and has been suggested to be a false positive 
artifact. It is important to point out that in both analysis highly significant results were 
detected for the same SNP, with small number of subjects tests (CRAE analysis N=374, 
Hb1c analysis N=411). These two traits did not show a significant correlation in 
Korcula, although wider arteriolar and venular calibers were associated with higher 
glycosylated hemoglobin in WESDR (Klein et al. 2003), and with wider venular calibers 
in Singapore Malay Study (Sun et al. 2009).  
  














rs2288569 A G 2 179166837 -3.790 0.726 0.870 -3.507 -4.276 0.913 1.197 1.80E-07 TTN 
rs3829747 A G 2 179105807 -3.714 0.726 0.870 -3.507 -4.070 0.913 1.197 3.15E-07 TTN 
rs744426 A G 2 179144266 -3.693 0.727 0.871 -3.507 -4.012 0.913 1.199 3.73E-07 TTN 
rs3731749 A G 2 179114437 -3.696 0.730 0.871 -3.474 -4.070 0.922 1.197 4.19E-07 TTN 
rs12707538 A G 7 82497792 3.304 0.685 0.854 3.830 1.943 0.807 1.298 1.42E-06 PCLO 
rs2303838 A G 2 179153185 -3.079 0.651 0.837 -2.815 -3.611 0.796 1.131 2.26E-06 TTN 
rs846523 A G 6 40673918 2.290 0.498 0.634 2.230 2.443 0.588 0.942 4.36E-06 LRFN2 
rs3731746 A G 2 179139243 -3.025 0.667 0.847 -2.743 -3.573 0.821 1.144 5.75E-06 TTN 
rs1011559 A C 7 20670473 2.975 0.664 0.150 2.658 4.097 0.752 1.416 7.55E-06 ABCB5 
rs10061888 A C 5 111652801 2.561 0.578 0.215 3.189 0.772 0.672 1.134 9.40E-06 EPB41L4A 
rs6962367 A C 7 42518912 -2.542 0.576 0.757 -2.653 -2.238 0.673 1.113 1.01E-05 GLI3 
rs1554624 A G 5 111683281 3.176 0.732 0.124 3.830 1.354 0.854 1.425 1.45E-05 EPB41L4A 
rs1033482 A G 6 40650051 2.113 0.499 0.636 2.051 2.275 0.587 0.949 2.31E-05 LRFN2 




rs160375 A G 7 28621226 -2.145 0.517 0.291 -2.000 -2.553 0.602 1.009 3.30E-05 CREB5 
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When the population specific results were analyzed in a joint meta-analysis a region on 
chromosome 2 was significantly associated with CRAE. Top ranking SNP (rs2288569) 
reported a p-value of 1.8x10-7, followed by three additional SNPs passing the Bonferoni 
corrected significance threshold (p<5x10-7). These markers are located in the region of 
chromosome 2q32 and fall within the TTN (titin) gene, which codes for a large abundant 
protein of striated muscle. This signal was supported by additional SNPs showing low p-
values in the same region of chromosome 2 (Figure 6.2), and showing comparable effect 




Figure 6.2. Association plot of the region on chromosome 2 associated with retinal arteriolar width 
(CRAE), by the combined population meta-analysis of Orkney and Korcula. A region of 500 kb around 
the association signals is displayed. The degree of LD between the top genotyped SNP (rs2288569) and 
other 42 SNP tested in the meta-analysis of this region is indicated by shades of red (bright red indicating 
high LD). Recombination rate is displayed by a blue line with scale on the right-hand axis. Genes are 




The LBC cohort was used for the replication of these significant results. The top 4 
markers were not significantly associated with CRAE in the LBC (p=0.18-0.19), 
however the direction of the effect were comparable to the results in Orkney and 
Korcula (rs2288569 β=-1.73 (1.32), rs3829747 (-1.73)(1.32)), but the magnitude 
smaller.  
 
Analysis of the imputed data did not display any new significant association signals 
(Figure 6.3), The association signals reported in the analysis of the genotyped data were 
confirmed, however none of the markers reached genome wide significance threshold 
for imputed data (p<5x10-8). Analysis of the imputed data also suggested potential new 
association between a different region on chromosome 2 (2q37.1) and also a region on 
chromosome 7 (7q21.11) within the PCLO gene (piccolo presynaptic cytomatrix protein). 
Modest genomic control inflation was observed for each population (genotyped: 
λorkney=1.001, λkorucula=1.006, λmeta-analysis=1.014; imputed: λorkney= 0.99 ,λkorcula=1.003, 
λmeta=1.004), and resulting qq plots illustrated minimal genomic controls inflation 
(Figure 6.4) and excess of positive results likely to be true positives.   
 
 
Figure 6.3. Manhattan plot of P-values for the association of imputed SNPs with CRAE in the meta-






Figure.6.4  Statistics from a genome wide meta-analysis on genotyped and imputed data, adjusting for age 
and systolic blood pressure, performed on 809 Orkney  and 389 Korcula participants using SNPs passing 
quality control checks are plotted (-log10 (P-value) on the x axis, chromosomal location on the y axis for 
the Manhattan plot-Observed and expected chi-square values were used for the QQ –plot). 
 
 
Sim et al. 2013 reported genome-wide significant association between CRAE and 
marker  rs2194025 on chromosome 5q14.3 (overall meta-analysis p=2.11x10-12, β=-
1.6(0.23SE)) located between (TMEM161B and MEF2C genes) . The marker was 
imputed in our datastes, and presented the same direction of the effect in the two 
Scottish populations (Orkney p=0.6, β=-0.64(1.22SE) and LBC (p=0.99, β=-
0.72(1.43SE)), with smaller effect sizes. Effect size of the same SNP was much smaller 
and in the opposite direction in Korcula (p=0.84, β=0.025(0.13SE).  The same study 
reported additional two markers showing suggestive associations with CRAE 
(rs3744061, rs2281827). The marker on chromosome 17 (rs3744061) showed 
comparable effect size for Orkney (combined published meta-analysis β=-0.86(0.13SE), 
Orkney β=-0.8(0.59SE)), and lower for LBC (β=-0.35(0.89SE). Marker on chromosome 
13 (rs2281827) presented same direction of the effect in Orkney (combined published 
meta-analysis β=-0.70(0.16SE), Orkney β=-0.81(0.72SE)) and Korcula (β=-





6.3.1.2. Central retinal venular equivalent –CRVE 
 
  
Table 6.5 Markers displaying suggestive association p-values (p<5x10-5) of genotyped data meta-analysis  
p-values of CRVE adjusted for systolic age and BMI. Meta-analysis effect size estimates along with its 
standard errors are given for each SNP, as well as population specific values. Allele frequency of the allele 






Genetic association analysis was carried out for CRVE in the same manner as described 
for CRAE. No genome-wide significant results were reported; the Manhattan plot of the 
meta-analysis of the imputed data is displayed in Figure 6.4. and suggestive SNPs are 















se  beta 
Korcula p 
GENE 
rs7548537 G 1 40384956 4.04 0.93 0.16 4.35 3.03 1.06 1.93 1.35E-05 
CAP1, RLF, 
ZMPSTE24, PPT1  
rs4823569 G 22 45376808 -3.44 0.80 0.75 -3.07 -4.32 0.95 1.47 1.70E-05 
GRAMD4, CERK, 
GRAMD4  
rs7542378 C 1 14817628 3.33 0.78 0.74 4.00 1.89 0.94 1.37 1.80E-05 
RP1-21O18.1, RP1-
21O18.1  
rs11786927 G 8 94744788 7.45 1.75 0.96 8.02 6.16 2.10 3.14 2.02E-05 
FAM92A1, RBM12B, 
TMEM67  
rs10927473 C 1 14832760 -3.24 0.77 0.27 -3.95 -1.68 0.93 1.38 2.72E-05 
RP1-21O18.1, RP1-
21O18.1  
rs9371850 G 6 1.55E+08 2.77 0.66 0.50 3.43 1.32 0.80 1.18 2.78E-05 
TIAM2, RBM16, 
CLDN20, TFB1M  
rs5769010 G 22 45371498 -3.11 0.74 0.67 -2.62 -4.24 0.89 1.35 2.89E-05 GRAMD4, CERK  





rs1835661 G 20 12973560 -3.07 0.74 0.72 -3.56 -2.06 0.91 1.30 3.80E-05 SPTLC3  
rs10484851 G 6 39086749 -5.51 1.34 0.93 -5.15 -6.23 1.64 2.34 3.95E-05 GLP1R, DNAH8  
rs4950887 G 1 2.01E+08 3.54 0.86 0.21 3.05 4.70 1.03 1.58 4.01E-05 
RABIF ,CYB5R1, 
KLHL12, ADIPOR1  
rs8179338 G 1 2.01E+08 -3.53 0.87 0.79 -3.05 -4.71 1.03 1.60 4.42E-05 
RABIF ,CYB5R1, 
KLHL12, ADIPOR1  
rs7204135 G 16 49183696 -2.85 0.70 0.51 -2.42 -3.89 0.83 1.29 4.64E-05 NKD1  
rs9919219 G 1 2.01E+08 3.52 0.86 0.21 3.03 4.71 1.03 1.60 4.68E-05 
RABIF, CYB5R1, 
KLHL12, ADIPOR1  




Figure 6.4. Minus log-transformed P-values are shown in a Manhattan plot (signal intensity plot) relative 
to their genomic position. Horizontal lines represent the threshold of suggestive significance (in blue). 
 
 
rs6849076 displayed the highest association p-value in the analysis of the imputed data 
(2.72x10-6). It is located on chromosome 4 within ABLIM2 gene, coding for actin 
binding LIM protein, but failed to reach genome-wide significance. Modest genomic 
control inflation was observed for each population (genotyped: λorkney=1.01, 
λkorucula=1.008, λmeta-analysis=1.0; imputed: λorkney= 1.009 ,λkorcula=1.0002, λmeta=1.0). 
 
 
Additionally, results for the association of CRVE and four loci previously reported to be 
associated with CRVE (Ikram et al 2010.) are reported here. Only one of the SNPs was 
genotyped in all three populations (rs225717), and displayed nominally significant 
association with CRVE in Orkney (p=0.0092), but not in Korcula (p=0.81) nor LBC 
(p=0.17). The direction and the size of the effect were comparable in all three population 
to the published meta-analysis (Table 6.6) (Ikram et al. 2010). Nominally significant p-
value was obtained after the results from all three of our populations were meta-analyzed 
(p=0.048, β=-1.99(1.01SE)). In addition rs10774625 displayed nominally significant 
association signal in Korcula (p=0.035), but not in Orkney (p=0.44) or LBC (p=0.36). 
However directions and magnitudes of the effect of this allele were not homogenous 
between our three populations (Table 6.5). rs2287921 displayed homogeneous effect 





SNP Orkney Korcula LBC Published meta-








































































Table 6.5. Look-up for SNPs associated with CRVE in a published meta-analysis of 8 different 
populations. Association p-value, effect and its standard errors, along with the frequency of the effect 
allele are given for three populations analysed (Orkney, Korcula, LBC). 
 
 
6.3.1.2. Arteriolar to Venular diameter Ratio – AVR  
 
Analysis of the AVR was performed with two sets of covariates. The first set was the 
one determined in the heritability analysis using covariates that most studies could 
reproduce and used throughout this study.  Since AVR presented significant correlations 
with both pulse-wave augmentation index and percentage of body fat in both Orkney 
and Korcula, additional analysis was done to see whether it impacts the heritability 
estimates and the results of the genetic association analysis. The main goal was to 
identify possible novel associations. 
 
Firstly, the analysis of genotyped and imputed data including standard covariates was 
performed. No significant associations were detected in any population or meta-analysis 
of genotyped or imputed data (Figure 6.5.). Very modest genomic control inflation was 
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observed for each population (genotyped: λorkney=1.004, λkorucula=1.02, λmeta-





Figure 6.6. Minus log-transformed P-values are shown in a Manhattan plot (signal intensity plot) relative 















Table6.6. Markers displaying suggestive association p-values in genotyped data analysis with diastolic 
blood pressure as a covariate. Meta-analysis effect size estimates along with its standard errors are given 
for each SNP, as well as population specific values. Allele frequency of the allele for the effect is reported. 




A second set of analysis was done using body fat percentage and pulse wave 
augmentation index as covariates. Heritability estimates were also evaluated to see 
whether the inclusion of these novel covariates would modify results. Analysis was done 
for the Orkney and Korcula populations on directly genotyped data. Percentage of body 
fat was a significant covariate in both populations (Orkney p=6x10-5, Korcula p=0.025), 
but explaining only a small proportion of variance (Orkney 1.6%, Korcula 1.5%).  
Heritabilty estimates were significant and very similar to the estimates with standard 
covariates (Orkney h2=0.27, Korcula h2=0.41). Results for pulse wave augmentation 
index should be taken with caution, since only 343 individuals form Orkney and 207 
individuals from Korcula had both AVR and pulse wave augmentation phenotypes 












rs12734075 G 1 2.28E+08 -0.25 0.05 0.22 -0.36 -0.19 0.09 0.06 9.45E-07 NUP133,ACTA1, ABCB10 
rs2884064 G 1 2.3E+08 -0.29 0.06 0.87 -0.35 -0.23 0.09 0.09 5.90E-06 SIPA1L2,DISC1 
rs2026 G 2 2.34E+08 -0.27 0.06 0.87 -0.42 -0.20 0.11 0.08 1.27E-05 ATG16L,USP40,DGKD 
rs7068299 G 10 72992635 0.21 0.05 0.77 0.18 0.23 0.08 0.06 1.93E-05 CDH23 
rs7121351 G 11 72086807 0.33 0.08 0.08 0.45 0.26 0.12 0.10 2.06E-05 CENTD2,STARD10 
rs277366 G 1 75073505 -0.20 0.05 0.69 -0.19 -0.20 0.08 0.06 2.17E-05 CRYZ, LHX8,TYW3, SLC44A5 
rs1563188 G 18 1728361 -0.18 0.04 0.49 -0.20 -0.17 0.07 0.05 2.26E-05  
rs5969812 G X 1.51E+08 0.15 0.04 0.39 0.19 0.14 0.07 0.04 2.29E-05 PASD1 
rs3122713 G 1 2.11E+08 0.27 0.06 0.87 0.33 0.21 0.09 0.08 2.37E-05 SIPA1L2,DISC1 
rs9569076 C 13 54125829 -0.23 0.06 0.18 -0.24 -0.23 0.10 0.07 2.69E-05 ATG16L,USP40,DGKD 
rs1897139 G 3 1.43E+08 -0.28 0.07 0.88 -0.39 -0.21 0.11 0.08 2.83E-05 ATF3, FAM71AATP1B3 
rs29232 G 6 29719410 -0.18 0.04 0.64 -0.21 -0.17 0.08 0.05 3.56E-05  
rs12839220 G X 1.51E+08 0.18 0.04 0.80 0.22 0.16 0.07 0.05 3.74E-05 PASD1 
rs277355 G 1 75063372 0.19 0.05 0.31 0.18 0.19 0.08 0.06 4.35E-05 CRYZ, LHX8,TYW3, SLC44A5 
rs10520531 G 4 1.84E+08 -0.36 0.09 0.94 -0.32 -0.36 0.20 0.10 4.38E-05 ODZ3 
rs9905895 G 17 22609947 0.18 0.04 0.61 0.15 0.19 0.08 0.05 4.76E-05 WSB1 
rs2306409 G 10 1036712 0.17 0.04 0.51 0.16 0.18 0.07 0.05 4.97E-05 GTPBP4 
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measured. Heritabilty estimates in Orkney when pulse wave was included in the analysis 
as a covariate did change, h2=0.35, however this is probably due to the lower number of 
individuals included in the calculation. Heritability estimates in Korcula was very low 
and incomparable (h2=1.01x10-8) to the values determined in the analysis using standard 
covariates, again most likely to the very low number of subjects included (N=207). 
 
GWAS was also performed using body fat percentage as a covariate, since the pulse 
wave analysis would include only half of the subjects tested in the original GWAS, and 
results would not be comparable. No significant associations were detected, nor did the 




6.3.2. GWAS of retinal vessel tortuosity measurements 
 
Genome wide association study was performed for each of the retinal vessel curvature 
tortuosity traits in zone C. Each trait has been rank transformed, because of the departure 
from normality (Chapter 4). Covariates used in this analysis were based on the best 
polygenic model identified in the heritability analysis. Analysis of the simple tortuosity 
measurements were performed, but yielded almost identical results to the curvature 
analysis, and is therefore not included in this thesis. 
 
 
6.3.2.1. Arteriolar curvature tortuosity 
 
Firstly genome-wide association analysis was performed using genotyped data for each 
of the populations separately. This analysis in Orkney yielded one biologically 
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interesting, yet not genome-wide significant result. The most significant SNP in the 
analysis of Orkney genotyped data (only reaching suggestive significance; rs2296845, 
p=2x10-6, β=0.25(0.05 SE)) is located within the COL4A2 gene, a very good biological 
candidate gene since it codes for the type 4 collagen subunit; the major structural 
component of basement membrane (a thin sheet of fibres which lie under the 
endothelium). This marker however, did not present even nominal significance in 
Korcula (p=0.18, β=0.076(0.072SE)), nor LBC cohorts (p=0.19, β=0.094(0.072SE)). 
The direction of the effect was consistent in all three populations, suggesting the need 
for greater number of subjects to be tested in order to confirm this result found in 
Orkney. Only very modest genomic control inflation was observed for each population 
(inflation factor, λ = 1.0 for and 1.005 for Orkney; meta-analysis λ=1.009), suggesting 
that the observed results were not due to population stratification. Meta-analysis of the 
imputed data confirmed the association between the same region on chromosome 13 
(13q34, COL4A2), and indicated a new region on chromosome 12 (12q24) as a possible 
region of association with cTORTa (Figure 6.6). The genomic inflation factor lambda 
was 1.003 for Orkney, 1.004 for Korcula, and 1.008 for the joint meta-analysis. The 
resulting quantile–quantile plot was consistent with a clear excess of true genetic 
associations .  
 
 
Figure 6.7. Minus log-transformed P-values are shown in a Manhattan plot (signal intensity plot) relative 




Table6.7. Markers displaying suggestive association p-values in genotyped data meta-analysis of 
curvature arteriolar tortuosity withage and systolic blood pressure as a covariates. Meta-analysis effect 
size estimates along with its standard errors are given for each SNP, as well as population specific values. 
Allele frequency of the allele for the effect is reported is given. List of genes underlying suggestive 




Figure 6.8. Statistics from a genome wide meta-analysis on genotyped and imputed data, adjusting for age 
and systolic blood pressure, performed on 809 Orkney  and 389 Korcula participants using SNPs passing 
quality control checks are plotted (-log10 (P-value) on the x axis, chromosomal location on the y axis for 













Se   
Orkney 
se  
Korcula p Gene 
 rs2450546 C 12 129813641 0.06 0.01 0.46 0.06 0.05 0.01 0.08 8.00E-07 STX2,RAN, GPR133,RIMBP2 
rs9555699 G 13 109898019 0.06 0.01 0.47 0.06 0.08 0.01 0.07 1.78E-06 COL4A2   
rs2296845 G 13 109898948 0.06 0.01 0.47 0.06 0.07 0.01 0.07 1.78E-06 COL4A2   
rs4103 C 13 109896227 -0.06 0.01 0.46 -0.06 -0.08 0.01 0.07 2.24E-06 COL4A2   
rs2632601 C 12 129834650 -0.06 0.01 0.60 -0.06 -0.03 0.01 0.08 5.04E-06 STX2,RAN, GPR133,RIMBP2 
rs4412792 G 12 129834522 -0.06 0.01 0.60 -0.06 -0.03 0.01 0.08 5.04E-06 STX2,RAN, GPR133,RIMBP2 
rs4759783 G 12 129831462 -0.06 0.01 0.60 -0.06 -0.03 0.01 0.08 5.04E-06 STX2,RAN, GPR133,RIMBP2 
rs7977276 G 12 129835141 -0.06 0.01 0.60 -0.06 -0.03 0.01 0.08 5.14E-06 STX2,RAN, GPR133,RIMBP2 
rs221579 C 6 99853258 -0.06 0.01 0.62 -0.06 -0.09 0.01 0.08 6.25E-06 C6orf168   
rs734931 G 19 2015016 0.11 0.02 0.10 0.12 0.04 0.03 0.12 6.43E-06 MOBKL2A, C19orf36 
rs221582 G 6 99850828 0.06 0.01 0.38 0.06 0.08 0.01 0.08 6.51E-06 C6orf168   





6.3.2.2. Venular curvature tortuosity 
 
Analysis of venular curvature tortuosity did not reveal any genome-wide significant 
results in either genotyped or imputed data analysis. The marker with the lowest p-
values was rs5952756 located on the X chromosome and reaching significance p-value 
of 2.88E-05 (genotyped analysis) (Table 6.10). Inflation factor λ (Orkney=1.04/1.006, 
Korcula=1.08/1.01, meta-analysis= 1.09/1; lambdas are given for genotyped/ imputed 
data) did not suggest inflation of significant results due to the population stratification. 
name 
Eff 












Korcula p Gene 
rs5952756 G X 45177745 0.24 0.06 0.11 0.25 0.22 0.07 0.10 2.88E-05 
CXorf36, 
UTX 
rs13108458 G 4 32614391 0.21 0.05 0.26 0.23 0.16 0.06 0.08 3.14E-05 
 rs2380422 G 2 12266840 0.24 0.06 0.16 0.29 0.11 0.07 0.10 3.97E-05 
 rs1982542 G 4 1.26E+08 -0.26 0.06 0.12 -0.20 -0.35 0.08 0.10 4.24E-05 ANKRD50 
Table 6.8. Markers displaying suggestive association p-values in genotyped data meta-analysis of venular 
curvature tortuosity with BMI as a covariate. Meta-analysis effect size estimates along with its standard 
errors are given for each SNP, as well as population specific values. Allele frequency of the allele for the 




Figure 6.9. Minus log-transformed P-values are shown in a Manhattan plot (signal intensity plot) relative 





 6.3.2.3 Total curvature tortuosity 
Table 6.9. Markers displaying suggestive association p-values in genotyped data meta-analysis of 
curvature  venular tortuosity with age fitted as a covariate. Meta-analysis effect size estimates along with 
its standard errors are given for each SNP, as well as population specific values. Allele frequency of the 
allele for the effect is reported is given. List of genes underlying suggestive (p<5x10-5) SNPs identified by 
GRAIL is given. 
 
Results of the genome wide analysis of both genotyped and imputed data did not reveal 
any significant results, and similar to the analysis of venular tortuosity marker with the 
lowest p-value in the genotyped analysis only reached 1.19x10-5.  
 
 
6.3.3. Fractal dimension measurements 
 
Genome-wide association analyses were carried out for four measurements of retinal 
vascular fractal dimensions (two measurements obtained by SIVA software and two 
obtained by VAMPIRE). No genome wide significant results were found in meta-
analysis of genotyped and imputed data. Results are given in Tables 6.12.-6.13. Two 
measurements of monofractal dimensions of the complete retinal microvasculature 
(obtained by two different softwares) did not show an overlap between top results, 
name 
eff 











Korcula p gene 
rs4434655 G 8 1.39E+08 0.27 0.06 0.12 0.31 0.21 0.08 0.11 1.19E-05   
rs1546331 G 4 1.73E+08 -0.19 0.04 0.55 -0.17 -0.22 0.05 0.08 1.22E-05 GALNT17 
rs2220655 G 4 1.73E+08 -0.18 0.04 0.42 -0.21 -0.13 0.05 0.08 2.13E-05 GALNT17 
rs200791 G 12 97832413 0.23 0.05 0.18 0.21 0.28 0.07 0.10 2.33E-05 ANKS1B 
rs1495324 G 11 40630351 -0.18 0.04 0.59 -0.10 -0.32 0.05 0.07 2.58E-05 LRRC4C 
rs2088147 G 11 40625056 0.18 0.04 0.41 0.10 0.32 0.05 0.07 2.77E-05 LRRC4C 
rs5908533 G      X 1.42E+08 0.17 0.04 0.25 0.14 0.24 0.05 0.07 3.17E-05 SAPANXN4 
rs1505727 G 2 1.56E+08 0.37 0.09 0.06 0.46 0.21 0.11 0.15 3.66E-05 KCNJ3 





which could be explained by a small number of individuals tested in these analysis, 
resulting in high variation of the two phenotypes.  Also, it has to be noted that only a 
subset of subjects from Korcula had fractal dimensions measured with VAMPIRE 
software (N=296; 390 individuals had SIVA measurements). When additional 396 LBC 
individuals were included in the analysis, a lack of overlap between the top results for 
the two traits was still seen (Appendix VI). Inflation factors λ was low for all population 
included in the analysis (monofractal dimension measurements; Dbox  λmeta-analysis=1.003 
; FractalDimC λmeta-analysis=0.99; multifractal dimension measurement Doλmeta-
analysis=1.002; monofractal dimensions of venules  λmeta-analysis=0.99). Measurements 
obtained by SIVA for monofractal dimension of the whole retinal microvasculature and 
for the venular microvasculature did show a substantial overlap between the top results 
as expected (Tables 6.12-6.13), as did the results for mono and multifractal dimensions 
































Korcula p gene 
rs2193849 G 3 1.77E+08 -0.23 0.05 0.21 -0.18 -0.32 0.06 0.08 1.74E-06 NAALADL2  
rs2681384 G 19 21517965 -0.23 0.05 0.82 -0.19 -0.34 0.06 0.09 3.76E-06 ZNF493, ZNF429, ZNF708  
rs6875935 G 5 1.73E+08 0.19 0.04 0.34 0.21 0.14 0.05 0.07 7.79E-06 CPEB4  
rs34118 G 5 80394308 -0.20 0.05 0.78 -0.17 -0.27 0.06 0.08 1.66E-05 RASGRF2  
rs17124619 G 20 31397839 -0.19 0.05 0.76 -0.14 -0.32 0.05 0.08 2.08E-05 
ZNF341, CBFA2T2, 
PXMP4, E2F1, NECAB3, 
CDK5RAP1, SNTA1  
rs9294390 G 6 88556380 -0.17 0.04 0.52 -0.19 -0.12 0.05 0.07 2.12E-05 C6orf166, ORC3L, RARS2  
rs4877107 G 9 90573421 0.18 0.04 0.40 0.17 0.20 0.05 0.08 2.16E-05 
C9orf47, SHC3, SPIN1, 
EDG3, NXNL2  
rs520865 G 5 80373213 0.17 0.04 0.54 0.14 0.22 0.05 0.07 2.37E-05 RASGRF2  
rs527506 G 5 80344906 0.17 0.04 0.48 0.14 0.24 0.05 0.07 2.71E-05 RASGRF2  
rs9315991 C 13 42629541 -0.23 0.05 0.84 -0.25 -0.17 0.06 0.10 2.74E-05 
ENOX1, DNAJC15, 
EPSTI1  
rs9386455 G 6 1.06E+08 0.18 0.04 0.70 0.18 0.18 0.05 0.07 3.21E-05 PREP  
rs1423726 G 16 72025417 -0.20 0.05 0.78 -0.21 -0.17 0.06 0.08 3.51E-05 
 rs7837028 G 8 1.16E+08 -0.17 0.04 0.34 -0.19 -0.13 0.05 0.07 3.85E-05 
 rs2677872 G 18 2498671 0.21 0.05 0.82 0.22 0.17 0.06 0.09 3.96E-05 METTL4, NDC80  
rs9388176 G 6 1.23E+08 0.17 0.04 0.69 0.12 0.28 0.05 0.07 4.02E-05 RLBP1L2, RLBP1L2  
rs7153045 G 14 55911652 -0.17 0.04 0.39 -0.12 -0.25 0.05 0.07 4.46E-05 PELI2, C14orf101  
rs2604296 G 11 1.14E+08 -0.16 0.04 0.59 -0.11 -0.28 0.05 0.07 4.55E-05 RBM7, REXO2  
rs7982593 G 13 42645747 -0.22 0.05 0.84 -0.25 -0.14 0.06 0.10 4.74E-05 
ENOX1, DNAJC15, 
EPSTI1  
rs1012040 G 19 21464254 0.20 0.05 0.20 0.17 0.28 0.06 0.09 4.83E-05 ZNF493, ZNF429, ZNF708  
rs9878975 C 3 43143226 0.22 0.05 0.17 0.19 0.27 0.07 0.09 4.90E-05 C3orf39 
name 
eff 













Korcula p gene  
rs4970420 G 1 1096336 -0.26 0.06 0.84 -0.19 -0.36 0.07 0.09 5.20E-06 TTLL10, C1orf159 
rs17124619 G 20 31397839 -0.22 0.05 0.76 -0.20 -0.25 0.06 0.09 5.20E-06 
ZNF341, CBFA2T2, PXMP4, 
E2F1, NECAB3, CDK5RAP1, 
SNTA1  
rs7007158 G 8 1.44E+08 0.19 0.04 0.41 0.14 0.31 0.05 0.08 1.02E-05 C8orf31  
rs4768689 C 12 44845032 -0.21 0.05 0.24 -0.18 -0.25 0.06 0.08 1.19E-05 SFRS2IP, SLC38A2, SLC38A1  
rs2177043 G 15 94918992 -0.19 0.04 0.69 -0.16 -0.26 0.05 0.08 1.40E-05 NR2F2  
rs6057924 G 20 31938232 0.17 0.04 0.52 0.16 0.19 0.05 0.08 2.77E-05 CHMP4B, ZNF341  
rs9315991 C 13 42629541 -0.23 0.06 0.84 -0.25 -0.20 0.07 0.10 3.02E-05 ENOX1, DNAJC15, EPSTI1  
rs2193849 G 3 1.77E+08 -0.21 0.05 0.21 -0.13 -0.37 0.06 0.09 3.47E-05 NAALADL2  
rs9386455 G 6 1.06E+08 0.19 0.04 0.70 0.17 0.21 0.06 0.08 3.85E-05 PREP  
rs7982593 G 13 42645747 -0.23 0.06 0.84 -0.25 -0.17 0.07 0.10 4.05E-05 ENOX1, DNAJC15, EPSTI1  
rs13282211 G 8 8797548 -0.20 0.05 0.74 -0.17 -0.25 0.06 0.08 4.10E-05 MFHAS1, CLDN23  
rs3762988 G 5 32745410 0.18 0.04 0.67 0.21 0.13 0.05 0.08 4.58E-05 NPR3  
rs9294390 G 6 88556380 -0.17 0.04 0.52 -0.17 -0.16 0.05 0.07 4.65E-05 C6orf166, ORC3L, RARS2  
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Table 6.10. Markers displaying suggestive association p-values in the genotyped data analysis with 
diastolic blood pressure and age as a covariate. Table A represent results of association analysis for fractal 
dimensions of the compete retinal microvasculature analysed by SIVA, while table B represents results for 
venular vasculatue fractal dimension. Meta-analysis effect size estimates along with its standard errors are 
given for each SNP, as well as population specific values. Allele frequency of the allele for the effect is 

















Korcula p gene  
rs2279475 C 2 28398613 -0.24 0.05 0.81 -0.22 -0.25 0.08 0.06 
1.02E-
06 BRE  
rs833605 G 4 1.67E+08 -0.18 0.04 0.37 -0.06 -0.22 0.08 0.05 8.02E-06 TLL1  
rs7830335 G 8 75024038 -0.18 0.04 0.63 -0.02 -0.23 0.08 0.05 1.29E-05 LY96, TMEM70, TCEB1  
rs1559797 G 8 75033201 0.18 0.04 0.36 0.02 0.23 0.08 0.05 1.55E-05 LY96, TMEM70, TCEB1  
rs9428780 G 1 2.37E+08 -0.27 0.06 0.90 -0.20 -0.31 0.12 0.08 2.02E-05 
 
rs1440371 G 15 64728138 0.18 0.04 0.71 0.16 0.19 0.08 0.05 2.26E-05 
SMAD6, ZWILCH, RPL4, 
MAP2K1, LCTL, SNAPC5  
rs1563517 C 5 60099268 -0.24 0.06 0.87 -0.24 -0.24 0.11 0.07 2.50E-05 
DEPDC1B, NDUFAF2, 
ERCC8, ELOVL7  
rs9428757 G 1 2.37E+08 0.27 0.06 0.10 0.20 0.30 0.12 0.08 2.57E-05 
 rs4738402 G 8 75042873 0.17 0.04 0.37 0.02 0.23 0.08 0.05 2.58E-05 LY96 ,TMEM70, TCEB1  
rs7827230 G 8 62117524 -0.31 0.07 0.92 -0.45 -0.25 0.14 0.09 2.97E-05 CHD7, RLBP1L1  
rs2176347 C 2 45821737 0.17 0.04 0.40 0.21 0.15 0.08 0.05 3.23E-05 PRKCE  
rs2274037 G 10 6102114 -0.40 0.10 0.96 -0.35 -0.42 0.16 0.12 
3.34E-
05 IL2RA  
rs2250952 C 3 67710973 0.20 0.05 0.81 0.11 0.25 0.09 0.06 3.50E-05 SUCLG2  
rs1473092 G 4 46535701 -0.17 0.04 0.73 -0.07 -0.22 0.08 0.05 4.43E-05 COX7B2  
. 
 
Table 6.11. Markers displaying suggestive association p-values in the genotyped data analysis with 
diastolic blood pressure and age as a covariate. Table A represent results of association analysis for 
monofractal dimensions of the complete retinal microvasculature analysed by VAMPIRE, while table B 
represents results for multifractal dimension analysed by the same software. Markers displaying 
suggestive association p-values in genotyped data meta-analysis of curvature venular tortuosity with age 
fitted as a covariate. Meta-analysis effect size estimates along with its standard errors are given for each 
SNP, as well as population specific values. Allele frequency of the allele for the effect is reported is given. 
List of genes underlying suggestive (p<5x10-5) SNPs identified by GRAIL is given. 
name 
eff 













Korcula p gene  
rs6703753 G 1 2.17E+08 0.21 0.05 0.78 0.26 0.20 0.09 0.06 1.90E-05 LYPLAL1  
rs1806507 G 13 96836578 -0.18 0.04 0.65 -0.12 -0.21 0.08 0.05 2.25E-05 RAP2A, MBNL2  
rs1893799 G 18 50868723 0.19 0.04 0.66 0.15 0.20 0.09 0.05 2.26E-05 CCDC68 ,TCF4 RAB27B  
rs2274037 G 10 6102114 -0.42 0.10 0.96 -0.55 -0.36 0.17 0.13 2.84E-05 IL2RA  
rs10778641 C 12 1.07E+08 0.18 0.04 0.41 0.18 0.18 0.08 0.05 2.87E-05 
SART3, ISCU, CORO1C, 
WSCD2, TMEM119, 
CMKLR1, SELPLG, FICD  
rs8020821 G 14 63284561 0.35 0.08 0.94 0.44 0.31 0.15 0.10 3.25E-05 WDR89, SGPP1  
rs2959232 G 2 45164823 -0.17 0.04 0.52 -0.15 -0.18 0.08 0.05 3.76E-05 SIX2, SIX3  
rs2279475 C 2 28398613 -0.21 0.05 0.81 -0.25 -0.19 0.09 0.06 4.66E-05 BRE  
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6.4. Pathway analysis 
 
Genes putatively underlying the association signals were identified using a protocol 
implemented in GRAIL, just as for the retinal detachment data (Raychaudhuri et al.). 
Association signals with p-value <5x10-5 from the meta-analysis of the genotyped data 
of all 10 traits tested were used to identify genes included in the pathway IPA analysis 
(detailed description in chapter 2), totalling 185 genes. Networks with a maximum of 35 
genes were created using IPA software. The analysis yielded 9 significant networks 
(Table 6.12). The two most significant networks showed functional associations with 
Cell Signalling, Neurological Disease, Organismal Injury and Abnormalities in the first 
network and Auditory and Vestibular System Development and Function, Connective 
Tissue Development and Function, Embryonic Development in the second highly 
significant network.  In addition, network overlapping was observed for networks 4, 5 
and 6, and for the networks 2 and 8. Nine significant “in-silico” pathway networks with 
a substantial degree of overlapping present evidence for the non-randomness of the top 












Molecules in Network Score 
Focus 
Molecules Top Functions 
ADCY,ADRA1B,ADRB, AKIRIN2,alcohol group 
acceptor phosphotransferase,Calmodulin, 
CAP1,CMKLR1,Cyclin E, DISC1, ERK1/2,FAM20B, 
GLP1R,GNRH,Gpcr, GPR133,Lh,MAP2K1,MAP2K1/2 
,NPR3 ,PDGF BB,PLC,PREP,PRKCE,Proinsulin,RAN, 
Ras,RASGRF2, RIMBP2,S1PR3, SGPP1, 
SHC3,SMAD6,SNTA1,TIAM2 1x10-39 21 
Cell Signaling, Neurological 
Disease, Organismal Injury and 
Abnormalities 
ACTA1, Actin, AP3B1, ATG16L1 ,BRE, 
CACNA1E,caspase,CD3,CHD7,E2F1,ERK,FSH,GLI3,GR
AMD4 ,GTPBP4, Histone h4, IL12 (complex), Insulin, 
KCNJ3, KLHL12,LY96,MFHAS1, NDC80, NFkB 
(complex), NR2F2, P38 MAPK, PCLO, Pka, Pkc(s),Ras 
homolog, SELPLG, SLC38A2, SOAT1, TFB1M, Vegf 1x10-39 21 
Auditory and Vestibular System 
Development and Function, 
Connective Tissue 
Development and Function, 
Embryonic Development 
ABL2,ADIPOR1,Akt,Alp,Ap1,ATF3, BCR 
(complex),Ck2, CLDN23,COL4A2, CREB5, 
Creb,DGKD,ERCC8, estrogen receptor,F 
Actin,Hdac,Histone h3,IL1 ,IL2RA, Immunoglobulin, 
Interferon alpha, NKD1, NPHS2,ORC3, PELI2, PI3K 
(complex), PPT1, RAP2A,RNA polymerase 
II,SCAF8,SIX3,TCF4,TMEM119,TTN 1x10-37 20 
Developmental Disorder, 
















MEM70,UBC,WFS1,ZNF493 1x10-26 15 








708,ZWILCH 1x10-26 15 
Lipid Metabolism, Nucleic Acid 

















3A,TTC1,vitamin K1 1x10-17 11 
Gene Expression, Auditory 




3,LRRC4C,mir-322,miR-16-5p (and other miRNAs w/seed 
AGCAGCA),PCDH10,PWWP2A,SDK1,SLC38A1,SLC52
A1,SLC6A9,SSTR4,SUSD2,TAF1L,TCEB1,TMF1,Ubiqui
tin,WSB1 1x10-13 9 
Cell Death and Survival, 
Developmental Disorder, 
Endocrine System Disorders 
Table 6.12. Genes creating nine functional networks obtained by IPA analysis are given, along with the 
significance score for each network and number of genes included in the output of our GWAS meta-
analysis. Top functions represent enrichment of known functional networks in the hypothetical pathways 





Cardiovascular diseases are complex influenced by numerous risk factors and their 
interactions. Identification of susceptibility variants underlying quantitative intermediate 
phenotypes (e.g blood pressure, arterial stiffness, BMI) has been used to identify novel 
disease pathways. The majority of the genetic association studies to date have focused 
on macrovascular disease phenotypes, and only two GWAS of the microvascular retinal 
traits have been published so far (Sim et al. 2013, Ikram et al 2009). Here we analysed 
rarely studied endophenotypes, derived from retinal vessel microvasculature which have 
been associated with various systemic risk factors and diseases (Chapter 5). None of the 
analyses led to genome-wide significant replicated findings but the sample sizes were 
modest. Still, most traits looked promising for future larger-scale GWAS analyses given 
the shape of the QQ plots obtained (excess of low p-values while genomic inflation was 




Narrowing of the retinal arterioles is a characteristic of hypertension, due to the 
increased peripheral vascular resistance (Levy et al. 2001). However it is still unresolved 
whether it is a consequence of it or it precedes and contributes to the development of 
hypertension. A few studies have presented evidence that retinal arterial narrowing may 
be linked to the development of hypertension (Wang et al. 2008, Wong et al 2004), and 
that retinal arteriolar diameter therefore presents an endophenotype for hypertension.  
However changes to microvasculature similar to the ones observed in hypertension are 
also seen in hypertrophic cardiomyopathy. In this study the region on chromosome 2 
found to be significantly associated with CRAE is located within the TTN gene, which 
encodes a large and abundant protein of striated muscle. Titin is involved in the passive 
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and restoring force of the cardiac sarcomere (the basic contractile unit of the myocyte or 
cardiac muscle cell) and makes a major contribution to the diastolic wall stress of the left 
ventricle (LeWinter and Granzier 2010). Mutations in this gene have been implicated in 
numerous myopathies involving cardiac and skeletal muscle (Vogan et al. 2012). A 
recessive mouse mutation (shrunken head mutation) that disrupts function of the Ttn 
gene has been associated with changes in blood vessel morphology making it a good 
biological candidate for a CRAE. This mutation results in weak heart contractility (May 
et al. 2004) causing reduced circulation in these mouse mutants which affects blood 
vessel morphogenesis (May et al. 2004).  The previously identified locus associated with 
CRAE was imputed in all of our cohorts and could be directly tested in this study. No 
significant association were found in any of the three cohorts tested, but the direction of 
the effect was consistent in Orkney and LBC, but not in Korcula. Interestingly, this 
marker (rs2194025) identified in the large meta-analysis of five cohorts of European 
ancestry and replicated in two additional independent cohorts of European ancestry, is 
located between TMEM161B and MEF2C genes. The closest gene, MEF2C; myocyte 
enhancer factor, is a transcription factor in MEF2 family and is involved in cardiac 
myogenesis (Lin et al. 1997, Han et al. 2000). Overexpression of MEF2C induces 
dilated cardiomyopathy and lengthening of myocytes in mice (Xu et al. 2006). The same 
locus was found to be associated with venular calibre in a large meta-analysis involving 
~22000 subjects. It did not reached genome-wide significance in our study, but it 
showed the same direction and smaller size of the effect as in the published data . 
Interestingly, similar phenotypes were reported for muscles from mef2c/d double 
knockdown zebrafish and mice lacking titin's M-line region (Hinits and Hughes, 2007). 
Therefore, even though our genome wide significant association result at the titin’s locus 
was not strengthened by the analysis of imputed data or look-up in the small 
independent Scottish cohort, functional evidence make this locus a strong candidate and 






GWAS of curvature arterial tortuosity revealed another functionally interesting 
candidate gene. The most significantly associated marker (rs2296845) in the analysis of 
the Orkney genotyped data falls with the region of the COL4A2 gene which encodes one 
of the six subunits of type IV collagen. This marker did not reveal significant association 
with arteriolar curvature tortuosity in Korcula nor LBC cohorts, however the direction 
and size of the effect was consistent across all three populations. Type IV collagens are 
the major structural component and most abundant protein of basement membranes 
(BM). Basement membranes provide support to the vessel wall and in retinal vessels and 
act as matrix controlling the passage and sequestration of vasoactive substances. In 
addition, type IV collagens play a role in angiogenesis. The role of COL4A2 in vessel 
structure makes this association a very interesting functional candidate. Mutations in 
COL4A2 have been found in sporadic and familial porencephally and small vessel 
disease in humans (Yoneda et al. 2012, Verbeek et al. 2012). Porencephally is a 
neurological disorder characterized by cysts in the brain, most likely caused by impaired 
blood supply. In addition, Col4a2 mutations in mice are associated with defects in the 
eye, brain and with vessel stability (Favor et al. 2007). COL4A2 shares a promoter and is 
co-expressed in the basement membrane of epithelia and endothelia with the 
neighbouring paralogue COL4A1. Mendelian variants in COL4A1 underlie syndromes 
which include tortuous retinal vessels (Plaisier et al. 2011). Further evidence that this 
retinal tortuosity association needs further research comes from the fact that SNPs in this 
region (COL4A1/COL4A2 locus) show genome-wide significant associations with 
vascular abnormalities, including coronary artery calcification (O’Donnell et al. 2011), 
coronary heart disease (Cradiogram; Schunkert et al. 2011) and arterial stiffness 
(Tarasov et al. 2009). Col4a2 mouse mutants report small vessel disease, intracerebral 
haemorrhage and retinal changes. The SLC2A10 gene found to be associated with 
general arterial tortuosity (Coucke et al. 2006, Cheng et al. 2008) did not show 
significant associations in analysis of this or other retinal tortuosity measurements. The 
marker presenting lowest p-value in the meta-analysis of the imputed data is located 
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between  RIMBP2 (encodes RIM-binding protein) and STX2 gene (encodes a protein 
that regulates epithelial-mesenchymal interactions and epithelial cell morphogenesis and 
activation). This SNP is located within the LD block that spans STX2 gene (Figure 
6.10). It is expressed in the connective tissue around various epithelial tissues, muscles 
and vessels; with strong staining  present on the adventitia (connective tissue that surrounds the 
vessel) of blood vessels (Zhang et al. 1998).  
 
Figure 6.11. Regional LD plot around rs2450546 is presented. A region of 500 kb around the SNP is 
displayed. Recombination rate is displayed by a blue line with scale on the right-hand axis and the R-
squared scale on the left-hand side. Genes are displayed in the bottom part of the figure, with the arrow 








Look-up of published vessel caliber associations 
Look-up of the published associations between several loci and retinal vessel calibers 
was performed.  Even though only one SNP identified in the large meta-analysis to be 
associated with CRVE replicated in Orkney and another one in Korcula, all tested 
markers presented same direction of the effect. Most likely due to the considerably 
smaller number of subjects included in our cohorts compared to the published study and 
winners curse effect, smaller p-values were reported. Each population tested in the meta-
analysis included between 2579 and 15,792 subjects and  despite larger sample sizes,  
one of the markers did not present nominally significant association with CRVE in all of 
the cohorts included in the discovery stage meta-analysis (AGES study, rs2287921 
p=0.075; rs17421627 p=0.058). Three out of four replication populations did not provide 
nominally significant p value for at least one of the markers identified in the discovery 
stage. A similar observation is true for the meta-analysis of arterial width (Sim et al. 
2013), results of which did not replicate in our populations. The smallest population of 
the replication stage (Australian Twin Study; N=1769) did not present nominally 
significant association for the identified SNP. Nevertheless our analysis yielded one 
genome wide significant result not identified in the larger published meta-analysis, but 
markers identified in both analyses lie in the regions of genes with very similar 
biological functions (TTN and MEF2C). 
 
Two large GWAS published on retinal microvasculature involved around 22000 
individuals, compared to ~1600 individuals used in this study. This study was 
underpowered to detect genes with small effects and will require inclusion of further 
population in order to confirm suggestive results identified, and to identify further 






Chapter 7. Conclusion 
 
This chapter briefly recapitulates the main achievements and the remaining challenges in 
the two main areas studied in this thesis; genetics of the retinal detachment and 
quantitative genetics of retinal microvasculature traits. 
 
Genetics of the retinal detachment 
The genetic basis of rhegmatogenous retinal detachment has been suggested by familial 
aggregation studies and a number of inherited disorders which present RRD as one of 
the symptoms. However no study prior to this explored the underlying genetics of the 
non-syndromic RRD. The genetic association study presented here was a continuation of 
the larger epidemiological study carried out in Scotland (Mitry et al. 2010). The 
genome-wide genetic association analysis was completed prior to this project, and my 
work started after a multi-center collaboration was formed in order to expand the 
original genetic association analysis of the Scottish samples. Based on the most 
promising results of the original GWAS, the most significant SNPs were selected for 
testing in two additional populations. Candidate gene markers were also included, in 
order to test the associations between genes with functional importance in genetic 
syndromes associated with RRD or the ones with the known role in vitreo-retinal 
adhesion. Finally, the most promising associations were tested in the replication set 
consisting of cases from two additionally recruited populations.  This multi-stage design 
was applied due to the financial restrictions. One genome wide significant and several 
suggestive common variants of moderate effect contributing to RRD risk were 
identified. Interestingly, several of the suggestive signals encompassed genes with a 
documented role in cell adhesion or migration; in particular these results suggested a 
major role of actin cytoskeletal organisation in the pathogenesis of RRD. None of the 
candidate gene SNPs were present among the suggestive results in the discovery stage 
meta-analysis. Among the selected candidate genes, the majority were molecules that 
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play a significant role in vitreo-retinal adhesion. Adhesion of the internal limiting 
membrane and vitreous is mediated thought the extra-cellular matrix (Sebag 1992). It is 
mainly sustained by collagens (types VI, VII and XVIII) that play a role in binding 
matrix components and stabilizing ILM (type IV) (Ponsioen et al. 2008), along with 
laminin, fibronectin and other glycoproteins. However, viteo-retinal adhesion plays a 
more important role in the development of retinal tears during posterior vitreous 
detachment, which is one of the risk factors for RRD development. Nevertheless, only a 
small proportion of the patients presenting with posterior vitreous detachment develop 
RRD, and the adhesion processes suggested by the genes underlying variants identified 
in GWAS are more likely to be involved in pathways involved in the adhesion between 
the neurosensory retina (NSR) and the retinal pigment epithelium (RPE). Since 
detachment of these two layers is responsible for the development of RRD from a 
predisposing tear.  Very little is known about the pathogenesis behind RRD and results 
presented here suggest that factors involved in the cell adhesion are potentially crucial in 
the progression from retinal tear to RRD. This study also highlighted the difficulty of 
imputation of case-control data genotyped on different genotyping platforms. The 
abundance of positive association in the analysis of the imputed data emphasised the 
need for careful planning of the study design and genotyping procedure before the 
imputation is carried out. The consequence of selecting just a subset of variants tested in 
the GWAS step, to be tested in the follow up steps resulted in the loss of potential 
associations that could have been detected given the larger sample size of the meta-
analysis. Given the constraints involved in the design of this genetic association study, 
which resulted from the financial limitations, there is a good prospect for further 
research. Whole genome genotyping of cases collected in the second discovery step and 
the replication step would be the obvious extension of the work presented here. This 
would enable the detection of variants missed due to the SNP selection procedure.  





The main limitation of this study was the number of cases and controls included in the 
analysis.  For a SNP with MAF of 10%, under a multiplicative model with heterozygote 
relative risk of 1.3, at least 1100 cases and controls are required to obtain 80% power at 
a significance level of 5% with no correction for multiple testing, and at least 6000 if a 
standard genome wide significance cut-off is applied 5x10-8 (Purcell et al. 2003). Based 
on this, the RRD study was underpowered to detect many of the variants of small effect, 
which are mainly revealed in GWA studies of complex traits (i.e., a median OR of 1.33 
(Hiendorf et al 2009) - which would be much lower if calculated today given the larger 
datasets and consequently smaller effects that may be found). Our results were mostly 
consistent with common variants individually contributing small effect, with a few of the 
suggestive markers showing slightly higher OR; probably due to the “winners curse” 
effect. Studies identifying risk alleles of larger effect can be performed with 
substantially lower number of individuals, e.g. 1660 European ancestry cases and 7,306 
controls in the GWAS of multiple myeloma reporting genome wide significant variants 
with OR of 1.8-1.95 (Weinhold et al. 2013). One important result was the quantification 
of the overall contribution of the common variants tested using the newly developed 
method GCTA (Yang et al. 2010). It suggests a polygenic basis of RRD, with 27.4% of 
the disease risk attributable to the additive effects of the genotyped SNPs.  Rare variant 
are not tested and detected by regular GWAS platforms and analysis and may contribute 
to the genetic risk.  
 
In addition to collecting larger number individuals for genome wide association studies, 
other sources of genetic variation should also be explored in future studies, in order to 
elucidate the genetic factors influencing RRD and retinal vessel morphology. Detection 
of the rare variants (MAF<0.05) would be of interest, since common variants are not 
likely to explain all of the genetic variation underlying complex diseases and traits. An 
alternative to the common disease-common variant hypothesis (Lander 1996, Reich and 
Lander 2001) is the common disease/rare variant - CD/RV hypothesis or the rare allele 
model (Wright et al. 2003). The only technology for detection of such rare SNPs is 
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sequencing (of either regions of interest or whole genome). Sequencing has been done 
on regions of repeated associations with common SNPs (identified by GWAS), or in 
large regions of the genome in people with extreme phenotypes (Manolio et al. 2009). 
Whole genome sequencing in general has become more affordable and sequencing 
individuals on the extreme of a quantitative trait (more likely to carry loss-of-function 
alleles (Romeo et al., 2007)) would be a potential way forward in the analysis of retinal 
traits. 
 
Empirical evidence supporting both hypotheses (common disease-common variants, 
common disease-rare variants) exists and therefore both directions should be followed in 
the future research. The infinitesimal model proposing that genetic component of 
complex traits can be attributed to a large number of small effects common variants is 
supported by the results of recently published GWAS including large number of 
individuals (N>100 000) that have uncovered numerous previously unidentified 
association signals (Lango–Allen et al. 2010, Kottgen et al. 2013, Morris et al. 2011, 
Speliotes et al. 2010). Evidence from the expression quantitative trait loci analysis 
showing that gene expression and splicing are heavily influenced by common variants 
support the CD-CV hypothesis (Cookson et al 2009, Lalonde et al. 2011).  Evidence 
favouring the rare allele model include population genetics data which gives evidence 
that deleterious variants are rare (exome-sequence data analysis demonstrated that non-
synonymous substitutions are found to have very low frequencies (Kryukov et al. 2007), 
and data showing that many rare familial genetic disorders are caused by rare alleles of 
big effect (e.g. breast cancer susceptibility mutation BRCA1 and BRCA2 (Easton et al. 
2007).   
 
Finally structural variants (poorly captured by existing arrays used for GWAS), epistatic 
and epigenetic effects may also be important in explaining the genetic architecture of 
complex traits (Manolio et al. 2009). Growing number of studies are giving evidence of 
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epigenetic effects (Feinberg et al. 2007), parent of origin effect (Kong et al. 2009, Small 
et al. 2011) and DNA methylation inheritance (Jablonka et al. 2009), suggesting these 
effects play a role in the genetic component of complex disease and are a part of the 
missing heritability not explained by the current GWAS. Contributions of rare variants 
and CNVs should also be explore in future studies.  
 
Retinal vessel traits 
The same issue of low sample size was observed in the genetic association analysis of 
the retinal vessel traits. Our sample size consisted of 1196 individuals used in the meta-
analysis and further 397 used as a replication cohort, which is very low when compared 
to the majority of the published GWAMA studies of quantitative traits (more recent 
studies included close to or even more than 100,000 individuals (Kotgen et al. 2013, 
Morris et al. 2011, Speliotes et al. 2010, Teslovich et al. 2010)). Both published reports 
on genome wide associations of retinal vessel calibre used approximately 20,000 
individuals and reported one variant for arterial calibre and four for venular widths that 
were confirmed in the replication cohorts (Sim e al. 2013, Ikram et al. 2010). Even 
though the sample sizes available in the retinal vessel traits GWAS were not comparable 
to large scale meta-analysis using numerous cohorts, two biologically very interesting 
results were reported and warrant further testing in additional cohorts.  
 
In addition to the genetic association studies, the work presented in this thesis revealed 
the first reported heritability estimates of vascular tortuosity measurements and fractal 
dimensions, providing evidence of the substantial additive genetic contribution to these 
traits.  This is further supported by the fact that the reported estimates were consistent 
between the two isolates for the majority of the traits tested. Subsequent association 
studies did not reveal any significant genetic associations, but some of the suggestive 
results present a good basis for further work involving more subjects. Reports of 
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moderate to high genetic correlations of most pairs of tested traits suggest common 
genetic variants influencing general retinal vascular morphology. 
 
Associations of several known systemic factors with retinal vessel morphology were 
confirmed, and presented a form of validation for this study. In addition, several novel 
associations were detected, and some of the systemic risk factors were tested for the first 
time (pulse wave augmentation index). Results presented confirmed the well-known 
associations, but also highlighted a need for more careful selection of covariates in 
future epidemiological and genetic studies involving retinal microvasculature, since 
some of the systemic factor tested showed very low and insignificant correlations with 
majority of the tested retinal microcirculation traits (e.g. glucose, HbA1c, fibrinogen).  
Future work involving associations between systemic risk factors and retinal 
microvasculature could potentially include a more dynamic measures of vasculare 
function (e.g flowmetry and dynamic vessel assessment), as they could convey more 
information on the prediction of cardiovascular disease. These measures are more 
difficult to obtain and therefore majority of studies have concentrated on more the static 
structural features of retinal microvasculature.  
 
The next important step in the retinal vessel analysis would be the additional 
phenotyping of fundus images available in both Orkney and Korcula in order to achieve 
larger sample sizes needed to increase the power of the genetic analysis. The work 






Since SNPs identified in GWAS are unlikely to be the causal variants influencing our 
phenotype of interest (due to the selection of tagging SNPs) but are in most cases in high 
LD with the variant influencing the trait, further work is needed in order to elucidate the 
real causal variant and to characterize its functional effects.  First step in this process is 
fine mapping of associated locus, which involves target re-sequencing of a region of 
association based on a known LD structure. The size of the region to be sequenced is 
usually defined by the LD structure, however the strength of the correlation between the 
associated SNP and causal variant is not known and therefore even the use of low r2 
values may be needed. One approach to shorten the region of re-sequencing is to use 
non-European populations due to the different LD pattern. Populations with overall 
shorter LD (populations of African descent (HapMap consortium, 2005)) blocks can 
potentially reduce the target region. Once the region of association is narrowed down, 
further steps in identifying causal variants can be performed. Firstly the computational 
methods should be explored, since they are quick to perform and can simplify further 
experimental work. Existing databases are explored to determine known information 
about our variants of interest (association with other disease or phenotypes) and to 
determine possible associations with levels of gene expression though expression 
quantitative trait loci (eQTLs; genetic variants affecting transcript levels). Potential 
genes underlying our variant of interest can also be selected by using text mining 
techniques of research papers (GRAIL; Raychaundhuri et al. 2009). Further approaches, 
especially in the large non-coding intergenic regions include characterization of the 
regulatory elements of the regions of associations. Regulatory elements include 
enhancers, promoters, insulators and silencers. While promoters are usually found at the 
transcription start sites of the genes, other regulatory elements could be found far from 
the genes they are influencing. Analysis of histone modification or DNase sensitivity 
sites has proven to be a good method of annotating regulatory elements (Visel et al. 
2009). However, these distal regulatory sequences are usually tissue specific and it 
should be taken into account in these types of analysis.  Once there is enough evidence 
for one or several genes as potential candidates underlying our region of association, 
gene expression analysis could be carried out. Empirical or experimental analyses of 
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gene expression in tissues of interest are usually performed. Regulatory regions analysis 
is usually done using ChIP-sequencing methodologies (used for identifying binding sites 
of DNA-associated proteins). Resequencing of the identified regulatory regions is used 
to capture all the variation within them. Following these steps, multiple experimental 
manipulations in model systems to functionally validate our implicated genes can be 
carried out.  Homologous recombination uses modification of cell’s or organism’s 
genotype to explore allele specific effects on phenotypes using recombination vectors, 
gene replacements and knockouts in animal models. Silencing of gene expression (RNA 
interference) is a method used to monitor the effect of different levels of gene 
expression. In addition, the use of morpholino (artificially synthesised molecule) is 
another method for modification of gene expression. Gene targeting by zinc finger 
nuclease can be also used for gene editing, and artificial ectopic gene expression for the 
modulation of expression levels using constructs with strong promoters. In summary, a 
good candidate for causal variant can be confirmed with significant associations with 
transcription levels (overlap between eQTL and GWAS signal), tissue specificity and 
effect on phenotypes in question on model systems (Freedman et al. 2011).  
 
Genetic analysis of rhegmatogenous retinal detachment revealed one good candidate 
SNP (rs267738) already associated with the expression levels of CERS2 gene 
(Montgomery et al. 2010). Literature search also confirmed expression of this gene in 
mouse retina (Freeman et al. 2011), and expression analysis in human retinal tissue 
would be the next step. Particularly expression in different layers of retinal tissue would 
be of interest, since the detachment is occurring in the basal part of the retinal pigment 
epithelium. Similar analysis will be considered for all variants showing associations 
close to genome wide significance. Further step of silencing genes found to be expressed 
in human retinal tissue using morpholino in a model organism (zebrafish) could be used 
to see whether it has an effect on the development of the retinal tissue. This would be of 
particular interest for rs12960119 considering the evolutionary highly conserved region 
of the SS18 gene it is in high LD with.  
206 
 
Similar functional follow up will be considered for the genes identified in the analysis of 
retinal vessel traits. Following the phenotyping of larger numbers of subjects, and 
subsequent genetic association analysis, functional analysis will follow. COL4A4 gene 
was already identified as a potential functional candidate gene associated with retinal 
arterial tortuosity considering the known role of this gene in the angiogenesis and 
confirmed association with a disease phenotype in humans which affects the vessel 
stability. It would be of interest to see the effects on retinal vessels in particular. 
Knockout mouse models using homologous recombination could help in identifying and 
confirming the role of COL4A4, and the role of specific variants within the gene, in the 
development and function of retinal arteries. Gene expression analysis of the TTN gene, 
and other markers reaching, or close to, genome wide significance will be considered 
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Sex separated results RRD 
 
Female only meta-analysis; Dutch, Englsih and Scottish original cohort 
chr position MarkerName Allele1 Allele2 OR P-value Direction HetISq GENE 
6 121168181 rs2789074 a g 1.58 2.10E-06 +++ 0 intergenic; c6orf170 
9 93321320 rs7856591 a c 1.52 2.87E-06 +++ 35.4 intergenic;ROR2/NFIL3 
6 121301788 rs12193473 a g 0.74 9.22E-06 --- 19.4 intergenic; c6orf170 
6 121410867 rs6914477 a g 1.37 1.57E-05 +++ 0 intergenic; c6orf171 
6 121193027 rs2789019 a g 0.68 1.73E-05 --- 52.6 intergenic; c6orf172 
6 121481259 rs12206641 a c 1.37 1.83E-05 +++ 41.2 intergenic; c6orf173 
11 132275836 rs2725451 a g 0.74 1.90E-05 --- 0 OPCML 
6 121388196 rs218843 a g 1.37 1.92E-05 +++ 16.7 intergenic; c6orf173 
6 121477769 rs13199297 a g 1.35 3.21E-05 +++ 51.4 intergenic; c6orf174 
6 121330001 rs12202993 a g 1.36 3.49E-05 +++ 9.8 intergenic; c6orf175 
 
 
Male only meta-analysis; Dutch, English and Scottish original cohort 
chr pos MarkerName Allele1 Allele2 OR P-value Direction HetISq GENE 
2 41814174 rs1920480 a g 1.29 2.01E-05 +++ 0  
20 59890586 rs8118581 a g 1.99 2.13E-05 +++ 22.6 CDH4 
3 23900401 rs6779573 a c 1.26 3.50E-05 +++ 7.3 UBE2E1 
2 60068526 rs6713648 a g 1.65 3.57E-05 +++ 0 intergenic 
13 30014373 rs7337496 a g 0.77 4.23E-05 --- 25.4 HPCAL4 
19 24045852 rs4932927 a g 1.78 5.16E-05 +++ 39.4 
intergenic; RPSA 
P58/ZNF7 26 
2 41835431 rs1560260 a g 1.26 5.51E-05 +++ 0  
19 367313 rs585487 a g 0.79 6.05E-05 --- 0 THEG 
17 52843452 rs9914327 a g 1.33 6.11E-05 -++ 21.7 intergenic; TOM1L1 
18 56165682 rs8086573 a c 0.73 6.90E-05 +?- 60.2 ALPK2 
19 366451 rs689448 a c 0.79 8.07E-05 --- 0 THEG 
18 24494875 rs1143735 a g 1.72 8.64E-05 +-+ 0 CHST9 
10 74090186 rs11000266 a g 0.67 8.93E-05 --- 0 intergenic; DNAJB12 







Magenta top 50 pathway results 




PANTHER_BIOLOGICAL_PROCESS Nuclear_transport 1.20E-01 0   
PANTHER_BIOLOGICAL_PROCESS mRNA_transcription 2.85E-01 0   
PANTHER_BIOLOGICAL_PROCESS Phagocytosis 3.23E-01 1 RGNEF 
PANTHER_BIOLOGICAL_PROCESS Signal_transduction 6.97E-01 1 RGNEF 
PANTHER_BIOLOGICAL_PROCESS DNA_degradation 7.10E-01 0   
GOTERM negative regulation of gene-specific transcription 7.52E-01 1 BMP7 
PANTHER_BIOLOGICAL_PROCESS Cell_structure_and_motility 7.65E-01 2 TIAM1, RGNEF 
GOTERM superoxide metabolic process 7.85E-01 1 SOD1 
GOTERM purinergic nucleotide receptor activity, G-protein 
coupled 
7.85E-01 0   
PANTHER_BIOLOGICAL_PROCESS Regulation_of_lipid,_fatty_acid_and_steroid_metabolism 7.89E-01 0   
GOTERM mismatch repair 7.95E-01 0   
GOTERM protein tyrosine kinase activity 7.95E-01 1 EPHB2 
GOTERM cilium membrane 7.96E-01 0   
GOTERM mitochondrial membrane 8.05E-01 0   
GOTERM quinone binding 8.08E-01 0   
GOTERM hippocampus development 8.12E-01 0   
GOTERM microvillus 8.13E-01 0   
GOTERM phagocytosis 8.18E-01 0   
GOTERM manganese ion binding 8.19E-01 1 PRUNE 
GOTERM SH3 domain binding 8.23E-01 1 CD2AP 
GOTERM extracellular matrix 8.26E-01 3 BMP7, SOD1, ADAMT  
GOTERM trophectodermal cell differentiation 8.27E-01 0   
PANTHER_BIOLOGICAL_PROCESS Other_amino_acid_metabolism 8.29E-01 0   
GOTERM negative regulation of MAP kinase activity 8.33E-01 1 BMP7 
GOTERM negative regulation of microtubule depolymerization 8.35E-01 0   
GOTERM proteolysis involved in cellular protein catabolic process 8.35E-01 1 PSMA8 
GOTERM peripheral nervous system development 8.38E-01 0   
GOTERM oligodendrocyte development 8.38E-01 0   
GOTERM transcription initiation factor activity 8.46E-01 1 TAF4B 
GOTERM release of cytochrome c from mitochondria 8.47E-01 0   
GOTERM septin complex 8.50E-01 0   
GOTERM translation factor activity, nucleic acid binding 8.51E-01 0   
GOTERM germ cell development 8.51E-01 0   
GOTERM protein amino acid deacetylation 8.51E-01 0   
GOTERM embryonic pattern specification 8.52E-01 1 BMP7 
GOTERM protein self-association 8.53E-01 0   
GOTERM specific transcriptional repressor activity 8.54E-01 0   
GOTERM integral to Golgi membrane 8.54E-01 0   
GOTERM negative regulation of ubiquitin-protein ligase activity 
during mitotic cell cycle 
8.55E-01 0   
GOTERM protein polyubiquitination 8.56E-01 0   
GOTERM spermatogenesis 8.57E-01 2 SOD1, SPO11 
GOTERM neuropeptide receptor activity 8.57E-01 1 NPFFR1 
PANTHER_MOLECULAR_FUNCTION DNA_methyltransferase 8.58E-01 0   
GOTERM exonuclease activity 8.61E-01 0   
GOTERM transcription factor TFIID complex 8.62E-01 1 TAF4B 
GOTERM metal ion transmembrane transporter activity 8.65E-01 0   
GOTERM regulation of Rho protein signal transduction 8.65E-01 2 TIAM1, RGNEF 
GOTERM snRNA processing 8.65E-01 0   







Primary GWAS results for the top 23 most significant SNPs in the discovery phase 
 
No high myopes in 
RRD cases 




n effect se(effect) p-value 
rs12960119 18 21868701 36 G 0.09 2525 0.0178 0.0050 0.00038 
rs267738 1 149207249 36 C 0.23 2524 -0.0091 0.0026 0.00065 
rs955943 4 16123506 36 A 0.04 2525 0.0147 0.00797 0.0654 
rs7097067 10 71676508 36 A 0.03 2525 0.0238 0.0089 0.0076 
rs1074463 5 22671126 36 A 0.13 2524 0.0117 0.00408 0.0041 
rs2045084 8 144764982 36 G 0.34 2500 0.0057 0.00195 0.0034 
rs8132771 21 31921294 36 A 0.07 2525 0.0213 0.00620 0.0006 
rs11259960 15 81379707 36 A 0.20 2525 0.0104 0.00301 0.00054 
rs2368106 2 180815911 36 A 0.10 2524 0.0107 0.0047 0.02354 
rs7234959 18 21816517 36 A 0.11 2523 0.0169 0.0046 0.00027 
rs6070015 20 55192062 36 A 0.05 2524 0.0164 0.0074 0.027 
rs913444 9 87051470 36 A 0.26 2523 0.0059 0.0024 0.016 
rs4893905 2 180867194 36 A 0.10 2523 0.0083 0.0049 0.0867 
rs1477441 5 22569230 36 A 0.13 2525 0.0115 0.0041 0.0053 
rs12193473 6 121301788 36 G 0.39 2524 0.0058 0.0017 0.0005 
rs218843 6 121388196 36 A 0.40 2525 0.0054 0.0016 0.0010 
rs4715056 6 47977103 36 G 0.28 2524 -0.0065 0.0023 0.0042 
rs2817896 1 22988636 36 G 0.26 2524 0.00964 0.0025 0.000098 
rs10515162 5 73090012 36 C 0.09 2524 -0.0082 0.0051 0.109 
rs11181447 12 41026298 36 A 0.13 2525 0.0076 0.0040 0.057 
rs12202993 6 121330001 36 A 0.39 2525 0.0056 0.0017 0.0008 
rs564351 6 47927523 36 A 0.19 2525 -0.0083 0.0032 0.0089 
rs6035211 20 19008513 36 C 0.13 2525 0.0067 0.0041 0.105 
All RRD cases 
rs12960119 18 21868701 36 G 0.10 2819 0.019 0.0054 0.00039 
rs267738 1 14920729 36 C 0.23 2817 -0.0095 0.0030 0.00123 
rs955943 4 16123506 36 A 0.04 2819 0.0238 0.0085 0.00534 
rs7097067 10 71676508 36 A 0.04 2819 0.0283 0.0096 0.00308 
rs1074463 5 22671126 36 A 0.13 2818 0.0154 0.0044 0.00047 
rs2045084 8 144764982 36 G 0.35 2794 0.0081 0.0021 0.00012 
rs8132771 21 31921294 36 A 0.07 2819 0.0183 0.0068 0.00701 
rs11259960 15 81379707 36 A 0.20 2819 0.0144 0.0032 0.000009 
rs2368106 2 180815911 36 A 0.11 2817 0.0188 0.0051 0.00021 
rs7234959 18 21816517 36 A 0.11 2817 0.0181 0.0051 0.00035 
rs6070015 20 55192062 36 A 0.05 2818 0.0291 0.0078 0.00018 
rs913444 9 87051470 36 A 0.27 2817 0.00799 0.0026 0.0024 
rs4893905 2 180867194 36 A 0.10 2817 0.0179 0.0052 0.00063 
rs1477441 5 22569230 36 A 0.13 2819 0.0157 0.0044 0.00040 
rs12193473 6 121301788 36 G 0.40 2817 0.0070 0.0018 0.00012 
rs218843 6 121388196 36 A 0.40 2819 0.00698 0.0017 0.000095 
rs4715056 6 47977103 36 G 0.28 2818 -0.0074 0.0025 0.0032 
rs2817896 1 22988636 36 G 0.26 2818 0.0067 0.0027 0.0144 
rs10515162 5 73090012 36 C 0.09 2818 -0.0173 0.0057 0.0024 
rs11181447 12 41026298 36 A 0.14 2819 0.013 0.0043 0.00187 
rs12202993 6 121330001 36 A 0.40 2819 0.0068 0.00180 0.00015 
rs564351 6 47927523 36 A 0.19 2819 -0.0099 0.00349 0.0046 










Protocol for bifurcation angles and branching coefficient measurements 
 
Parameters are measured using semi-automated software VAMPIRE (by TM and AP, 
written in Matlab) and are operated by one individual (MK) 
1. Open VAMPIRE interface and load the images for analysis. 
2. Identify optic disc location manually (press “Locate OD” button on the interface) 
for every image using the greyscale image (press “Grey image” button). The 
boundary is set on the inner circle. In some cases there may be lighter (fuzzy) 
area outside the optic disc, you should ignore this.    
3. Start processing images (press “Process images” button) 
4. After the processing is done tick the “processed junctions” box (all the junctions 
detected by the program appear on the screen). 
5. Choose 3-6 junction points for both venules and arteriols 
- if images of both eyes are available for an individual choose the one with  
more actual branching points detected 
- images that are out of focus and ones with only few measurements are not 
used for further analysis 
- for every image check for the presence of faint arteries and interceptions 
of the vessel paths by ticking the “binary segmentation” box, such images 
are not used in the further analysis (they are put in a separate folder until 
the new segmentation algorithm is completed) 
- start with the most proximal junction points to the optic disc and go to up 
to the 3rd order junctions until at least 3 and maximum of 6 branching 
points are selected for both venules and arterioles 
6. Mark the branching points of venules and arterioles separately (arterioles-white, 
venules-black) . Venule branching points are marked black by clicking on the 
point and holding the “shift” key. Arteriole points are left white (default after 
clicking on a branching point). 

















SIVA grading protocol 
1. Open image into SIVA 
2. Process the images 
3. Check if the image is gradable 
 Criteria for gradable image:  
• Clear view of optic dsic 
• At least 4 venules and arterioles 
• Ensure zone C is not blocked 
4. Optic disc placement 
5. Detection of types of vessel 
• For hidden vessel start where the area becomes visible-closest to zone B 
• Arterioles- straighter, less tortuous, thinner than veins, paler in colour 
• Venules- more tortuous , thicker than arterioles, darker in colour 
6. Trace the full length of vessels 
• Let SIVA trace as much as possible 
• Avoid manual tracing as much as possible 
• Covers traced all the way till the end of the Zone B; up to u appoint 
where grader is confident 
• Use black and white or Red-free filter for better view 
• Amend incorrect tracing 
• Take only vessel SIVA automatically traced 
• Ignore other small vessel not picked up by SIVA 
• Use red-free function to locate the end point of small vessels 
7. Connect broken segments 
8. “Cover” vessels 
• use covers to switch on and off only 
• a minimum of 5 covers are needed, no maximum number 
• use edit segment only if all the covers are wrong 
• use standard deviation of the mean width as a guide only 
• need to accept that SIVA will sometimes take shadows, but not when the 
covers are twice the width size 
9. Check all vessels 
10. Save data 












AVR genome wide association analysis results with body fat percentage and pulse wave augmentation index used as covariates 
 
Meta-analysis of AVR (Orkney and Korcula genotyped data)  with pulse wave augmentation index as a covariate 
name effallele CHR position beta Se beta eff allele freq beta Korcula beta Orkney se Korcula se Orkney p 
rs10904588 G 10 981737 0.26 0.05 0.43 0.27 0.25 0.10 0.06 1.85E-06 
rs2884064 G 1 230386210 -0.37 0.08 0.88 -0.34 -0.41 0.12 0.11 2.75E-06 
rs12734075 G 1 227759755 -0.29 0.06 0.23 -0.30 -0.29 0.11 0.08 4.15E-06 
rs4610449 C 5 152139377 -0.70 0.16 0.97 -0.58 -0.72 0.39 0.17 6.48E-06 
rs7088825 G 10 17544941 0.33 0.08 0.85 0.32 0.33 0.14 0.09 1.43E-05 
rs7856322 C 9 9821142 -0.30 0.07 0.79 -0.37 -0.26 0.12 0.08 1.43E-05 
rs11135327 G 5 164191345 0.27 0.06 0.76 0.22 0.30 0.11 0.08 1.55E-05 
rs7735637 G 5 164191750 -0.27 0.06 0.24 -0.22 -0.29 0.11 0.08 1.59E-05 
rs1993023 G 4 163484911 -0.28 0.07 0.79 -0.12 -0.35 0.12 0.08 1.78E-05 
rs1460060 C 4 167034879 -0.26 0.06 0.31 -0.20 -0.28 0.12 0.07 1.92E-05 
rs2167190 G 4 163495091 0.28 0.06 0.21 0.12 0.34 0.12 0.08 1.98E-05 
rs8055236 C 16 81769899 -0.31 0.07 0.84 -0.35 -0.30 0.14 0.09 2.40E-05 
rs2761748 C 9 9807514 0.23 0.06 0.43 0.21 0.24 0.10 0.07 3.23E-05 
rs2570171 G 8 76000717 0.32 0.08 0.14 0.19 0.39 0.12 0.10 3.32E-05 
rs5969812 G         X 150577130 0.19 0.05 0.40 0.33 0.14 0.09 0.05 3.48E-05 
rs7208001 G 17 5095000 0.33 0.08 0.87 0.32 0.33 0.16 0.09 4.13E-05 
rs2761752 G 9 9809028 0.23 0.06 0.42 0.22 0.24 0.10 0.07 4.14E-05 
rs9984592 G 21 14449488 0.27 0.07 0.78 0.32 0.25 0.12 0.08 4.45E-05 











Meta-analysis of AVR (Orkney and Korcula genotyped data)  with percentage of body fat as a covariate 
 
 













rs12734075 G 1 227759755 -0.25 0.05 0.22 -0.36 -0.19 0.09 0.06 9.45E-07 
rs2884064 G 1 230386210 -0.29 0.06 0.87 -0.35 -0.23 0.09 0.09 5.90E-06 
rs2026 G 2 234045405 -0.27 0.06 0.87 -0.42 -0.20 0.11 0.08 1.27E-05 
rs7068299 G 10 72992635 0.21 0.05 0.77 0.18 0.23 0.08 0.06 1.93E-05 
rs7121351 G 11 72086807 0.33 0.08 0.08 0.45 0.26 0.12 0.10 2.06E-05 
rs2689790 G 7 79176147 0.74 0.17 0.95 0.74 NA 0.17 NA 2.16E-05 
rs277366 G 1 75073505 -0.20 0.05 0.69 -0.19 -0.20 0.08 0.06 2.17E-05 
rs1563188 G 18 1728361 -0.18 0.04 0.49 -0.20 -0.17 0.07 0.05 2.26E-05 
rs5969812 G X 150577130 0.15 0.04 0.39 0.19 0.14 0.07 0.04 2.29E-05 
rs3122713 G 1 210866493 0.27 0.06 0.87 0.33 0.21 0.09 0.08 2.37E-05 
rs9569076 C 13 54125829 -0.23 0.06 0.18 -0.24 -0.23 0.10 0.07 2.69E-05 
rs1897139 G 3 143088651 -0.28 0.07 0.88 -0.39 -0.21 0.11 0.08 2.83E-05 
rs29232 G 6 29719410 -0.18 0.04 0.64 -0.21 -0.17 0.08 0.05 3.56E-05 
rs12839220 G X 150549192 0.18 0.04 0.80 0.22 0.16 0.07 0.05 3.74E-05 
rs277355 G 1 75063372 0.19 0.05 0.31 0.18 0.19 0.08 0.06 4.35E-05 
rs10520531 G 4 183572185 -0.36 0.09 0.94 -0.32 -0.36 0.20 0.10 4.38E-05 
rs9905895 G 17 22609947 0.18 0.04 0.61 0.15 0.19 0.08 0.05 4.76E-05 
rs710652 C 12 69079783 0.30 0.07 0.50 0.30 NA 0.07 NA 4.89E-05 








Genome wide meta-analysis of genotyped data form Orkney, Korcula and LBC for fractal dimensions measurements 
 
Dbox meta-analysis of three cohorts 
name effallele chr position beta sebeta eff allele freq  beta Korcula beta Orkney beta LBC se Korcula se Orkney se LBC p 
rs7759428 G 6 85428117 -0.01 0.00 0.72 0.03 -0.02 -0.01 0.08 0.05 0.00 1.03E-05 
rs7943162 G 11 91195221 0.01 0.00 0.94 0.11 -0.07 0.01 0.13 0.10 0.00 1.19E-05 
rs748344 C 15 54177908 0.01 0.00 0.43 -0.02 -0.09 0.01 0.08 0.05 0.00 1.90E-05 
rs625204 G 6 36077746 -0.01 0.00 0.41 -0.03 0.02 -0.01 0.07 0.05 0.00 2.23E-05 
rs4339430 C 6 1.62E+08 0.01 0.00 0.10 -0.09 -0.05 0.01 0.11 0.08 0.00 3.33E-05 
rs1254643 G 2 2.21E+08 -0.01 0.00 0.66 0.01 0.04 -0.01 0.08 0.05 0.00 4.23E-05 


















Orkney se LBC p 
rs2159042 G 17 66920924 -0.021 0.004 0.96 0.05 -0.23 -0.02 0.20 0.12 0.004 2.18E-07 
rs917344 G 17 66910868 -0.021 0.004 0.96 0.01 -0.23 -0.02 0.23 0.13 0.004 2.21E-07 
rs10488477 G 7 53518990 0.014 0.003 0.07 0.30 0.05 0.01 0.20 0.09 0.003 4.02E-06 
rs10231525 G 7 1.44E+08 -0.012 0.003 0.89 0.09 0.06 -0.01 0.13 0.07 0.003 5.82E-06 
rs2124216 G 11 1.02E+08 -0.007 0.002 0.73 -0.04 0.02 -0.01 0.10 0.05 0.002 1.26E-05 
rs10487665 G 7 1.39E+08 0.011 0.003 0.10 0.15 -0.04 0.01 0.16 0.08 0.003 2.23E-05 
rs3779258 G 7 1.23E+08 -0.011 0.003 0.90 -0.11 0.01 -0.01 0.12 0.08 0.003 2.24E-05 
rs2361285 G 14 75956281 -0.008 0.002 0.83 -0.04 -0.01 -0.01 0.11 0.06 0.002 2.44E-05 
rs2145641 C 14 96309884 0.011 0.003 0.09 0.08 0.03 0.01 0.12 0.09 0.003 2.61E-05 
rs1991549 G 17 49927285 -0.012 0.003 0.92 -0.09 0.01 -0.01 0.12 0.10 0.003 3.25E-05 
rs748344 C 15 54177908 0.006 0.002 0.43 -0.05 -0.10 0.01 0.08 0.05 0.002 3.56E-05 
rs4533289 G 16 25840965 -0.010 0.002 0.88 -0.04 -0.04 -0.01 0.12 0.08 0.002 4.08E-05 
rs2107785 G 7 80802211 0.010 0.002 0.10 -0.01 0.04 0.01 0.12 0.09 0.002 4.48E-05 
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Rhegmatogenous retinal detachment (RRD) isan importantcause of vision loss andcan potentially lead to blind-
ness. The underlying pathogenesis is complex and incompletely understood. We applied a two-stage genetic
association discovery phase followed by a replication phase in a combined total of 2833 RRD cases and 7871
controls. The discovery phase involved a genome-wide association scan of 867 affected individuals and 1953
controls from Scotland, followed by genotyping and testing 4347 highest ranking or candidate single nucleotide
polymorphisms (SNPs) in independent sets of cases (1000) and controls (2912) of Dutch and British origin. None
of the SNPs selected reached a Bonferroni-corrected threshold for significance (P < 1.27 3 1027). The strongest
association, for rs12960119 (P 5 1.58 3 1027) located within an intron of the SS18 gene. Further testing was car-
ried out in independent case–control series from London (846 cases) and Croatia (120 cases). The combined
meta-analysis identified one association reaching genome-wide significance for rs267738 (OR 5 1.29, P 5
2.11 3 1028), a missense coding SNP and eQTL for CERS2 encoding the protein ceramide synthase 2. Several
of the top signals showing suggestive significance in the combined meta-analysis encompassed genes with
a documented role in cell adhesion or migration, including SS18, TIAM1, TSTA3 and LDB2, which warrant further
investigation. This first genetic association study of RRD supports a polygenic component underlying RRD risk
since 27.4% of the underlying RRD liability could be explained by the collective additive effects of the genotyped
SNP from the discovery genome-wide scan.
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Despite advances in surgical treatment, rhegmatogenous retinal
detachment (RRD) remains an important cause of visual loss.
It accounts for up to 4% of the blind and partial sight registrations
in Ireland (1). Following the formation of a break in the retina,
the neural retina separates from the underlying retinal pigment
epithelium (RPE) due to the egress of fluid from the vitreous
cavity into the subretinal space. This leaves the neurosensory
retina (NSR) deprived of nutrients and oxygen, severely redu-
cing visual function, especially when the macula is affected.
Pathological changes at the vitreoretinal interface are critical
both to the development of a retinal break and to the progression
of retinal detachment, since liquefied vitreous passes through the
open break and the NSR is separated from the underlying RPE.
The adhesion between the NSR and RPE is relatively weak
since no junctional attachments exist between these two layers
(2). The adhesion is maintained by the physical interconnection
of the RPE cells’ apical microvilli with the outer segments of
NSR photoreceptors, mechanical support from the interphotore-
ceptor matrix and the net fluid transport from the retina to the
choroid. Once these forces are overwhelmed, the subretinal
space expands, allowing the fluid to accumulate and retinal de-
tachment to occur. The exact mechanisms involved in this
complex and synergistic adhesion system are incompletely
understood.
The annual incidence of RRD is 10–15 cases per 100 000
individuals (3), and prevalence 1%, (4) with notable differ-
ences between ethnic groups (5–7). The rate of RRD has been
reported to be higher in elderly patient (5,8,9) and in men com-
pared with women (6,10–13). Other risk factors for RRD
include high myopia, lattice retinal degeneration, trauma and
previous cataract surgery.
A genetic predisposition to RRD is suggested by a number of
inherited disorders (with known causal genetic variants) present-
ing RRD as an associated feature and by familial aggregation
studies (14,15). Cases of non-syndromic familial RRD, inherited
in a dominant fashion, have also been ascribed to mutations in the
COL2A1 gene (a known Stickler’s syndrome gene [MIM
609508]) (16,17). Very little is known about the genes under-
lying non-syndromic RRD in the general population and no pre-
vious study has investigated the role of common genetic variants.
We conducted a genome-wide association study of RRD using
a two-stage discovery phase followed by a replication phase
(Fig. 1). A full genome-wide scan was first performed with
close to 300 000 single nucleotide polymorphisms (SNPs) in a
large collection of Scottish RRD cases (n ¼ 867) (18) and eth-
nically matched controls (n ¼ 1953) (19). The most significant
Figure 1. Our study included a two-stage discovery phase followed by a replication phase where the seven most promising findings were brought forward for testing.
GWAS was conducted in a Scottish study in the first stage of the discovery phase. The best ranked SNPs were selected for follow-up and complemented with candidate
gene markers. Four thousand and three hundred and forty-seven SNPs were successfully genotyped and analyzed in the UK and Dutch studies in the second stage of the
discovery phase, and results from both discovery stages were combined in a meta-analysis (significance threshold for discovery phase meta-analysis was set to 1.27 ×
1027). An overall combined meta-analysis of discovery (two stages) and replication phases was completed for the seven SNPs carried all along (significance threshold
set at 2.5 × 1028). Studies are labeled according to the location of the center(s) where the RRD cases were collected.











results were then tested in independent sets of cases and controls
of Dutch (252 cases; 320 controls) and British origin (748 cases;
2592 controls). Replication and follow-up was sought through
the use of further samples from populations of English (846
cases; 2737 controls) and Croatian descent (120 cases; 269 con-





A genome-wide association study (GWAS) was carried on 867
RRD cases and 1953 controls from Scotland, using 299 737 gen-
otyped SNPs, after applying stringent quality control criteria.
GWAS results showed a very slight excess of low P-values com-
pared with those expected under the null hypothesis of no asso-
ciation (Fig. 2 and Supplementary Material, Fig. S2). One SNP,
rs10510663, achieved genome-wide significance after correc-
tion for multiple testing (P ¼ 1.88 × 1029). This marker is
located on chromosome 3p22.3, upstream of the ARPP21
gene. The full GWAS results corresponding to Figure 2 are avail-
able Supplementary Material, Table S7.
The most significant SNPs associated with RRD by GWAS
plus some selected candidate gene markers (see section
‘Methods’ and Supplementary Material, Table S1) were then
genotyped on a custom-made Illumina iSelect array in an add-
itional 1000 RRD cases (Discovery stage 2; 252 Dutch and
748 UK individuals). The meta-analysis of the SNP association
data from these two steps constituted the discovery phase
and involved analyses of three distinct case–control cohorts
(of Scottish, British and Dutch ancestry). A stringent genome-
wide significance threshold based on the number of SNPs
tested in the initial whole-genome scan (1.27 × 1027; see
section ‘Methods’) was applied in this meta-analysis. Index
SNPs with association P-value ,1024 are displayed in
Table 1 for an additive model of allelic effect (for a dominant
model, see Supplementary Material, Table S2). The highest
ranking marker in the initial Discovery GWAS in Scottish
cases (rs10510663) was not significantly associated with RRD
in either the UK (P ¼ 0.86) or Dutch cohorts (P ¼ 0.24) and
its association P-value after meta-analysis of discovery studies
increased to be .1024. The most significantly associated
marker after this stage was rs12960119, with an association
P-value of 1.58 × 1027, just below the genome-wide signifi-
cance threshold. This marker is located on chromosome
18q11.2 within an intron of the SS18 gene (OR ¼ 1.46; 1.26–
1.67 95% CI). The magnitude and direction of the signals were
consistent across all three populations, translating into a low het-
erogeneity score across studies (I2 ¼ 0; P ¼ 0.67). Cases
showed an excess of the rs12960119 minor allele G compared
with controls in all three cohorts (Table 2). Another marker
(rs7234959), located upstream of the SS18 gene, displayed a sug-
gestive P-value in the meta-analysis (P ¼ 2.68 × 1025),
strengthening the validity of an association signal in this
region. Most suggestive SNPs (P , 1024) also showed compar-
able directions of effect across all three populations (Table 1).
The genes putatively underlying the association signals were
identified using a protocol implemented in GRAIL (20) (several
genes were assigned to one association signal—Table 1) and
inter loci functional networks sought out using the pathway ana-
lysis tool implemented in IPA (Ingenuityw Systems, www.
ingenuity.com, last accessed 04/09/2012). Analysis using only
the six most significant SNPs (additive model) as index SNPs
revealed one highly significant network (P ¼ 10262) involving
35 molecules in total, 21 of which were present in the top six
signals (Supplementary Material, Fig. S3). This network
showed enrichment for molecules involved in cell death, DNA
replication, recombination and repair, and haematological
system development and function. Additional pathway analysis
was carried out using the 23 top results (P , 1024) from the dis-
covery meta-analysis (Table 1). Four direct interactions were
identified in this extended pathway analysis (MCL1-RAE1,
rs267738-rs6070015; BMP7-SETDB1, rs6070015-rs267738;
SETDB1-PPA1, rs267738-rs7097067;TIAM1-TrkB, rs81232771-
rs913444). The latter is strongly supported by experimental evi-
dence of a protein–protein interaction (21).
Replication phase
In the replication phase, we followed up the six most significant-
ly associated markers displaying low heterogeneity across
Figure 2. Manhattan plot (A) and Quantile–quantile (B) plot for the discovery stage1 genome-wide scan results. Statistics from a logistic regression adjusting for age
sex and co-ancestry, performed on 867 Scottish RRD cases and 1953controls (SOCCS participants) using 299 737 genotyped SNPs which passed quality control, are
displayed. In the Manhattan plot (A) 2log10 (P-value) is plotted on the x-axis, and chromosomal location on the y-axis. In the QQ plot (B), distributions of observed
and expected Chi-square values are compared.






















GRAIL input genes Genes in LD block r2 . 0.8
with index SNP
rs12960119 G 18 21 868 701 0.075 1.46 (1.26–1.67) 1.58E-07 +++ 0.67 PSMA8, TAF4B, SS18 SS18, PSAM8
rs267738 C 1 149 207 249 0.275 0.79 (0.71–0.87) 6.7E-06 222 0.65 GOLPH3L, CTSK, FAM63A,




rs955943 A 4 16 123 506 0.067 1.54 (1.27–1.87) 9.9E-06 +++ 0.67 LDB2 LDB2
rs7097067 A 10 71 676 508 0.075 1.65 (1.32–2.07) 1.28E-05 2++ 0.99 PPA1, NPFFR1, TYSND1, AIMF2,
SAR1A
PPA1, NPFFR1a
rs1074463 A 5 22 671 126 0.092 1.31 (1.16–1.48) 1.28E-05 +++ 0.73 CDH12 CDH12
rs2045084 G 8 144 764 982 0.425 1.21 (1.11–1.31) 1.54E-05 +++ 0.25 TSTA3 TSTA3
rs8132771 A 21 31 921 294 0.075 1.43 (1.21–1.69) 1.96E-05 +++ 0.21 TIAM1, SOD1, SCAF4 SOD1, SCAF4
rs11259960 A 15 81 379 707 0.200 1.35 (1.17–1.54) 2.36E-05 +2+ 0.41 HOMER2 HOMER2
rs2368106 A 2 180 815 911 0.125 1.35 (1.17–1.54) 2.58E-05 2++ 0.76 CW22 CW22, UB2E3a
rs7234959 A 18 21 816 517 0.083 1.34 (1.17–1.53) 2.68E-05 +++ 0.77 TAF4B, PSMA8, SS18 SS18, PSMA8
rs6070015 A 20 55 192 062 0.067 1.67 (1.31–2.13) 2.91E-05 +++ 0.9084 RAE1, SPO11, BMP7, RBM38 BMP7
rs913444 A 9 87 051 470 0.250 1.22 (1.11–1.34) 3.00E-05 +++ 0.94 TRKB TRKB, AGTPBP1a
rs4893905 A 2 180 867 194 0.100 1.33 (1.16–1.52) 3.32E-05 +++ 0.59 CW22 CW22, UB2E3a
rs1477441 A 5 22 569 230 0.124 1.31 (1.15–1.49) 4.03E-05 +++ 0.87 CDH12 CDH12
rs12193473 G 6 121 301 788 0.375 1.20 (1.10–1.31) 4.25E-05 +++ 0.32 C6orf170 MAN1A, C6orf170a
rs218843 A 6 121 388 196 0.375 1.20 (1.10–1.31) 4.40E-05 +++ 0.30 C6orf170 MAN1A, C6orf170a
rs4715056 G 6 47 977 103 0.275 0.81 (0.73–0.90) 4.94E-05 +22 0.59 GPR115, OPN5, CD2AP, GPR111 C6orf38
rs2817896 G 1 22 988 636 0.242 1.24 (1.12–1.37) 5.35E-05 2++ 0.82 EPHB2 EPHB2
rs10515162 C 5 73 090 012 0.050 0.72 (0.61–0.85) 6.48E-05 222 0.95 RGNEF RGNEF
rs11181447 A 12 41 026 298 0.150 1.28 (1.13–1.45) 6.68E-05 +++ 0.85 GLT8D3, YAF2, ZCRB1, PPHLN1,
PRICKLE1
ZCRB1, PPHLN1, PRICKLE1
rs12202993 A 6 121 330 001 0.375 1.20 (1.10–1.31) 7.48E-05 +++ 0.30 C6orf170 MAN1A, C6orf170a
rs564351 A 6 47 927 523 0.208 0.79 (0.70–0.89) 7.49E-05 +22 0.91 GPR115, OPN5, CD2AP, GPR111 OPN5, PTCHD4a
rs6035211 C 20 19 008 513 0.117 1.30 (1.14–1.47) 8.66E-05 +++ 0.99 SLC24A3 C20orf79, SLC24A3a
Odds ratios with 95% confidence intervals are given with respect to the minor allele for an additive model of allelic effect, association P-values, direction of the minor effect in, respectively, the Netherlands, UK
and Scotland study (+ increasing risk, 2 decreasing) and the heterogeneity test P-values are also displayed. Genes potentially underlying each SNP signal as identified by a protocol within the GRAIL software and
genes falling within the higher LD block tagged by the top associated SNP (defined by markers in high LD with it, r2 . 0.8, based on based on CEU haplotypes HapMap2 build36 using the SNAP webtool http://
www.broadinstitute.org/mpg/snap/ldplot.php, date last accessed 14/04/2013) are listed.
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studies (rs12960119, rs267738, rs955943, rs8132771, rs2045084,
rs1074463—Table 1) and in addition, rs913444, the next highest
ranking with low heterogeneity across studies marker with the
highest minor allele frequency (to increase replication power).
Furthermore, the product of the gene associated with thisaddition-
almarker,TrkB, isknowntobindandphosphorylate the product of
TIAM1 (21), a gene close to the rs8132771 association signal. A
brief description of the genes included in or flanking the corre-
sponding association signals is reported in Supplementary Mater-
ial, Table S3. The seven selected markers were typed in 846 cases
from London and 120 cases from Croatia (Fig. 1). All but one
marker (rs1074463) displayed same direction of effect in the rep-
lication analysis compared with those in the discovery analysis,
and one of them reached the Bonferroni-corrected significance
threshold of 0.0035 (Supplementary Material, Tables S4 and
S5). This marker, rs2045084, is located on chromosome 8q24.3,
949 bp 3′ of TSTA3 and 7.8 kb 5′ of PYCRL gene and displayed
a statistically significant association under a dominant model
(P ¼ 9 × 1024, OR¼ 1.31) and nominally significant associ-
ation under an additive model (P ¼ 0.028, OR¼ 1.13). The
next best associated marker, rs267738, is located on chromosome
1q21.3 within an exon of the ceramide synthase 2 (CERS2) gene
and displayed a nominally significant association under both addi-
tive and dominant models (additive P ¼ 7.1 × 1023, OR¼
0.83). rs12960119, which almost reached genome-wide signifi-
cance in the discovery phase, did not replicate in the London
cohort (P ¼ 0.37 additive effect). The minor allele of this
marker (allele G, frequency¼ 0.092) was, however, associated
with increased risk, as in the previous analysis, but the effect
was smaller in size (OR additive model ¼ 1.07, OR dominant
model ¼ 1.07). This reflected the frequency of the G allele of
rs12960119 in the Wellcome Trust Case Control Consortium
(WTCCC) NBS controls used in this replication analysis being
higher (MAF¼ 0.087) than that of the CEU HapMap population
(MAF¼ 0.075) or the WTCCC 1958BC control sample used in
the discovery stage (MAF¼ 0.078), whereas the minor allele fre-
quencies were comparable in cases. This marker was successfully
genotyped in 109 cases and 265 controls from Croatia. It did not
reach statistical significance (P ¼ 0.36) in this sample due to the
small sample size, but the direction and size of the effect (OR ¼
1.23; 0.79–1.91 95% CI) were comparable with those in the dis-
covery cohorts, with the minor allele frequency of the risk allele
higher in cases (MAF¼ 0.14) compared with the controls
(MAF¼ 0.11).
Combined analysis
Results for the seven SNPs analyzed through both discovery and
replication steps were combined into an overall meta-analysis
(Table 3) and this yielded one variant (rs267738) reaching the
conventional genome-wide significance threshold and the next
most significant SNP (rs2045084) falling just below our initial
GWAS threshold (dominant model P-value ¼ 2.59 × 1027;
threshold set at 1.27 × 1027). SNP rs267738, within the
CERS2 gene, showed the strongest association signal under a
dominant effect model (P ¼ 2.11 × 1028). The SNP effect
size was consistent in both direction and magnitude across all
four populations (Fig. 3), with cases showing an excess of the
major allele homozygote genotype AA (OR ¼ 0.78; 0.71–
0.85 95% CI). The signal in this region was further supported
by an additional SNP (rs267733) showing suggestive signifi-
cance in the discovery phase meta-analysis (P ¼ 5.29 ×
1025). This marker is located within the gene ANXA9, which is
5′ of CERS2. The next most significant SNP association in the
combined meta-analysis (rs2045084) is located 3′ of the
TSTA3 gene, and showed some heterogeneity between studies
(I2 ¼ 32.8, P ¼ 0.22, Fig. 3). The association was not significant
in the UK discovery cohort [P ¼ 0.55, OR ¼ 1.09 (0.85–1.40
95% CI)].
The rs12960119 SNP, located in the SS18 gene, which almost
reached genome-wide significance at the discovery phase, did
not replicate in the London cohort and did not reach genome-
wide significance in the overall meta-analysis (P ¼ 2.04 ×
1026, dominant model; P ¼ 2.49 × 1026 additive model). Het-
erogeneity in the overall meta-analysis was high under both
models (I2 ¼ 50.2, P ¼ 0.09, under a dominant model; I2 ¼
49.6, P ¼ 0.09, under an additive model) and contrasted with












Scottish 0.115/0.086 1.42 (1.16–1.75) 1.40 (1.30–1.73) 0.0009/0.003
UK 0.104/0.077 1.41 (1.13–1.76) 1.46 (1.17–1.82) 0.002/0.0008
Dutch 0.117/0.075 1.76 (1.13–2.76) 1.90 (1.17–3.1) 0.013/0.009
rs12960119 allele frequencies, odds ratios and association P-values for the minor
G allele by discovery population.
Table 3. Combined discovery and replication phases meta-analysis results
SNP Additive model Dominant model
OR L95% CI U95% CI P-value Direction OR L95% CI U96%CI P-value Direction
rs267738 0.81 0.75 0.88 1.43E-07 2222? 0.78 0.71 0.85 2.11E-08 2222?
rs2045084 1.16 1.09 1.24 2.85E-06 ++++? 1.25 1.15 1.36 2.59E-07 ++++?
rs12960119 1.26 1.14 1.39 2.49E-06 +++++ 1.27 1.15 1.41 2.04E-06 +++++
rs955943 1.41 1.21 1.64 5.45E-06 ++++? 1.42 1.21 1.66 1.51E-05 2+++?
rs8132771 1.31 1.16 1.48 1.65E-05 ++++? 1.31 1.16 1.49 1.64E-05 ++++?
rs913444 1.17 1.09 1.26 2.09E-05 ++++? 1.17 1.08 1.29 3.38E-04 ++++?
rs1074463 1.15 1.05 1.26 2.59E-03 +++2? 1.21 1.09 1.35 2.90E-04 +++2?
Odds ratios with 95% confidence intervals and direction of effect with respect to the SNP minor allele. Direction of the effect is given for, respectively, the Netherlands,
UK, Scotland, London and Croatia studies.











the homogeneity of association signal in the discovery phase,
where three diverse study populations had been used.
Genetic risk score
Each of these markers contributed only a modest amount to indi-
vidual risk of RRD. To assess the combined effect of our
top-ranked markers, we prioritized five of the SNPs that were fol-
lowed up at the replication phase (see section ‘Methods’) and
combined them in a genetic risk score using a simple allele
counting approach. The difference in a mean number of risk
alleles between cases and controls was statistically significant
in all studies using the Mann–Whitney test (discovery Dutch
P ¼ 2.05 × 1025; discovery Scottish P ¼ 2.19 × 10211; dis-
covery UK P ¼ 4.1 × 1026; replication London P ¼ 2.4 ×
1023). Figure 4 illustrates the distribution of the risk alleles in
our four-independent studies, displaying, in each study, a
higher proportion of cases compared with controls among indi-
viduals carrying four or more risk alleles. The odds ratios calcu-
lated relative to the median number of risk alleles in the controls
for each population show a significantly increased RRD risk (OR
.1) for the individuals with five or more risk alleles: with odds
ratios of at least two in the discovery cohorts and .1.22 in the
London replication cohort (Supplementary Material, Fig. S4).
Variation in disease liability explained
Following stringent QC procedures and using the method of
Yang et al., implemented in the Genome Wide Complex Trait
Analysis (GCTA) software, 27.4% of the variance in underlying
disease liability could be assigned to the combined effect of the
markers tagged by the primary genome-wide scan SNPs. The
proportion of the variance explained remained comparable
when different minor allele frequencies and missing genotype
cut-offs were used (Table 4). The signal was not due to
Figure 4. Distribution of the number of identified risk alleles in cases (dark grey)
and controls (light grey) in four different populations. The horizontal axis repre-
sents the number of RRD risk alleles and the vertical axis represents the percent-
age of individuals with a given number of risk alleles in cases and controls.
Figure 3. Forest plots for the SNPs with the strongest association signals in the
combined analysis under a dominant model for the minor allele effect. Population
odds ratio with respect to the minor allele and its 95% CI is represented by a grey
box and horizontal line. The bottom rhombus shows the weighted estimate of the
odds ratio overall studies.











population structure within Scottish cases and controls since it
was not found when the Scottish Colorectal Cancer Study
(SOCCS) control group was artificially split into cases and con-
trols (liability transformed estimate ¼ 0.000001, SE ¼ 0.23).
These GCTA estimates further supported the evidence of a
modest polygenic contribution by common genetic variants in
RRD.
Discussion
This is the first large-scale genome-wide association study ever
performed for RRD, a condition which continues to result in sig-
nificant vision loss. Our results support a polygenic etiology for
this condition and identified several common contributory risk
variants of small effect.
A genome-wide significant signal of association with RRD
was found for the marker rs267738. This is a missense (Glu to
Ala) coding SNP located within the CERS2 gene, in a gene-rich
region. The index SNP has been associated with the expression
level of CERS2 in lymphoblastoid cell lines (exon eQTL for
CERS2) making the regulation of CERS2 expression a strong
functional candidate for the RRD association. CERS2 encodes
the protein CerS2, the most abundantly and ubiquitously
expressed member of the ceramide synthase family (22).
Ceramide-enriched membrane domains amplify diverse
signals and are critically involved in inducing apoptosis (23).
In vitro, ceramides have been shown to mediate apoptosis of
mammalian photoreceptors (24,25) and RPE cell lines (26–
28). In a mouse model of retinitis pigmentosa, inhibition of cer-
amide synthesis slowed disease progression and mutation in the
ceramide kinase-like gene CERKL has been implicated in a re-
cessive form of retinitis pigmentosa in humans (29). Increased
cellular ceramide levels were found in brains of patients with
Batten’s disease (30) and in retinas of patients with Farber’s
disease (31). A feature of both diseases is blindness, although
this is due to retinal degeneration rather than detachment. An as-
sociation signal with RRD in this region is supported by an add-
itional association with SNP rs267733 (P ¼ 5.3 × 1025,
dominant model), located 11 kb from CERS2. A variant in
high LD (rs267734; r2 ¼ 1) with this SNP has previously been
reported to be associated with chronic kidney disease (32).
Within or near each of the five suggestive signals of the com-
bined analysis (2.5 × 1028 , P combined , 1024) was a gene
expressed in the retina, several of which with a documented
role in cell adhesion or migration (Supplementary Material,
Table S3 for genes within suggestive signals). Both TSTA3
and SS18 can modify integrins. Integrins are transmembrane
glycoproteins that bind extracellular matrix components to the
actin cytoskeleton and activate a signaling cascade leading to
cytoskeletal reorganization and cell adhesion. The products of
LDB2 and TIAM1, the later close to- not within- a suggestive
signal (rs8132771), have a role in cytoskeletal reorganization.
TIAM1 encodes a guanine nucleotide exchange factor which
activates a small GTPase of the rho family and modulates
changes in cytoskeleton downstream of membrane receptor
stimulation. These receptors include TrkB (21), encoded by a
gene within another suggestive signal, but also adhesion mole-
cules such as b1 integrins (33,34).
While single marker associations were weak, association with
RRD jointly using the five markers showing the most significant
and consistent association was significant in all four studies
(Scottish discovery, Dutch discovery, UK discovery, London
replication) so that the combined genetic score was a potentially
useful predictor of disease. Using all the genotyped SNP additive
effects from the discovery genome-wide scan jointly, explained
27.4% of the underlying liability to RRD, supporting a moderate
polygenic contribution to disease status (solely due to the
common variants tested in this scan). It has been suggested
that estimating the proportion of variance explained that is due
to all SNPs jointly may be inflated due to the confounding
effect of population structure (35). However, we believe that
this should not be a strong contributory factor in our discovery
cohort as the variance explained in the controls alone, randomly
labeled as cases and controls, was negligible. The ancestry clus-
ters drawn in RRD cases and Scottish controls were overlapping
(Supplementary Material, Fig. S1) and care was taken to remove
systematic differences between RRD cases and controls due to
the different genotyping platforms used (36).
There were a number of limitations to this study. As we fol-
lowed up only a subset of the variants tested in the GWAS dis-
covery step, variants which displayed a non-statistically
significant association at this first stage may have been missed
and yet could have been statistically significant in the larger
sample size of the combined data sets (false negatives due to
lack of power). Furthermore, there was a substantial failure
rate (14%) of the SNPs tested on the customized iSelect Illumina
platform in the follow-up discovery step. We tried to minimize
the effect of this by (re)genotyping the most significant
markers not represented by a proxy SNP; however, true associa-
tions could still have been missed. A further limitation was the
Table 4. Variation in RRD liability explained by the combined GWAS SNPs using different parameters
Threshold Number of SNPs Estimate (SE) Adjusted estimate (SE) Liability transformed estimate (SE)
MAF .0.01
SNP missingness 0.05 257 095 0.3587 (0.1206) 0.4479 (0.1498) 0.275 (0.092)
SNP missingness 0.005 255 704 0.3573 (0.1207) 0.4467 (0.1502) 0.274 (0.092)
MAF .0.05
SNP missingness 0.05 250 817 0.3701 (0.1192) 0.4612 (0.1480) 0.283 (0.091)
SNP missingness 0.005 249 439 0.3687 (0.1194) 0.4601 (0.1484) 0.282 (0.091)
Estimated proportion of the variance in disease liability on the observed scale (estimate), corrected for imperfect LD between SNPs and causal variants (adjusted
estimate) and liability scale (Liability transformed estimate), explained by the consensus panel of SNPs typed on both the Illumina CNV370v3-Quad array (Scottish
RRD cases) and Illumina-300 and 240S HumanHap array (SOCCS controls).











use of controls from studies or repositories that were genotyped
independently using different genotyping platforms. This can
create confounding but true associations should remain consist-
ent across the case–control sets assembled. The controls were
unselected with regard to phenotype therefore a number of
RRD cases might be expected within the control series given
the relatively high prevalence of RRD (0.8%) (15). Since the
number of affected RRDs may have fluctuated across control
series by chance, this may partly explain the heterogeneity
across studies. Furthermore, significant population structure
has been reported in two of the WTCCC control cohorts, 1958
BC and NBS (35), that we used in the discovery and replication
stages, respectively, making it a possible explanation for the
non-replication of the SS18 locus. NBS controls had a 1.2%
higher allele frequency for rs12960119 compared with that in
the HapMap CEU population, and a 0.9% higher allele fre-
quency than that in the other control group used in the discovery
step (1958 Birth Cohort). The fact that only a subset of SNPs had
been typed in the RRD cases used after the stage 1 discovery pre-
vented us from correcting for population structure for the
matched RRD cases and controls in the usual manner (by adjust-
ing for ancestry principal components). Heterogeneity of the
RRD phenotype is an additional concern as other underlying
pathologies usually precede its development, e.g. posterior vitre-
ous detachment, high myopia, lattice degeneration. Larger
studies will be useful to tease apart the possible overlap
between these pathologies. Nevertheless, results from the pub-
lished GWAS on myopia (37,38) and lattice degeneration (39)
did not show any overlap with our most significant associations
and neither the SS18, CERS2 or TIAM1 signal strengths were
affected by removing high myopes from the RRD cases in the
primary analysis (Supplementary Material, Table S6) although
the TSTA3, TrkB and LDB2 associations may be influenced by
myopia. This study was not designed to explore the association
of rare variants with RRD, and given the fraction of underlying
disease liability not accounted for by the common variants
tested in this study, the search for rare variants influencing
RRD is warranted. Finally, given our sample size, we had
limited power to detect and replicate variants of moderate
effect sizes.
Despite these limitations, this first genetic association study of
RRD supports a polygenic component underlying RRD risk, and
identified several common variants of moderate effect contribut-
ing to risk. Additional studies will be required to confirm the in-
dividual variants highlighted in this study and additional
genotyping and increased sample size will be needed to extend
this first exploration of the genetic basis of RRD. Since the patho-
genesis of RRD is not fully understood, the identification of
genes influencing it should make an important contribution to
furthering our understanding of the disorder and in time lead to
better prevention and treatment.
MATERIALS AND METHODS
Study subjects
All participating studies received approval from their local
ethics committees and followed the tenets of the Declaration
of Helsinki.
Retinal detachment cases
All Scottish cases [aged 9–91 (mean ¼ 58.91)] were recruited as
a part of a population-based epidemiology study of RRD recent-
ly carried out in Scotland (18). All incident cases of RRD
reported in any of the six vitreoretinal surgical sites (Ayr,
Glasgow, Edinburgh, Dundee, Aberdeen and Inverness) were
invited to participate in the study. The diagnosis of RRD was
based on a case definition of ‘a full thickness break in the NSR
with a surrounding area of sub-retinal fluid extending greater
than 2 disc diameters’ (12,40–42). All other types of retinal
detachment (exudative, tractional and combined) and re-
detachments cases regardless of the duration of attachment post-
operatively were excluded. Also excluded were participants
with a cataract surgery within 2 years of the detachment diagnos-
tic or with known syndromic features. 6.9% of RRD Scottish
subjects evaluated reported an affected first degree relative
(15). Care was taken that cases from London, UK n ¼ 457 in
the discovery phase (aged 9–92, mean ¼ 57.87); n ¼ 846 in
the replication phase (aged 14–90, mean ¼ 58.58), Cambridge,
UK (n ¼ 173, aged 15–91, mean ¼ 61.38), Nijmegen, the Neth-
erlands (n ¼ 252; aged 12–95, mean ¼ 59.92) and Zagreb,
Croatia (n ¼ 120, aged 20–83, mean ¼ 59.96) were collected
using the same phenotypic inclusion criteria as for the Scottish
sample. Positive family history was recorded in 11.3% of cases
from the London recruitment, 7.1% of Croatian cases and
5.6% of a subset of 180 Dutch cases had an affected first
degree relative (14). Family history information for cases
collected in Cambridge was not available.
Controls
Control groups were readily available population-matched
samples unselected with regard to RRD;, i.e. unselected controls,
a small fraction of which would have RRD. The SOCCS was
used as a control group for the Scottish samples in the first
stage of the discovery. This is a prospective population-based
study in Scotland (1999–2006), with colorectal cancer cases
drawn from all over Scotland, matched to healthy controls by
age, sex and area of residence (19). One thousand and nine
hundred and sixty-seven genotyped individuals were used in
the analysis, aged 18–62 (mean ¼ 50.25). Two sets of control
groups from the WTCCC were also used in subsequent stages:
2592 samples from the 1958 UK birth cohort (1958BC) was
used in stage two of the discovery phase and 2737 individuals
from National Blood Service (aged 17–69, mean ¼ 43.5) in
the replication phase (43). Controls for the Dutch samples
were 320 control individuals from an independent schizophrenia
study that were locally recruited, aged 36–74 (mean ¼ 50.22).
Finally, Croatian participants to a colorectal cases and controls
on-going study were used as a control data set for the Croatian
RRD cases (269 individuals; aged 24–92, mean ¼ 66.1).
Genotyping
Genome-wide scan
Nine hundred and twelve Scottish RRD cases were genotyped
using the Illumina CNV370v3-Quad array, and compared with
population-matched Scottish controls from the SOCCS study
previously genotyped on the Illumina-300 and 240S HumanHap
arrays. Raw data analysis was done using the Illumina genotype
analysis software GenomeStudio with a GenCall scoring cut-off











of 0.15 and solely on the new data itself (not using external refer-
ences). A final clustering was done using only the 892 samples
with an overall genotype call .90%. Further quality control
was performed separately for cases and controls using the
check marker function of the ‘GenABEL’ R package. This
step removed SNPs with a low call rate (,97%), those in a
high Hardy–Weinberg disequilibrium (P , 1 × 1026), as well
as samples identified as duplicates or highly related, mixed
(high heterozygosity), those with a low call rate (,97%), sex
discrepancies, and outliers based on whole-genome identity-
by-state sharing. In total, 870 cases, 1968 controls and 299 789
common SNPs (minor allele frequency .0.02) remained for
analysis. When cases and controls were analyzed jointly, three
additional samples failed quality control. Deeper relatedness
check based on genomic kinship coefficients derived from the
whole-genome identity-by-state sharing identified 15 pairs of
individuals related to the first-cousins or greater level
(p-hat . 0.125 in PLINKv1.07, F . 0.0625 in ‘GenABEL’
(44)). Removing one individual of each related pair left 867
cases and 1953 controls for the final analysis. Plots using princi-
pal components derived from the identity-by-state sharing mea-
sures showed good overlap of ancestry between the Scottish
RRD cases and controls (Supplementary Material, Fig. S1).
Further to these standard QC steps, SNP showing strong
signals in association analysis were examined more closely.
Several were removed due to poor clustering in either cases or
controls or both after visualization of individual clusters (e.g.
presence of four rather than three clusters) and two SNPs,
rs4862110 and rs4957798, were removed due to discordance
between SNP arrays (36). In the final analysis presented here,
299 737 SNPs, genotyped in both cases and controls and
QCed, were used.
Imputation of the genotyped SNPs and the subsequent ana-
lysis was not performed since different genotyping platforms
had been used in cases and controls. It is well documented that
in this scenario imputation is tricky and often leads to type I
error inflation (45).
iSelect platform
Five thousand and nine hundred and eighty-one SNPs were
selected for the second stage of the discovery phase to be
assayed on an iSelect Illumina platform, 4706 selected from
the genome-wide scan results complemented by 1275 from 18
candidate gene regions (listed in Supplementary Material,
Table S1). Tagging SNPs in the candidate gene regions were
selected with Tagger program within the Haploview v4.0 soft-
ware using Centre d’Etude du Polymorphisme Humain from
Utah (CEU) population of the HapMap project (International
HapMap consortium) (46). A threshold for r2 was set at 0.8.
Region of 100 kb upstream and downstream from each gene
was used in the selection process. Eight hundred and thirteen
assays failed design, including 183 of the candidate genes set
(in agreement with failure rate to be expected from the Illumina
Infinium technology). The list of the candidate genes tagging
SNPs that were tested are listed Supplementary Material,
Table S1. Clustering was done using Illumina Genome Studio
software and QC steps (call rate, HWE, sex discrepancies)
were carried as described for the genome scan analysis. Differ-
ence in genotype missingness rates between cases and control
was also tested separately for each new study using the
function—test-missing in PLINKv1.07 (47). No SNPs displayed
significant missingness difference (P , 0.00001) between cases
and controls. To ensure that signals from all of the SNPs with best
ranks in the discovery stage 1 were taken forward in stage 2 (i.e.
among the best 200 of any stage 1 analysis), we investigated the
representativity by proxy (LD r2 . 0.2) of those which failed on
the iSelect chip or QC. Eight SNPs with initial P-values , 1024
or in possible functional gene, FRMD4A and GRM7 were thus
additionally typed using the Taqman technology. The final
number of SNPs carried on for the second stage of the discovery
phase was 4347.
Single SNP typing
Seven SNPs in total were genotyped in the replication phase
using the Taqman technology. The six top associated SNPs,
which displayed consistent direction of effect across all
cohorts and one additional SNP (rs913444) based on the
pathway analysis results. Quality control tests were carried out
as described above. Call rates for SNPs genotyped using
the TaqMan technology were set to 90%. The highest in the
London replication samples was 99.8% (rs8132771) and the
lowest 93.5% (rs955943). Only one marker (rs12960119; call
rate ¼ 93.6%) passed this threshold in the Croatian samples.
Statistical analysis
Association testing
The genome-wide scan was performed using a regression model
with age and sex as covariates and fitting an additive SNP effect,
using the egscore function of the ‘GenABEL’ R package (44)
which takes into account possible population stratification
(48). QQ plots of observed versus expected ordered test statistics
were drawn using the ‘snpMatrix’ R package (49). The grey area
represents the area between the 2.5 and 97.5% probability
bounds of non-departure to the null hypothesis. Five analyses
were performed, all RRD Scottish cases versus all SOCCS Scot-
tish controls, RRD cases with known high myopes (spherical
equivalent refraction ≤-5) removed, SOCCS controls with
cancer cases removed and gender separate analysis (QQ plots
presented in Fig. 2 and Supplementary Material, Fig. S2). The
top ranking associated SNPs from each analysis (P-value ,
1023) were listed to be taken forward in the second stage of
the discovery.
In the second stage of the discovery phase, association
between RRD with SNP genotypes was tested using logistic re-
gression including sex and age as covariates and using the
PLINKv1.07 software (47). Both additive and dominant
models were tested. Association analyses were done for each
cohort separately and the results from all cohorts (with the Scot-
tish discovery step 1 rerun using the PLINKv1.07 implementa-
tion of the logistic regression adjusting for age sex and three
ancestry principal components) combined in an inverse
variance-weighted fixed effect meta-analysis using METAL
(50). We calculated empirical significance levels for the associ-
ation in all of the cohorts by permutation as implemented in
PLINKv1.07, and used these empirical significance levels for
further meta-analysis.
Given the low sample size of our replication cohorts and that
inclusion of covariates in case–control association studies has
been shown to reduce their power in this scenario and with low











disease prevalence, we carried out analysis in the replication
phase without the inclusion of covariates. Results from both dis-
covery stages and the replication phase were also combined in a
meta-analysis (unadjusted for covariates). Forrest plots and het-
erogeneity measures for the most significant SNPs were obtained
using the ‘meta’ R package (51).
P-value threshold
To correct for multiple testing in the initial genome-wide scan,
we used a multiple testing correction method that takes into
account the correlation structure due to linkage disequilibrium
(LD) among the GWAS genotyped SNPs tested, using the
‘SimpleM’ R library (52). Imputation of the missing genotypes
was carried out using k Nearest Neighbors using the ‘scrime’
R package (53). The calculated effective number of independent
SNPs, n ¼ 197 628, was then used to correct for multiple testing
using the standard Bonferroni procedure. Discovery stage sig-
nificance threshold was additionally corrected for the testing
of two genetic models (additive and dominant). The genome-
wide significance threshold was therefore set at 1.27 × 1027
(¼0.05/(197 628 × 2)). Despite following up only a subset of
SNPs used in the first step of the discovery phase into the
second step, the same genome wide significance threshold was
used for the meta-analysis of the two steps to be conservative.
The overall meta-analysis (combining discovery stage and rep-
lication stage data) used the conventional 5 × 1028 significance
threshold, additionally corrected for the use of two genetic
models, hence set at 2.5 × 1028.
Genetic risk score
The multilocus genetic risk score was calculated for each indi-
vidual using five risk variants (the most significant homogeneous
results from the discovery phase). A simple allele count was used
to calculate the genetic risk score using PLINK’s v1.07 ‘score’
option. Individuals with one or more missing genotypes were
not included in the analysis. Odds ratios were calculated relative
to the median number of risk alleles among controls using SPSS
v16.0 (54) (subjects with five or more risk alleles were collapsed
together due to the low number of individuals with high-risk
allele numbers).
Genetic variance of disease liability explained
The GCTA software (55) was used to estimate the proportion of
variation in disease liability captured by the genome-wide SNP
array (discovery stage 1). The combined-SNP effect was fitted as
a random effect in a mixed linear model predicting the trans-
formed trait (probit transformation) and its variance estimated
by restricted maximum likelihood. This estimation is then cor-
rected for the incomplete LD between the tag SNP and the
causal variant and for the ascertainment of cases (compared
with the disease prevalence in general population). Stringent
QC procedures (PLINK v1.07) (47) were implemented on the
genotyped data to avoid experimental biases causing false
case–control differences in relatedness (56). Closely related
individuals were removed to make sure only distant relationships
were taken into account (kinship coefficient threshold was set at
0.05 and implemented within the GCTA software). As a
population structure control, the control cohort (SOCCS
without colorectal cases) was split into two groups and the pro-
cedure repeated in order to check that the detected explained
variance there was negligible.
Pathway analysis
The top six SNPs from the discovery phase were selected in a first
pathway analysis. Identification of all possible genes underlying
the SNPs’ association signals was done using the ‘seed’ output
from the GRAIL (20) (Gene Relationships Among Implicated
Loci) software. All genes located in the interval were considered
in the subsequent pathway analysis using the IPA software (Inge-
nuityw Systems, www.ingenuity.com). IPA uses an internal
manually maintained database to identify networks that maxi-
mize connectivity. When running the analysis, endogenous che-
micals were excluded from the search and only the direct
interactions were taken into account. An extended analysis, in-
cluding all SNPs from the discovery phase with associated
P-value , 1024 (23 SNPs in total, Table 1), was also performed
using the same parameters.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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